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Abstract
Characterization of the immune response to lipopolysaccharide in early pregnant ewes as a model to study
bacterial infection induced embryonic loss.
Jessalyn Marie Hadfield
An immunological balance has to be established during pregnancy that protects the mother yet tolerates the
semi-allogenic fetus. To understand the innate immune response during bacterial infections that may cause early
embryonic loss, a lipopolysaccharide (LPS) treated sheep model was used. Two objectives of this study were to
examine if omega-3 PUFAs in the form of supplementary whole flaxseed could reduce the inflammatory response to
an LPS challenge and to examine if there is a differential immune response to LPS in Suffolk and Dorset ewes. A
total of 3 experiments were conducted; two investigating the effect of supplement and one investigating the effect of
breed. Estrus was synchronized by CIDR insertion for 5 days, followed by 20 mg of PGF2α at CIDR withdrawal.
Early pregnant ewes received via the jugular vein, either phosphate buffered saline (PBS) (3 ml) or LPS (2.5 µg/kg).
Blood was collected via jugular venipuncture at hour: 0, 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 5, 6, 9, 12, and 24. Whole
blood samples were used to determine white blood cell counts (WBCs) before centrifugation to collect white blood
cells for RNA extraction. Rectal temperature and change in behavior/physical (lethargy, coughing, nasal discharge,
absence of eating) appearance were recorded hourly. Real-time PCR was performed for expression of cytokines
(CXCL8, IL6, TNFα, IFNγ, IL-10, and TGFβ), receptors (TLR4, MRC1), enzymes (COX2, SOD2), transcription
factors (NF-κB, PPARγ, and Foxp3) and complement component 3. In all experiments, temperature increased in
response to LPS, peaking at hour 4 before returning to normal by hours 6-9; WBCs dropped by hour 1 before
returning to normal by hours 6-9. In trial 1 of the supplement study (flaxseed versus a control supplement) (Dorset
ewes flaxseed + LPS n=3; flaxseed + PBS n=3; control + LPS n=5; control + PBS n=5), LPS increased haptoglobin
and cortisol levels and affected gene transcription of CXCL8, IFNγ, TLR4, MRC1, SOD2, Foxp3 (by hour), and
C3.There was a diet effect with regard to cortisol and gene expression of CXCL8, and TLR4. There was a diet x
LPS interaction with regard to temperature, WBCs (by hour), haptoglobin, serum amyloid A and gene expression of
CXCL8, IL-6, and TLR4. In trial 2 of the supplement study (Dorset ewes flaxseed + LPS n=11, flaxseed + PBS
n=10, control + LPS n=11, control + PBS n=10), LPS increased haptoglobin and cortisol and affected gene
expression of CXCL8, TLR4, MRC1, SOD2, PPARγ, Foxp3, and C3. There was a diet effect on cortisol and gene
expression of C3.There was a diet x LPS interaction with regard to temperature and cortisol. In the breed effects
study (Dorset + LPS n=11; Dorset + PBS n=10; Suffolk + LPS n=16; Suffolk + PBS n=16), LPS increased cortisol
and affected gene transcription of CXCL8, TLR4, MRC1, SOD2, PPARγ, and C3. There was an effect of breed on
temperature; haptoglobin, serum amyloid A (by hour), and cortisol levels; and gene transcription of IL-6, IFNγ, IL10, TLR4, COX2, SOD2, PPARγ, Foxp3, and C3. There was a breed x LPS interaction on change in temperature
from hour 0, the frequency of behavior/physical changes; haptoglobin, serum amyloid A (by hour), and cortisol; and
gene transcription of IL-6 and C3. Pregnancy status was assessed at 25 dpc with transrectal ultrasound and
progesterone was measured in plasma samples. In trial 1 of the supplement study, flaxseed increased progesterone
but it did not differ between groups in trial 2. There were no differences in progesterone between the breeds tested.
The number of ewes that lambed in each treatment group was not different in any of the experiments. In summary,
acute infections may cause embryonic loss by shifting the environment to be pro-inflammatory. There was no clear
benefit of supplementary ω-3 PUFAs in reducing the inflammatory response. Suffolk ewes had an elevated
inflammatory response to LPS compared to Dorset ewes and may be more susceptible to embryonic loss in response
to infection.
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Chapter 1. Literature Review
The Post-Partum Dairy Cow and Infection
High producing dairy cows are under considerable metabolic stress as they experience a large
increase in nutritional and energy requirements for milk production (peaks 4-8 weeks post-partum) after
calving. The increased energy requirements are only partially offset by increased feed consumption (due
to limitations in intake and appetite), and the remainder is met by mobilization of body reserves (Bauman
and Currie, 1980; Evans and Walsh, 2012). This often leads to a state of severe negative energy balance
(NEB) characterized by loss in body condition, low blood glucose levels, elevated non-esterified fatty
acid (NEFA) levels, and elevated ketone bodies such as β-hydroxybutyrate (BHB). These changes
indicate increased lipid mobilization and fatty acid oxidation. This metabolic environment has negative
effects on immune cells with the resulting immunosuppressive environment making cows more
susceptible to mammary (mastitis) and uterine (endometritis) infections with less ability to clear the
infection (Mallard et al., 1998; Hammon et al., 2006; Wathes et al., 2009; Morris, 2014). The immune
system uses energy produced from oxidative phosphorylation, therefore, being in a state of ketosis
impairs immune system function. For example, in response to lipopolysaccharide (LPS) the mitochondrial
activity of macrophages exposed to BHB in vitro was decreased and they produced less reactive oxygen
species (ROS), which are used to eliminate bacteria. However, with the addition of eicosapentaenoic acid
(EPA), ROS production by macrophages in response to LPS increased, while docosahexaenoic acid
(DHA) had no effect (Morris, 2014).
In selecting dairy cows for high milk production, a global decline in fertility and an increase in
the incidence of infectious diseases has occurred (Uribe et al., 1995; Thatcher et al., 2010; Walsh et al.,
2011). Cows undergo metabolic adaptations to NEB during the first weeks of lactation (Suriyasathaporn
et al., 2000), which will impair immune system function making them prone to infectious diseases and,
subsequently, impacting fertility (Hogan et al., 1989; Goff, 2006; Evans and Walsh, 2012). A number of
factors contribute to poor fertility in high-producing dairy cows including short duration and low intensity
of oestrous due to low circulating estrogen (E2) concentrations and increased metabolic clearance rate of
steroids related to liver blood flow resulting in lowered peripheral concentrations of progesterone (P4) and
E2. Lowered concentrations of P4 may be unable to prevent prostaglandin F2α (PGF2) release and
luteolysis and may affect the uterine secretion of proteins and growth factors needed for early embryo
development (Diskin and Morris, 2008). The most frequent factor contributing to low fertility, however,
is high embryonic mortality. Embryonic loss can be due to poor oocyte quality resulting from the adverse
1

metabolic environment or due to poor uterine environment influenced by uterine infection and low
circulating P4 concentrations (Evans and Walsh, 2012).
For optimum economic return, farmers need to rebreed cows within 2-3 months of calving,
however, poor fertility is a major problem in the dairy industry with metabolic stress and reproductive
issues being linked (Roche, 2006). To achieve a 365 day calving interval with a 282 day gestation,
breeding usually commences 60 days post-partum and the cow needs to conceive by 83 days postpartum.
For the cow to become and stay pregnant any uterine infections need to be resolved; she needs to recover
from post-partum NEB; and she needs to resume normal estrous cycles (Walsh et al., 2011). Cows that
suffer from metabolic disorders (acidosis, fatty liver disease, displaced abomasum, hypocalcaemia,
hypomagnesaemia, ketosis) in the peri-parturient period are more likely to have increased incidence of
mastitis, lameness, and endometritis (Roche, 2006) and reduced pregnancy success.
After parturition, the uterus undergoes remodeling to get back to the pre-pregnant state including
a reduction in size, removal of cellular debris, and restoration of normal architecture (Gier and Marion,
1968; Leslie, 1983; Sheldon and Dobson, 2004). It is normal to have uterine contamination with bacteria
at parturition or during the first few days postpartum with 80-100% of cows having bacterial
contamination in the first two weeks after calving (Foldi et al., 2006; Lewis, 1997; Sheldon et al., 2006).
The most prevalent bacteria in the post-partum uterus are Escherichia coli and Arcanobacterium
pyogenes, but other common bacteria include Fusobacterium necrophorum, Prevotella melaninogenicus,
and Proteus species, which are associated with increased endometrial inflammation and purulent vaginal
mucus (Bondurant, 1999; Sheldon et al., 2009a). Initially, mucosal defense and the innate immune system
are responsible for dealing with the pathogens and eliminating the contamination, which is usually cleared
within ~3 weeks of calving with complete involution of the uterus and cervix within 4-6 weeks. However,
lactating dairy cows are predisposed to reduced immune competence, and the immune system of cows
that cannot clear the bacteria can become overwhelmed resulting in uterine disease (metritis) (King et al.,
2003; Sheldon et al., 2006; LeBlanc, 2008; Walsh et al., 2011). Metritis can develop within 3 weeks postpartum and in about 20% of cows the pathogenic bacteria will persist in the uterus for longer than 3
weeks, the consequence being endometritis (Sheldon et al., 2009a). Endometritis is caused by chronic
bacterial infection in the uterus causing uterine inflammation without systemic illness. The condition is
characterized by disruption of the endometrial epithelium, infiltration of inflammatory cells and
lymphocytes, stromal edema, and vascular congestion (Bondurant, 1999). Approximately 15-20% of
cows have clinical endometritis at 4-6 weeks postpartum, and 30-35% will have subclinical endometritis
between 4 and 9 weeks postpartum (LeBlanc, 2008). Events associated with parturition can influence
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subsequent infection: cows having twins, dystocia, a stillbirth, or retained fetal membranes have increased
the risk of infection (LeBlanc, 2008).
Uterine infections are characterized by extensive leukocyte infiltration of the endometrium and
chronic inflammation (Foldi et al., 2006; Sheldon et al., 2006) resulting in longer intervals to conception
which increases the likelihood of culling (Lewis, 1997; Fourichon et al., 2000; Gilbert et al., 2005; Wise,
2016). Indeed, being diagnosed with clinical mastitis between artificial insemination (AI) and pregnancy
confirmation (45 days post-AI; 14 days after ultrasound diagnosis) increased the odds of pregnancy loss
(odds ratio 2.80 clinical mastitis versus no symptoms of disease) in lactating Holstein cows (Chebel et al.,
2004). Several studies have found that the type of bacteria (gram negative or positive) did not affect the
reproductive parameters evaluated but reported differences when comparing cows without clinical
mastitis, cows that had mastitis before first AI, and cows that got mastitis after pregnancy diagnosis. The
group of cows that were diagnosed between first AI and pregnancy confirmation had the lowest percent of
conception at first AI, the lowest pregnancy rate at 320 DIM, the highest average number of services per
conception, and the highest number of days open, showing that infection during early pregnancy is
detrimental to reproductive performance (Barker et al., 1998; Santos et al., 2004b). Progesterone reduces
cervical mucus production, prevents uterine contractility (Rodriguez-Martinez et al., 1987) and
counteracts estrogen’s effects on immune protective responses of the reproductive tract such as antibody
secretion and increased activity of antigen presenting cells in the uterus (Wira et al., 1995; Bondurant,
1999). Therefore, the presence of a CL and P4 production makes the uterus susceptible to infection and
hinders the ability of the immune system to clear pathogens, and the presence of bacteria can result in a
clinical infection after ovulation with the production of P4.

Embryonic Loss
In the cow, embryo loss between fertilization and day 24 of gestation is considered early embryo
mortality, loss between day 25 and 45 (embryonic differentiation is completed) is considered late embryo
mortality, and losses between day 46 and parturition are considered fetal mortality (Committee on Bovine
Reproductive Nomenclature, 1972). The peri-implantation period is a critical time in determining if
pregnancy will be successful. As milk production has increased over the last 50 years in dairy cattle,
fertility has decreased (Diskin et al., 2006; Sartori et al., 2010; Walsh et al., 2011). In lactating cows, first
service conception rates are ~32%, whereas in heifers the rate is over 50%. With a fertilization rate over
80%, the low conception rate does not seem to be due to problems with fertilization (Sartori et al., 2010).
The low conception rate is instead related to high rates of embryonic loss with 70-80% of embryos being
lost during the first 3 weeks after insemination (Inskeep and Dailey, 2005; Diskin et al., 2006; Diskin and
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Morris, 2008; Hansen, 2011b). This has a huge impact on milk production efficiency and profitability
(Thatcher et al., 2011; Evans and Walsh, 2012).
During the first 7 days after insemination the embryo develops into a blastocyst dependent on its
inherent ability to develop, which is associated with oocyte quality, sperm quality, and timing of
fertilization (Evans and Walsh, 2012). The uterine environment also impacts early embryonic
development, and persistent issues in the post-partum uterus can make the environment suboptimal
(Evans and Walsh, 2012). In support of this idea, Rizos et al (2010) conducted a zygote transfer (to the
oviducts at day 2) experiment that showed that in post-partum lactating Holstein-Friesian cows were less
able to support very early embryo development compared to Holstein-Friesian heifers. They suggested
that the reproductive tract of the lactating dairy cow is a less suitable environment for early embryo
development compared to the tract of a heifer. It is estimated that by day 7 of gestation only 45-55% of
inseminated lactating cows are pregnant whereas ~75% of inseminated heifers are pregnant (Sartori et al.,
2010; Walsh et al., 2011).
The presence of pathogenic bacteria can compromise the uterine environment causing embryonic
death and abortion (Sheldon et al., 2004; 2006). The majority of cows have uterine bacterial
contamination post-partum, but clinical infection does not always result. (Sheldon et al., 2006). Even
without clinical infection, inflammation induced by the bacteria can perturb embryo survival (Hansen et
al., 2004). The majority of microbes enter the uterus by ascending through the reproductive tract after
being introduced following parturition, abortion, natural service, or AI. Endometrial cells have pattern
recognition receptors (PRRs) that recognize pathogen associated molecular patterns (PAMPs) such as
unmethylated DNA, lipids, and LPS. Following interaction of a PRR with its PAMP, antimicrobial
peptides, pro-inflammatory cytokines, and chemokines are released resulting in activation and
mobilization of immune cells and an inflammatory environment (Akira et al., 2006; Herath et al., 2006;
Sheldon et al., 2009a; Cronin et al., 2012).
Demand for milk and milk production per dairy cow are expected to continue to increase. In order
to have dairy cows capable of high milk production and efficient reproduction, it is necessary to optimize
health, nutrition, and breeding management strategies (Walsh et al., 2011). Strategies that minimize
embryonic loss will improve the reproductive efficiency of ruminants.

Maternal Recognition of Pregnancy
To establish a pregnancy after conception, three events must occur: pregnancy recognition
signaling, implantation, and placentation (Guillomot et al., 1995; Spencer et al 2004). In ruminants,
endometrial function in early pregnancy is regulated mostly by P4 produced by the CL and by conceptus
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secreted factors like IFN-τ produced by the mononuclear trophectoderm cells (Spencer et al., 2004b;
Spencer et al., 2008; Bazer et al., 2010). Progesterone from the CL acts on the uterus to stimulate
preimplantation blastocyst growth and conceptus elongation in ruminants (Spencer et al., 2004b), which
are critical for production of IFN-τ and prostaglandins (PGs) by the trophectoderm (Spencer et al., 2007).
Progesterone production is required for the duration of pregnancy; in some species the placenta will
eventually take over production while in others, the CL is solely responsible. To maintain CL function
past its normal lifespan during a luteal phase the conceptus must produce a hormone that acts on the
uterus and/or CL (Bazer et al., 2013).
In cyclic sheep, the uterus produces luteolytic pulses of PGF2α on days 15-16 of the cycle to
regress the CL. In ruminants, pregnancy is recognized by the dam through production of IFN-τ by the
conceptus (Helmer et al., 1989; Bazer, 2013). The IFN-τ gene arose in ruminants through duplication of
the IFN-ω gene (Roberts et al., 1998) and through evolution the promotor region lost its viral control
elements while gaining two regions that make its expression trophectoderm-specific (Hansen et al., 1991;
Ezashi et al., 1998; Roberts et al., 2003). In one of these acquired regions is an enhancer element for the
transcription factors Ets-2 and AP-1. The transient expression of IFN-τ is regulated by Ets-2, which is
activated in response to growth factors and cytokines released by the maternal endometrium perhaps in
response to P4 (Ezashi et al., 1998; Roberts et al., 2003). Secretion of IFN-τ begins at the blastocyst stage,
peaks during elongation, and is terminated upon trophectoderm attachment to the uterine endometrium in
ewes (maximum production on days 14-16; production stops on days 21-25) (Guillomot et al., 1990;
Bazer, 1992; Martal et al., 1998).
In sheep, pregnancy recognition occurs on day 13 post-mating, and communication between the
endometrium and conceptus continues during implantation and synepitheliochorial placentation, which
begins on days 15-16 and is completed between days 50-60 (Wimsatt, 1950; Guillomot, 1995). Binding to
receptors in the endometrium (Han et al., 1997), IFN-τ acts to suppress transcription of the estrogen
receptor alpha gene (ESRI) stopping E2-induced expression of the oxytocin receptor (OXTR) in the uterine
luminal and superficial glandular epithelia. This prevents the oxytocin dependent release of luteolytic
pulses of PGF2α and regression of the CL, allowing for continued P4 production by the CL (Helmer et al.,
1989; Bazer et al., 2008; Bazer, 2013). Progesterone is the unequivocal hormone of pregnancy as it
influences uterine functions needed for early embryonic development, implantation, placentation, and
placental and fetal development (Spencer and Bazer, 1996; Martal et al., 1998; Spencer and Bazer, 2004;
Roberts et al., 2008; Bazer et al., 2010). During implantation the uterus grows and remodels, placentomes
develop in the caruncular area of the endometrium, angiogenesis and vascular remodeling occur, and
intercaruncular endometrial glands increase in size (Wimsatt, 1950). Endometrial epithelial gene
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expression and function for conceptus elongation in early pregnancy are regulated not only by ovarian,
CL-produced P4 but also by cortisol, PGs, and IFN-τ (Spencer et al., 2004b; Spencer et al., 2008; Bazer et
al., 2010; Dorniak et al., 2011; Dorniak et al., 2012a). Endometrial glands are responsible for the
production of histotroph consisting of growth factors, cytokines, lymphokines, enzymes, hormones, and
transport proteins, which are needed for conceptus survival and development, fetal and placental growth,
and the onset of pregnancy recognition signals (Roberts and Bazer, 1988; Gray et al., 2001a, b).

Implantation
The success of implantation affects ongoing pregnancy, and any complications at this stage will
contribute to pregnancy complications and embryonic loss (Song et al., 2002; Dey, 2005). Blastocyst
implantation in the uterus is required for delivery of nutrients and gas exchange between the developing
offspring and dam. Implantation involves shedding the zona pellucida (blastocyst hatching), blastocyst
elongation, orientation of the blastocyst, apposition (trophectoderm becomes closely associated with the
endometrial luminal epithelium (LE) without adhesion), attachment and adhesion between the
trophectoderm and the uterine LE forming the placenta (Spencer et al 2004; Guillomot et al., 1995;
Degrelle et al., 2005; Bazer et al., 2009a).
A sheep embryo enters the uterus at the morula stage on day 4 post-mating before developing into
a blastocyst (inner cell mass and blastocoele surrounded by a monolayer of trophectoderm) by day 6 and
hatching from the zona pellucida on day 8 to 9. The blastocyst then develops into an ovoid or tubular
form by days 11 to 12 when it is then called a conceptus (embryo-fetus plus associated extraembryonic
membranes) (Guillomot et al., 1995; Spencer et al 2004). The conceptus then elongates into a filamentous
form on days 12 to 16. During conceptus elongation the trophectoderm increases exponentially in length
and weight (Wales and Cuneo, 1989), and this process requires substances secreted from the endometrial
LE and glandular epithelia (GE) (Gray et al., 2001a; 2002). Blastocyst elongation is critical for
developmentally regulated production of IFN-τ (Guillomot et al., 1990; Gray et al., 2002) The period of
elongation also includes the start of extraembryonic membrane differentiation, gastrulation of the embryo,
formation of the yolk sac and allantois, and cross-talk with the endometrium (Guillomot, 1995; Diskin
and Morris, 2008). This is a critical time for successful pregnancy with over 70% of pregnancy failures
associated with embryonic death during the early and late pre-implantation period (before d16 following
breeding) (Diskin and Morris, 2008).
Ruminants have a bicornuate uterus with the endometrium having caruncles and intercaruncular
areas. The caruncles are aglandular structures composed of LE and compact stroma that are distributed
over the endometrial surface; they connect to the cotyledons (fetal part of placenta) to form placentomes.
This type of superficial implantation is called synepitheliochorial placentation, and the placentomes have
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the role of delivery of nutrients and fetal-maternal gas exchange. The intercaruncular areas contain
endometrial glands that produce histotroph, a mixture of nutrients, growth factors, enzymes, hormones
and cytokines particularly important for the embryo before it has attached to the uterus (Spencer and
Bazer, 2004; Spencer et al., 2004a).
In sheep, adhesion to the endometrial LE occurs on day 16 between the mononuclear trophoblast
cells and the endometrial LE. Syncytia form from the fusion of trophoblast binucleate cells with the LE.
The binucleate cells begin to differentiate in the trophoblast between days 14 and 16 before migrating and
fusing with the endometrial LE to form syncytia that eventually cover the caruncular surface and help in
formation of the placentome. Implantation involves loss of expression of the glycoprotein mucin1
(MUC1) (an antiadhesive protein) and expression of adhesion molecules by the trophoblast and
endometrial LE (Spencer et al., 2004a), allowing for interdigitation of uterine microvilli with cytoplasmic
projections on the trophoblast. Even in the intercaruncular regions, villi on the trophoblast interact with
the endometrial LE; however, these projections disappear by day 20, and attachment is completed around
day 22 (Boshier, 1969; Guillomot et al., 1981).
For the embryo to attach and implant in the uterus, the cell surface of the uterine epithelial cells
undergo biochemical changes including changes to glycan structures. Through the secretion of leukemia
inhibitory factor (LIF) and IL-1β, macrophages (MΦ) induce the expression of fucosyl transferases that
increases the surface expression of fucosylated structures on uterine epithelial cells that are involved in
trophoblast attachment (Jasper et al., 2011; Nakamura et al., 2012). Therefore, changes in the quantity or
activity of uterine MΦ could impair implantation.
Implantation will occur only between an implantation-competent blastocyst and a receptive uterus
which occurs for a limited period of time known as the “window of implantation.” The uterus will be
unreceptive to a blastocyst before this time and become hostile to blastocyst survival after this receptive
period (Yoshinaga, 1988; Dey, 2005). Therefore, anything that interferes with implantation during this
“window of implantation” will cause embryonic loss. Synchronization between acquisition of
implantation competency by the blastocyst and a receptive uterine endometrium is controlled by maternal
hormones (E2 and P4) along with locally produced signaling molecules that include cytokines, growth
factors, lipid mediators, and transcription factors (Dey et al., 2004).
Lipid signaling has been shown to be critical during implantation. Knock out of cyclooxygenase2 (COX-2) in mice has resulted in implantation failure (Lim et al., 1997; Wang et al., 2004). In addition,
cytoplasmic phospholipase A2α (cPLA2α) null mice had a brief delay of the normal “window” of
implantation leading to embryonic loss, retarded feto-placental development, and, post implantation
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retarded development. Exogenous PGE2 and PGI2 , however, restores the normal timing of implantation
(Song et al., 2002). PLA2α is an enzyme that releases FAs from the second carbon group of glycerol; after
catalytically hydrolyzing the bond, arachidonic acid (AA) is released which can then be turned into PGH2
by cyclooxygenases (the rate limiting enzyme in PG synthesis) followed by conversion into eicosanoids
by specific enzymes (Smith et al., 2000). While COX1 is constitutively expressed, COX2 expression is
induced by cytokines, growth factors, and mitogens and is responsible for increased PG production
involved in inflammation, mitogenesis, angiogenesis, and differentiation (Smith et al., 2000).
Implantation is an inflammatory process, therefore, a role for COX2 and PGs during implantation is
logical.
Histotroph is derived mostly from transport and/or synthesis and secretion of substances by the
endometrial LE and GE (Gray et al., 2001b). The substances (proteins, amino acids, saccharides, lipids,
cytokines and growth factors) in histotroph control the elongation of the conceptus through effects on
proliferation and migration of trophectoderm, and play a role in the attachment and adhesion to the
endometrial LE (Bazer et al., 2010; Carter, 2012). In ewes, endometrial gland hyperplasia occurs between
days 15 and 50 and is largely dependent on ovine placental lactogen secreted by binucleated trophoblast
cells starting on day 16 (Wooding et al., 1992; Noel et al., 2003). Hypertrophic growth of the uterine
glands then occurs after day 60 under the influence of ovine growth hormone of trophoblastic origin
resulting is maximal histotroph production (Stewart et al., 2000; Noel et al., 2003). Histotroph is secreted
in response to steroids, IFNτ, ovine prolactin, and placentally expressed ovine growth hormone (Noel et
al., 2003; Carter, 2012).
One component of histotroph, lipids, is an important component of cells and have both bioactive
and structural properties (Ribeiro et al., 2016c). When Ribeiro et al (2016a) categorized recovered dairy
cow conceptuses as ovoid (1 to 4mm), tubular (5 to 19mm), or filamentous (20 to 60mm) before
comparing their transcriptomes, they determined that one of the major categories of differently expressed
genes was lipid metabolism. As the conceptus transitioned from ovoid to tubular to filamentous, genes
involved in lipid uptake, lipid droplet formation, activation and oxidation of FAs, biogenesis of
peroxisomes, desaturation and elongation of FAs, mobilization of membrane phospholipids, biosynthesis
of phospholipids and prostaglandins, and transport of prostaglandins/lipid metabolites became
upregulated (Ribeiro et al., 2016a). The process of elongation involves rapid remodeling and proliferation
of cells that need lipids for their membranes (cell and organelle). This lipid is supplied by the uptake of
lipids from the uterine lumen and from de novo synthesis; therefore, genes related to the uptake of lipids
from extracellular space (transporters) and genes involved in the synthesis and modification (elongases,
desaturases) of FAs increase at the start of elongation (Ribeiro et al., 2016a). Lipid accumulates mainly in
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the LE and superficial GE and is mainly under the control of P4 (Brinsfield and Hawk, 1973) and is likely
an important FA source for the conceptus. A reduced number of lipid droplets in endometrial epithelial
cells of pregnant ewes indicates use of the lipids by the conceptus and uterus (Boshier et al., 1987). Not
only are lipids used in the production of cells, but they are also an energy source, they serve as signaling
molecules and as precursors of lipid derivatives like eicosanoids (Fernandis and Wenk, 2007; Ribeiro et
al., 2016a).
Ribeiro et al (2016c) specifically pointed out that peroxisome proliferator-activated receptor
gamma (PPARγ) is likely to play an important role in elongation because they saw expression of PPARγ
increase at the start of elongation; functional analysis selected PPARγ as an upstream regulator of
transcriptome changes; and PPARγ expression was correlated with gene expression of other genes
involved in conceptus development and lipid metabolism (Ribeiro et al., 2016c). PPARγ is a receptor that
functions as a transcription factor in several biological processes (Berger and Moller, 2002; Wieser et al.,
2008) and functions in cell differentiation, uptake and metabolism of FAs, and vascularization in the
placenta (Schaiff et al 2007; Fournier et al., 2007; Fournier et al 2011; Shalom-Barak et al., 2012). Brooks
et al. (2015) conducted a loss-of-function study in sheep in which PPARγ was shown to regulate
elongation. Without PPARγ, conceptuses were growth-retarded and there was reduced secretion of IFN-τ
and PGs, which affected endometrial physiology.
Cortisol, P4, IFN-τ, and PGs each have individual actions in addition to interactive and
coordinated actions to regulate expression of genes in the endometrial epithelium related to elongation
and implantation. Altering expression of these genes results in secretion or transport of substances from
the endometrium into the uterine lumen that control conceptus elongation by affecting trophectoderm
proliferation, migration, attachment, and adhesion (Dorniak et al., 2013a). During days 10 to 12 after the
onset of estrus or mating in the ewe, P4 induces the expression of genes in the endometrial LE and
superficial GE that encode intracellular enzymes (prostaglandin synthase 2: PTGS2, 11-betahydroxysteroid dehydrogenase type I: HSD11B1), secreted attachment and migration factors, secreted
proteases, secreted proteases inhibitors, a secreted cell proliferation factor, glucose transporters, and a
cationic amino acid transporter. In the endometrial GE, P4 induces expression of genes that encode for a
secreted cell proliferation factor, a secreted adhesion protein, a glucose transporter, a regulator of
calcium/phosphate homeostasis, and an immunomodulatory factor (Spencer et al., 2007; Bazer et al.,
2010). The result of these gene changes induced by P4 is an increase in specific amino acids, glucose,
cytokines, and growth factors in histotroph that support blastocyst growth into an ovoid conceptus and
elongation to form a filamentous conceptus (Bazer et a, 2010).
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IFN-τ inhibits the expression of ESR and OXTR in uterine LE and superficial GE, but it does not
inhibit the expression of PTGS2 (Kim et al., 2003), the rate limiting enzyme in synthesis of PGs.
Therefore, PGs can still be synthesized, just not in response to oxytocin. Cells of the bovine uterus are
stimulated to produce PGE2 by IFN-τ, and other type I IFNs stimulate production of phospholipase A2
(PLA2), providing the substrate for PTGS2, and synthesis of PGE2 and PGF in various cell types (Arosh
et al., 2004; Bazer et al., 2013; Dorniak et al., 2013). In the ewe, PTGS2 expression is induced by ovarian
P4 and appears between day 10 and 12 post-estrus and mating in the endometrial LE and sGE (Charpigny
et al., 1997a; Simmons et al., 2010). Epithelial and stromal cells of the uterus secrete PGs that affect
expression of genes critical for elongation and implantation of the ovine conceptus and the elongating
conceptus synthesizes and secretes additional PGs that have paracrine effects on uterine cells, and
autocrine effects on the conceptus. Receptors for PGE2 (PTGER2 and PTGER4) and PGF2α (PTGFR) are
expressed by the conceptus trophectoderm and the endometrium epithelia in the ovine uterus during early
pregnancy (Dorniak et al., 2011). In addition, the PGI2 receptor (PGIR) and nuclear PG receptors
(peroxisome proliferating and activating receptors (PPARs)) are expressed by the endometrial epithelia
and by sheep conceptus during early pregnancy (Cammas et al., 2006).
Ovine conceptuses secrete 6-keto-PGF1α (stable metabolite of PGI2), PGF, and PGE2 during the
peri-implantation period that mediate, in part, the effects of IFN-τ and P4 to regulate endometrial
functions for growth and development of the conceptus during this time (Charpigny et al., 1997b; Dorniak
et al., 2011; Dorniak et al., 2012b; Bazer et al., 2013; Dorniak et al., 2013). Dorniak et al (2011) reported
that giving a PTGS inhibitor from days 8-14 post-mating resulted in embryos that had not elongated by
day 14 when they were flushed. When the PTGS inhibitor was given from days 10-14 post-estrus in
cyclic ewes a decrease in the expression of P4-induced endometrial genes such as insulin growth factor
binding protein-1 (IGFBP1) (mediate trophectoderm migration and attachment) and HSD11B1 (Simmons
et al., 2009; 2010) was reported. When IFN-τ was infused, instead of the PTGS inhibitor, PTGS activity
and PG levels in the uterine lumen increased. However, when IFN-τ was co-infused with the PTGS
inhibitor, IFN-τ stimulation of many genes was reduced (Dorniak et al., 2011). When IFN-τ or PGs
(PGE2, PGI2) were infused into the uteri from days 10-14 post-estrus, genes of glucose transporters
increased and expression of genes thought to be involved in cell proliferation and migration,
trophectoderm migration and attachment, and angiogenesis increased (Farmer et al., 2008; Simmons et
al., 2009; Satterfield et al., 2009; Dorniak et al., 2012a). Apparently, PTGS derived prostaglandins are
involved in mediating endometrial functions and changes in gene expression in response to IFN-τ and P4,
which are critical for conceptus elongation (Dorniak et al., 2011; 2012a; 2012b; 2013b).
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The enzyme HSD11B1, which is involved in regulation of intracellular levels of bioactive
glucocorticoids (GCs), has been suggested to be involved in elongation of the conceptus and to be
regulated by P4 (Satterfield et al., 2009; Simmons et al., 2010). In the endometrium, P4 induces, and IFN-τ
stimulates expression of HSD11B1 and HSD11B1 activity to increase regeneration of cortisol from
cortisone during early pregnancy in sheep (Satterfield et al., 2009; Simmons et al., 2010). Effects of P4
and IFN-τ are partly mediated by PGs based on a study reporting reduced HSD11B1 activity and cortisol
levels in the uterine lumen of ewes given an intrauterine infusion of a PTGS inhibitor from days 8-14 of
pregnancy, whereas, cyclic ewes receiving intrauterine infusions of IFN-τ or PGs had increased
endometrial HSD11B1 expression and activity and increased uterine lumen cortisol levels (Dorniak et al.,
2012b). Both the ovine uterine endometrium and the conceptus use the enzyme to turn cortisone into
active cortisol, which then regulates the expression of genes involved in lipid metabolism and triglyceride
homeostasis.
Cortisol acts through the GC receptor located in all endometrial cells of the ovine uterus during
the estrous cycle and pregnancy and in trophectoderm (Dorniak et al., 2011; Satterfield et al., 2009;
Simmons et al., 2010). When cortisol or IFN-τ were administered to cyclic ewes from 10-14 days post
estrus by intrauterine infusion; HSD11B1 expression and activity was stimulated, there was increased
PTGS2 activity and increased PG in the uterine lumen suggesting cortisol increases total PGs in the
uterine lumen via effects on PTGS and HSD11B1 in the endometrium. In addition, intrauterine infusion
of cortisol or INF-τ resulted in up-regulation of genes in the endometrium related to conceptus elongation
(Dorniak et al., 2013b). Intrauterine infusion of a HSD11B1 inhibitor into cyclic ewes resulted in reduced
expression of several P4 induced epithelial genes implicated in governing conceptus elongation and,
indeed, the conceptuses failed to elongate when infused into pregnant ewes from day 10-14 post mating.
However, IFN-τ infusion along with the enzyme inhibitor rescued elongation suggesting that HSD11B1
derived cortisol is involved in mediating ovarian P4 actions on endometrial function (Dorniak et al.,
2013b). This set of studies suggest that HSD11B1 derived cortisol helps mediate actions of ovarian P4 and
works with IFN-τ and PGs to regulate endometrial functions necessary for conceptus elongation and
implantation (Simmons et al., 2010; Dorniak et al., 2012b; Dorniak et al., 2013b).
During the pre-implantation period, endometrial gene expression has been found to be
significantly different compared to the equivalent day of the estrous cycle (Grey et al., 2006). Genes with
differential expression included ones involved in the innate immune response and variations in
endometrial gene expression coincided with changes in immune cell populations (Sandra et al., 2015). It
is important that the uterine immune system is modulated to prevent the embryo from being rejected (Lea
and Sandra, 2007; Hansen, 2010; Walker et al., 2010). The uterus is not an immunologically inert site; the
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immune system needs to be present for prevention of reproductive tract infections caused by the
introduction of microorganisms during mating or parturition (Hansen, 2010). Progesterone has a major
influence on the immune system preventing rejection of allografts and clearance of infections (Hansen,
2010).

Immune System at the Feto-Maternal Interface
The maternal-fetal interface once was thought to be immunologically inert but it is now
understood that the uterus contains numerous types of immune cells playing important roles in
establishing an adequate microenvironment during pregnancy, tolerance to “non-infectious self”
(placenta, fetus), placental development, spiral artery remodeling, and elimination of ‘infectious non-self’
(pathogens) (Trowsdale and Betz, 2006; Koga et al., 2014). Subfertility can be due to disturbances in preimplantation embryonic growth and/or endometrial receptivity; both processes are heavily influenced by
the maternal immune system. Development and acquisition of implantation competence by the blastocyst
are influenced by the cytokine environment within the female reproductive tract while fetal tolerance and
endometrium receptivity are affected by the phenotypes of the immune cell populations present at the
implantation site (Robertson and Moldenhauer, 2014).
The maternal immune system recognizes fetal antigens at the decidual-trophoblast interface and
peripherally due to shedding of fetal antigens into maternal circulation (Lissauer et al., 2009) leading to
maternal immunological awareness of the developing fetus (Tafuri et al., 1995). In order to have a
successful, uncomplicated pregnancy, the maternal immune system has to tolerate the semi-allogeneic
fetus (Erlebacher, 2013; Sharma, 2014). Several mechanisms are involved in generating maternal-fetal
tolerance including a shift towards T helper cytokine production of a “tolerogenic profile” (Saito et al.,
2010), inhibition of complement activation (Mellor et al., 2001; Girardi et al., 2006b), chemokine gene
silencing that prevents accumulation of activated T cells (Nancy et al., 2012) expansion of uterine
immunomodulatory natural killer (uNK) cells (Tabiasco et al., 2006) and generation of regulatory T cells
(Tregs) specific to paternal antigens (Rowe et al., 2012a). Typical immunoregulatory molecules in this
environment include indoleamine 2,3-dioxygenase (IDO), tryptophan 2,3-dioxygenase (TDO),
programmed death ligand 1 (PDL1-an inhibitory T cell costimulatory molecule), galectins, interleukin-10
(IL-10), and transforming growth factor-beta (TGF-β) (Curti et al., 2009; Blidner and Rabinovich, 2013;
Santner-Nanan et al., 2013; Zhang et al., 2013).
IDO and TDO catabolize tryptophan, and the subsequent decrease can suppress T cell activity
defending against maternal rejection (Munn et al., 1998; Suzuki et al., 2001). Tryptophan is an essential
amino acid that is needed for cell proliferation, and T cells are sensitive to changes in local concentrations
of the amino acid (Trowsdale and Betz, 2006). IDO is produced by some tissue MΦ and antigen
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presenting cells (APCs) in response to interferon gamma (IFNγ), by fetal syncytiotrophoblasts, and by the
decidua during pregnancy. It can control T cell-dependent inflammatory responses to fetal alloantigens by
regulating T cell proliferation and activity (Munn et al., 1998; Caucheteux et al., 2003; Trowsdale and
Betz, 2006). Galectins (Gal) are a family of β-galactoside-binding lectins expressed by several types of
immune cells and by tissue resident stromal cells that have functions related to the activation (or
prevention of), proliferation, survival., and migration of effector T cells along with influencing what
cytokines are produced by T cells. Specifically, gal-1 is important for fetal survival as it functions in the
generation of tolerogenic dendritic cells (tDCs) and Tregs, can induce the death of effector T cells,
stimulates the production of anti- verses pro- inflammatory cytokines (PICs) by T helper (Th) cells, and
controls transendothelial T cell migration (Chung et al., 2000; Stillman et al., 2006; Blois et al., 2007b;
Rabinovich et al., 2007; Toscano et al., 2007; Motran et al., 2008; Norling et al., 2008; Ilarregui et al.,
2009; Blidner and Rabinovich, 2013).
The Th1/Th2 paradigm was developed to describe a predominantly Th2 cytokine profile during
pregnancy to prevent fetal rejection (Wegmann et al., 1993). Indeed, Th2 cytokines have been shown to
be necessary to prevent fetal resorption, whereas increased levels of Th1 cytokines cause fetal loss
(Chaouat et al., 1995). However, with continued research this paradigm seems to be an oversimplification of what is occurring at the feto-maternal interface. Instead, there seems to be sequential
windows of a series of cytokine interactions that govern immune regulation, adhesion, vascularization,
and implantation in the uterus (Chaouat et al., 2002). For example, the process of implantation has been
found to rely on several PICs (ex: LIF) that regulate expression of adhesion molecules and their receptors,
like laminin and fibronectin, on trophoblasts and uterine decidual cells (Stewart et al., 1992; Chaouat et
al., 2002; Dimitriadis et al., 2005).
Even though PICs are important signaling molecules at the beginning of pregnancy, immune
mediators and the implantation process must be tightly regulated to obtain the correct amount of
blastocyst invasion and angiogenesis. What has become to be appreciated is that the immune mediators at
the feto-maternal interface are not strictly pro- or anti- inflammatory, but both types of cytokines have
specific roles, and they must be produced in appropriate quantities in a correct temporal manner for
pregnancy success. For example, uNKs regulate trophoblast invasion and uterine vascular remodeling by
secreting angiogenic factors and chemokines for cells involved in the vascular and tissue remolding
during implantation including CXCL8, IP-10, (interferon-inducible protein-10) and IFNγ (Ashkar et al.,
2000; Hanna et al., 2006). However, as a PIC, IFNγ can cause fetal loss when produced in large quantities
in response to infection or in some cases the presence of foreign paternal antigen (Chaouat et al., 1995).
After implantation, the uterine environment is dominated by anti-inflammatory factors until parturition.
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Early pregnancy involves implantation, placentation, and vascular remolding; events that include
invading cells, cells that are dying, and cells that are repairing tissue. A controlled inflammatory
environment in the uterus is needed to have adequate repair of the uterine epithelium and removal of
cellular debris. Early pregnancy has been characterized by the presence of CXCL8, Macrophage
Chemoattractant Protein 1 (MCP-1), RANTES (Regulates on activated normal T cells where it is
expressed and secreted), and Granulocyte-Colony Stimulating Factor (G-CSF) (Mor, 2008). One source
of these chemokines are monocytes that are induced to produce them in response to trophoblast cells (Fest
et al., 2007). While these factors tend to be immune stimulatory, RANTES also has immunosuppressive
functions (Ramhorst et al., 2004). Trophoblast cells themselves have been found to produce chemokines
such as GRO-α, MCP-1, and CXCL8 that attract monocytes and macrophages (Abrahams et al., 2005;
Fest et al., 2007). These cells are important APCs and are involved in tissue remodeling and spiral artery
transformation (Abrahams et al., 2004). The monocytes will evolve into MΦs and surround the
trophoblast. In the study by Fest et al (2007) Macrophages stimulated trophoblast cells to secrete more IL6 and MCP-1, indicating that monocytes recruited by the trophoblast may then support implantation by
communicating with trophoblast cells and providing appropriate signals for implantation. After
placentation, the uterine environment is predominantly anti-inflammatory until the end of gestation as
parturition is also an inflammatory event (Mor, 2008). While some inflammation is needed to get
adequate implantation, tipping the scales too far towards pro-inflammation or inflammation as a result of
infection or failure to tolerate paternal antigens can cause embryonic loss.
The process of implantation involves extensive tissue remolding and apoptosis of cells that have
to be cleared to prevent the release of antigens (Abrahams et al., 2004). Macrophages at the feto-maternal
interface have the job of scavenging the dying cells as well as actively orchestrating apoptosis of
unwanted cells during tissue remodeling (Savill and Fadok, 2000). In response to phagocytosing
apoptotic cells, MΦs synthesize and secrete cytokines and growth factors that govern local cellular and
tissue interactions (Hunt, 1989; Garcia-Velasco et al., 1998). Specifically, uptake of apoptotic cells
induces MΦs to produce anti-inflammatory/immunosuppressive cytokines (IL-4, IL-6, IL-10) while
suppressing MΦs from secreting PICs (TNF-α, IFNγ) (Abrahams et al., 2004). These uterine MΦs have
an M2 phenotype characterized not only by the production of immune-inhibitory cytokines (TGFβ, IL-10)
(Heikkinen et al., 2003) but also by the production of pro-tolerance factors PGE2 (Tawfik et al., 1986) and
IDO (Munn et al., 1999; Renaud and Graham, 2008), upregulation of arginase activity (counteracts NO
synthesis) (Munder et al., 1998), and increased secretion of the IL-1 receptor antagonist (IL-1Ra) (Fenton
et al., 1998). Uterine MΦs also produce and regulate matrix metalloproteinases (MMPs), proteases,
growth factors, chemokines, and cytokines that influence implantation and placental development
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(Renaud and Graham, 2008). However, a uterine infection can induce MΦs to produce IL-12, IL-1 and
TNFα through activation of PPRs, or through phagocytosing an overabundance of apoptotic or necrotic
cells (Hunt, 1989; Abrahams et al., 2004; Nagamatsu and Schust, 2010). Thus, pathogen exposure can
shift polarity of uterine MΦs from an M2 to an M1 inflammatory phenotype (Nagamatsu and Schust,
2010).
Trophoblast cells stimulate MΦs to produce inflammatory mediators needed for implantation but
may also be able to limit their inflammatory potential during a minimal threat. MΦs exposed to
trophoblast cells followed by stimulation with a low dose of LPS (0.1μg) did not have an increase in
inflammatory mediators compared to MΦs only exposed to LPS (Fest et al., 2007). However, when a high
dose of LPS was used (10μg) the trophoblast cells were unable to control the MΦ’s inflammatory
response (Fest et al., 2007). High doses of LPS mimic bacterial overgrowth and infection that have
detrimental effects on pregnancy (Deb et al., 2004). Abortion can result with high doses of LPS (Murphy
et al., 2005) as a result of the release of embryotoxic substances and excessive release of PICs (IL-1, IL-6,
TNFα) from MΦs (Hill et al., 1987; Hunt, 1990). Therefore, there is a tipping point where the infection is
severe enough that the immune system “chooses” to use all its force in clearing the infection to protect the
mother over continuing the pregnancy.
One critical immune cell type during pregnancy is maternal Tregs. While Tregs are specific to
paternal alloantigen, expansion of the Treg population is not dependent on exposure to paternal
alloantigen as the population expands in both allogeneic and syngeneic pregnancies (Tafuri et al., 1995;
Aluvihare et al., 2004), and suppression by Tregs is not antigen specific (Chaouat et al., 2012). In
addition, maternal T cells acquire only a transient state of tolerance for those paternal alloantigens (Tafuri
et al., 1995), which has been demonstrated in vivo with graft rejection studies in female mice. Pregnant
mice accept an allogeneic tumor graft as long as the paternal graft displayed the same MHC-peptide
complexes as the fetus; a graft from a father with different MHC peptides was rejected. In addition, the
mother would tolerate the allogenic tumor graft only while she was pregnant; after parturition the tumors
were rejected (Tafuri et al., 1995). In order to generate immune tolerance to paternal antigens the antigens
need to be presented to maternal immune cells. Generation of tolerance starts before pregnancy with
antigens present in seminal plasma deposited during copulation (Roberson et al., 2013) being presented to
T cells. Continued suppression of maternal immune responses to paternal alloantigens may involve
maternal APCs picking up fetal antigen from buds and microparticles that are shed from the trophoblast
into the maternal circulation (Chamley et al., 2011). Fetal tissue remodeling involving apoptosis that
generates cellular debris also is a likely source of fetal antigens that can be presented, as phagocytic cells
like APCs would be responsible for cleaning up the dead cells.
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Abumaree et al (2012) showed that phagocytosis of trophoblast debris in vitro by MΦs resulted in
protein expression changes in the MΦs that would encourage maternal tolerance to be generated. MΦs
that phagocytosed trophoblast debris reduced cell-surface expression of MHC-II molecules, costimulatory molecules (CD80, CD86, CD40), MCP-1, and ICAM-1 while upregulating PD-1 expression.
MΦ expression of IDO was increased after exposure to trophoblast debris. These MΦs increased
secretion of IL-10, IL-6, and IL-1Ra, while decreasing secretion of IL-1β, IL-12p70, and CXCL8
(Abumaree et al., 2012). Downregulating MHC-II and co-stimulatory molecules means the MΦ is less
able to activate effector T cells and, with increased IDO, is able to regulate T cell proliferation. These
changes will make the MΦ guide maternal immune responses toward tolerance of the fetal antigens
instead of an inflammatory response.
The importance of downregulating co-stimulatory molecules was shown in murine studies where
blocking CD86 or CD80 and CD86 with antibodies early in gestation shifted the cytokine profile to a Th2
dominance at the feto-maternal interface, and caused expansion of peripheral Treg cells, which led to
decreased fetal resorption in abortion prone mice pairings (Jin et al., 2005; Zhu et al., 2005).
The PD-1/PD-L1 pathway has been reported to be critical for feto-maternal tolerance, blocking
PD-1 signaling increases rejection of allogenic but not syngeneic fetuses in mice (Guleria et al., 2005;
Wafula et al., 2009; Zhang et al., 2015). PD-1 is a receptor involved in co-stimulatory interactions
between immune cells. Co-stimulatory signals are the second signal provided to T cells being shown
antigen. The first signal is interaction between the T cell receptor (TCR) and the MHC molecule with
bound antigen. Co-stimulatory molecules are either positive secondary signals that promote T-cell
activation or negative signals that inhibit T-cell responses and mediate T-cell tolerance. PD-1 delivers
inhibitory signals and its expression can be induced on CD4+ T cells, CD8+ T cells, NK T cells, B cells,
and by activated monocytes (Sharpe et al., 2007). The PD-1 receptor responds to two ligands: PD-L2,
which is expressed by DCs and MΦs and PD-L1, which is constitutively expressed by B cells, DCs, MΦs,
and T cells (Sharpe et al., 2007). PD-L1 also can be expressed by non-hemopoietic cells in certain
locations, including the placenta (Zhang et al., 2015). PD-1 is involved in inhibiting the activation of
effector T cells while promoting development and function of induced regulatory T cells (Francisco et al.,
2009; Zhang et al., 2015) Tregs express high levels of both PD-1 and PD-L1 (Lohr et al., 2006), and PDL1 has been shown to increase the generation of Treg cells from naïve CD4+ T cells in the presence of
TGFβ, increase expression of FOXP3, and is produced by Tregs to suppress activated effector T cells
(Francisco et al., 2009; Zhang et al., 2015).
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Uterine Natural Killer Cells
The predominant leukocyte population in the endometrium during implantation and early
pregnancy are natural killer cells (NK cells) (Croy et al., 2006). NK cells may migrate from the peripheral
blood into the endometrium in response to chemokines upregulated in response to steroid hormones
(Sentman et al., 2004; Carlino et al., 2008; Cerdeira et al., 2013) or may be derived from CD34+ cell
precursors that differentiate into uNKs after interaction with decidual cells (Vacca et al., 2011b).
Trophoblast cells also secrete chemokines to actively recruit NK cells to the area (Hanna et al., 2003).
The NK cells are important players in immune responses to infections, and peripheral NK cells
fight pathogen infections through their cytotoxic activity of perforin and granzyme secretion. These cells
can have two major phenotypes; however, CD16+ CD56dim NK cells have high cytotoxic potential but are
not major producers of cytokines whereas CD16neg CD56bright NK cells have poor cytotoxic activity
(Crncic et al., 2007). The majority (~90%) of peripheral NK cells are highly cytotoxic with ~ 10%
producing high levels of cytokines (Koopman et al., 2003). The uNK (CD16neg CD56bright), however, are
specialized in that even though they possess the machinery (perforin and granzyme cytotoxic granules) to
lyse cells, they have low cytotoxic activity (Koopman et al., 2003; Kopcow et al., 2005; Crncic et al.,
2007), which may be regulated by P4 upregulating gene expression of non-polymorphic MHC molecules,
which can bind to inhibitory receptors on NK cells (Yie et al., 2006).
Instead of having a cytotoxic role in the uterus, uNKs play an important role in establishing and
maintaining maternal-fetal immune tolerance, in inducing Treg cells, acting as local guardians against
infection, controlling trophoblast invasion and vascular angiogenesis through the secretion of
angiogenesis-regulating molecules (Hanna et al., 2006; Tabiasco et al., 2006; Kalkunte et al., 2009; Vacca
et al., 2010; Vacca et al., 2011a; Winger and Reed, 2013). The uNK cells, like other immune cells at the
feto-maternal interface, express high levels of gal-1, which is a critical mediator of immune tolerance
during pregnancy (Koopman et al., 2003; Blois et al., 2007b; Rabinovich and Toscano, 2009). The
trophoblast and maternal-fetal interface is assumed to modify recruited peripheral NK cells, changing the
phenotype and function to that of uNK cells (Du et al., 2014; Tao et al; 2015; Li et al., 2016).
Uterine NKs produce IFNγ early in pregnancy that acts in an autocrine manner to further
stimulate IFNγ production in addition to vascular endothelial growth factor (VEGF), angiopoietin 2, and
PGF involved in angiogenesis in early pregnancy and nitric oxide (NO), which stimulates vasodilation
(Warning et al., 2011). Interferon-γ (IFN-γ) also has been shown to regulate inflammatory Th17 cells (Fu
et al., 2013). While IFNγ contributes to the important placentation step of spiral artery remodeling
(Ashkar et al., 2000), production of the cytokine must be regulated as elevated levels, like during an
infection, can cause fetal loss (Shiono et al., 2007).
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While uNKs do not display the cytotoxic functions of their peripheral counterparts, uncontrolled
or exaggerated inflammation at the maternal-fetal interface can cause uNKs to revert back into their
peripheral NK phenotype and cause embryonic loss (Murphy et al., 2005; Murphy et al., 2009; KwakKim et al., 2014). IL-12 stimulates IFNγ production by NK cells and induces their cytotoxic activity. The
PICs TNFα, IL-1β, and IL-15 synergize with IL-12 to induce IFNγ production and IL-15 also promotes
NK cell maturation. IL-10 can regulate IFNγ production by NK cells by inhibiting IL-12 production while
TGFβ can block proliferation and cytotoxicity of NK cells as well as inhibit IFNγ and IL-12 production
(Biron et al., 1999; Eriksson et al., 2004; Eriksson et al., 2006). IL-10 and TGFβ are produced by Tregs
and tDCs in the uterus to regulate fetal tolerance and the amount of the cytokines produced at the fetomaternal interface (Simpson et al., 2002) regulating the response/phenotype of uNK to pathogens.
When uNK cells gain cytotoxic capability during inflammation they cause apoptosis of
trophoblast cells with the transfer of granulysin with the help of perforin (Nakashima et al., 2008).
Several authors haves suggested that LPS can act on NK cells directly and that uNK cells are major
players in LPS stimulated embryonic loss. The NK cells express TLR4 (Duriez et al., 2014), and
treatment of uNK cells results in production of TNF-α (Li et al., 2016). LPS has been shown to recruit
additional NKs to the uterus and trigger a phenotypic change in uNK cells that leads to abortion. This
effect is likely to be mediated by PICs as depletion of NK cells or neutralization of TNFα prevented
pregnancy loss (Murphy et al., 2009). LPS not only triggers a robust inflammatory response characterized
by the production of PICs, such as TNF-α and IL-1β, and a shift in the Th1/Th2 balance at the fetalmaternal interface (Park et al., 2009) but also has been reported to induce uNK cytotoxic activation that
could lead to NK cell mediated killing of embryonic cells (Murphy et al., 2005). Indeed, treatment of
peripheral blood mononuclear cells with LPS results in proliferation and enhanced cytotoxic activation of
NK cells (Miranda et al., 1998; Goodier and Londei, 2000). In IL-10 null mice treated with LPS,
depletion of NK cells can restore pregnancy (Murphy et al., 2005). IL-10 null mice are missing a
cytokine used to regulate the phenotype of NKs in the uterus making it easier for them to gain cytotoxic
capability. Restoration of pregnancy in an LPS model by depleting these cells demonstrates how critical it
is that they maintain their phenotype.

Regulatory T Cells
Regulatory T cells are a subset of CD4+ T cells that express FOXP3 and CD25 constitutively and
can suppress immune responses in an antigen-independent fashion (Sakaguchi, 2004; Wan and Flavell,
2006). There are two ways for Tregs to be generated. Natural Tregs (nTregs) originate in the thymus by a
selective process involving T cells being presented with self-antigens and gaining a regulatory function.
Inducible Tregs are produced in lymph nodes by a mechanism that generates Tregs with receptors specific
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for antigens not expressed in the thymus but instead restricted to different peripheral tissues (Shevach et
al., 2002). The APCs can induce naïve CD4+ cells to become Tregs (iTregs) by presenting antigen that is
recognized by their T cell receptor while producing IL-2 and TGFβ (IL-10 may also contribute) which
leads to FOXP3 expression (Chen et al., 2003; Horwitz et al., 2003; Fantini et al., 2004; Wan and Flavell,
2006; Murphy, 2012).
Treg cells are characterized by the transcription factor, FOXP3. In order for a naïve CD4+ T cell
to polarize into a Treg cell, TGFβ must be present at the time of TCR ligation with its antigen. The APC
not only provides the antigen to stimulate the naïve CD4+ T cell but produces the cytokines that
determine how the naïve CD4+ cell is polarized in response to that particular antigen (Chen et al., 2003).
TGFβ is important during Treg polarization because it induces FOXP3 expression via SMAD3- and
retinoic acid receptor binding sites (Zheng et al., 2010). TGFβ also may aid in the proliferation of mature
Tregs by modifying the function and signaling capabilities of DCs (Ghiringhelli et al., 2005b). PGE2, also
delivered to the female reproductive tract during mating, may work with TGFβ in generating Tregs as
PGE2 has been reported to enhance the inhibitory capacity of human Treg cells in vitro and to induce a
regulatory phenotype in CD4+CD25- T cells (Baratelli et al., 2005).
After the naïve CD4+ T cell has recognized its antigen, it is activated, will proliferate and then
leave the lymph node (Walker et al., 2003). Inducible Tregs are critical for successful pregnancy because
Tregs with TCRs specific to paternal alloantigens, which are foreign to maternal self, must be generated
to control aggressive immune responses to foreign looking antigens displayed by the conceptus (Samstein
et al., 2012). While all inducible Tregs generated in peripheral tissues have to undergo antigen driven
activation and proliferation to gain full suppressive function, actual suppressive effector function is
antigen non-specific (Thornton and Shevach, 1998; Samy et al., 2006). The maternal immune system first
encounters paternal antigens when seminal fluid is delivered to the female reproductive tract at coitus
(Robertson and Sharkey, 2001). Treg cells populations start to expand within days of mating (Aluvihare
et al., 2004) and must be at the feto-maternal interface and functional before implantation (Zenclussen et
al., 2005; Shima et al., 2010).
CD25 is the alpha chain of the IL-2 receptor; upon IL-2 binding, the IL-2Rα, β, and γc chains
oligomerize, and a JAK (Janus Kinase)-STAT (signal transducer and activator of transcription) pathway
is activated. IL-2 is required for the generation and maintenance of Tregs (Horwitz et al., 2003). JAK1 is
associated with IL2Rβ while JAK3 is associated with IL-2Rγc but can also interact with the β chain. The
activated JAKs phosphorylate tyrosine residues in the β chain then phosphorylate STAT5, which is
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responsible for expression of FOXP3, the transcription factor for development of Tregs and their
immunosuppressive phenotype (Wan and Flavell, 2006).
At ovulation, the elevated E2 levels cause a systemic expansion in Tregs and recruitment to the
uterus by inducing FOXP3 mRNA expression and increasing uterine expression of Treg chemokines,
CCL3, CCL4, and CCL5 (Polanczyk et al., 2004; Kallikourdis and Betz, 2007). The corpus luteum (CL)
is formed after ovulation, and P4 may be involved in sustaining and further expanding Treg populations.
In vitro, P4 was able to convert CD4+CD25- T cells into CD4+CD25+ Treg cells (Mao et al., 2010). P4
was also seen to be able to convert naïve fetal (cord blood) T cells into Treg cells that had been
allogenically activated. These differentiated Treg cells expressed FOXP3, high levels of memory T-cell
markers and had impaired expression of the IL-6 receptor, which should stabilize them towards having a
regulatory phenotype and inhibit conversion to a Th17 cell (Lee et al., 2011). The E2 induced Treg
expansion occurs after every ovulation with E2 probably targeting Tregs regardless of their TCR
specificity meaning these Tregs will not be specific to paternal alloantigen. Indeed, E2 was seen to expand
Treg cells in different tissues in mice while in vitro E2 converted CD4+CD25- cells, to CD4+CD25+ cells
which then expressed FOXP3 and IL-10 and were able to suppress naïve T cell proliferation in a mixed
lymphocyte reaction (Tai et al., 2008).
To be activated and have suppressive function, inducible Tregs require TCR ligation with antigen
and appropriate polarizing signals. During coitus, seminal fluid delivers paternal antigens that also will be
expressed by conceptus tissues as well as TGFβ and PGE2 into the female reproductive tract (Robertson
et al., 2009; Robertson et al., 2013; Schjenken and Robertson, 2014). This will cause DCs to be recruited
to the uterus, mature into a tolerogenic phenotype, pick up the alloantigen and take it to the draining
lymph nodes to present to naïve CD4+ T cells polarizing them towards a Treg phenotype by TCR ligation
with the antigen in the presence of IL-2 and TGFβ. These Treg cells will be specific to alloantigen and are
recruited to the uterus by chemokine CCL19 that is expressed on glandular and luminal epithelial cells
and binds to the CCR7 receptor on Tregs (Guerin et al., 2011). Seminal fluid is responsible for induction
of uterine expression of CCL19 mRNA, which regulates Treg cell retention in peripheral tissues (Alt et
al., 2002; Engelhardt et al., 2006). The presence of sperm in addition to seminal fluid was reported to be
required for maximal expression of the chemokine and local Treg accumulation in the uterus before
implantation (Guerin et al., 2011). Interaction with paternal antigens also induces Tregs to express the
chemokine receptor CCR5, and the chemokine CCL4 is involved in sequestering activated, antigenspecific CCR5+ Treg cells to the gravid uterus (Kallikourdis et al., 2007). During and after implantation,
tissue remodeling of gestational tissues and the growing fetus will release additional alloantigens and the
chemokine CCL4 to further expand and recruit Treg cell populations to the feto-maternal interface
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(Robertson et al., 2013). Placental trophoblasts secrete TGFβ that is likely involved in regulating the Treg
population. Trophoblast cells have been shown to induce FOXP3 expression along with a Treg cytokine
profile in naïve T cells and to secrete inducible Treg chemoattractants (Ramhorst et al., 2012).
With regard to the E2 induced peri-ovulatory expansion of the Treg cell pool, seminal fluid
provides the signals to select clones that are specific to paternal antigens from the broader TCR repertoire
and expand them to provide protection for the fetus (Robertson et al., 2013). TGFβ, derived from male
accessory glands like the prostate and seminal vesicle (Robertson et al., 2002), along with PGE-related
prostaglandins have been associated with the generation of Treg cells by inducing naïve CD4+CD25- T
cells to differentiate into suppressor T cells that express FOXP3 (Chen et al., 2003; Baratelli et al., 2005).
Studies have shown that seminal fluid and TGFβ in the seminal fluid delivered during coitus are
responsible for activation and proliferation of Tregs. In mice, Treg cells are increased about 2 fold 3.5
days post-coitus compared with the estrus associated increase in cycling females, but if seminal vesicles
were removed from males before mating, the increase did not occur (Robertson et al., 2009; Guerin et al.,
2011). The importance of TGFβ is shown by studies in which exogenous TGFβ given to female mice of
abortion-prone matings increased vaginal Treg cell numbers and reduced fetal loss (Clark et al., 2008).
After becoming activated and fully functional, Tregs leave the lymph nodes and travel through
the circulation to the appropriate peripheral location in response to chemokines where they interact with
other cells in the local environment to exert immune suppressive functions in an antigen non-specific
manner (Thornton et al., 2000). Immunosuppressive functions of Tregs are mediated by cell-cell contact
involving cell-surface molecules, by the production of specific cytokines, and by competitive deprivation
of other T cells of IL-2 (Thornton et al., 1998; Nakamura et al., 2001; Boussiotis et al., 2001; Scheffold et
al., 2005; Wan and Flavell, 2006; Shevach, 2009). Tregs suppress the proliferation of other T cell
subtypes, the production of IFNγ and IL-2 by effector cells and can suppress immunoglobulin production
by B cells (Thornton and Shevach, 1998; Nakamura et al., 2001; Garín et al., 2007). Mature Tregs secrete
the cytokines IL-10 and TGFβ which further expand the Treg cell response through paracrine suppressive
properties (Fontenot et al., 2003; Hori et al., 2003; Wahl et al., 2004).
Besides CD25, other surface markers on Tregs include cytotoxic T-lymphocyte antigen-4
(CTLA-4), glucocorticoid-induced tumor necrosis factor receptor (GITR) family-related gene,
lymphocyte activation antigen-3 (LAG-3) (Sakaguchi, 2004; Huang et al., 2004) and the cell surface
bound form of TGFβ (Nakamura et al., 2001). These surface molecules are used for cell contact mediated
actions of Tregs (Thornton et al., 2000). TGFβ also is secreted when CD3 is stimulated on the Treg, and
secretion is enhanced when CD28, IL-2R, and CTLA4 are engaged in co-stimulation (Nakamura et al.,
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2001). LAG3 is a CD4-related molecule that binds MHC class II molecules on APCs, and interaction
between Tregs and immature DCs using these molecules induces an ITAM (immunoreceptor tyrosinebased activation motif) mediated inhibitory signaling pathway in the DC that prevents maturation and
immunostimulatory capacity of the APC (Huang et al., 2004; Liang et al., 2008).
Tregs constitutively express CTLA4 (Takahashi et al., 2000) and ligation of the molecule induces
production of TGFβ (Chen et al., 1998) by the Treg cell, which enhances their suppressive function.
CTLA-4 interacts with CD80/CD86 on APCs, which can prevent the up-regulation (or cause downregulation) of expression of these co-stimulatory molecules by APCs (Oderup et al., 2006; Onishi et al.,
2008). Reduced expression of CD80 and CD86 by APCs will limit the ability of the cells to activate naïve
T cells through CD28 and in fact, antigen presentation without sufficient co-stimulatory molecule
interaction can cause a naive T cell to become anergic (Murphy, 2012). Crosslinking of CTLA-4 with
CD3 and CD28 inhibits T cell proliferation, IL-2 secretion, suppression of IFNγ from Th1 cells and IL-4
from Th2 cells (Chen et al., 1998).
Tregs, through CTLA4-CD80/CD86 interaction along with production of TGFβ and IL-10 induce
local DCs to express IDO, which catabolizes tryptophan (Grohmann et al., 2002; Fallarino et al., 2003).
Expression of IDO by DCs also is a mechanism for DCs to activate Tregs and stimulate them to maintain
suppressive functions. Thus, a positive feedback loop to ensure a suppressive local immune environment
is created (Sharma et al., 2007, Grohmann et al., 2002).
Tregs influence the population of T helper cells in the local environment by inhibiting Th1 cell
proliferation and inducing Th1 cell apoptosis (Robertson et al., 2013). IDO catabolizes tryptophan to
kynurenine, which is toxic to T cells that are neighboring the producing cell (La Rocca et al., 2014).
Tryptophan metabolites can inhibit activation of T cells and NK cells (Frumento et al., 2002, Terness et
al., 2002), and low doses of kynurenine induce selective apoptosis of Th1 versus Th2 cells (Terness et al.,
2002; Fallarino et al., 2002), which could aid in creating a Th2 cytokine bias in the uterus. Tregs also can
kill cells in a granzyme-and perforin dependent manner or send negative signals to the targeted cell that
control its function, proliferation, and survival (La Rocca et al., 2014). Tregs provide signals to
responding T cells through the co-stimulatory molecules CD80 and CD86 expressed on the responder cell
(Paust et al., 2004). In a cell-contact mediated mechanism, cAMP is transferred through gap junctions
from Treg cells to the responder T cells where it inhibits proliferation and IL-2 production (Bopp et al.,
2007). In a different mechanism, using surface expressed CD39 and CD37, the Treg cell generates
pericellular adenosine from extracellular nucleotides that binds to the adenosine A2A receptor on
activated effector T cells (Deaglioet al., 2007) inhibiting T cell activation, proliferation, and expansion
(Huang et al., 1997). Extracellular ATP is a DAMP signal that can increase CD86 expression on DCs;
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activated Tregs express CD39, which hydrolyzes extracellular ATP to AMP thus eliminating the
inflammatory signal (Shevach, 2009). Tregs express Nrp-1, which promotes long interactions between the
Treg cell and immature DCs and in doing so limits interactions between effector cells and the APC
(Shevach, 2009).
The importance of Tregs during pregnancy is demonstrated in murine studies showing Treg
deficient BALB/c nude females transferred Treg depleted polyclonal T cells experienced fetal resorption
in allogenic pregnancies but not in syngeneic pregnancies (Aluvihare et al., 2004). Regulatory T cell
depletion with anti-CD25 monoclonal antibodies during implantation resulted in implantation failure or
during early pregnancy resulted in fetal resorption in allogeneic but not syngeneic pregnancies (Munn et
al., 1998; Darrasse-Jéze et al., 2006; Shima et al., 2010). The Tregs that expand during pregnancy are
specific to fetal antigens (Kahn and Baltimore, 2010; Rowe et al., 2012a). Comparing synergistic and
allogenic mice matings, allogeneically pregnant females had a greater increase in Treg number, which
resulted in enhanced immune suppression to paternal antigens. (Kallilourdis et al., 2007; Zhao et al.,
2007). Decidual lymphocytes from mice that had abortions produced significantly less IL-10 and
significantly more TNFα than decidual cells from normal pregnant mice (Zenclussen et al., 2005). This
group also reported that mice that had abortions had reduced numbers of Treg cells and showed that
exposure to paternal antigen is necessary to generate Tregs that are competent at promoting protection to
the fetus as transfer of Tregs from normal non-pregnant mice to pregnant abortion prone mice had no
benefits. It is also critical that Tregs be at the feto-maternal interface during the peri-implantation period
when the trophoblast starts making contact with maternal tissues, as transfer of Tregs after implantation in
mice did not prevent abortion (Zenclussen et al., 2005). These results show that Tregs are important for
generating maternal tolerance to paternal antigen expressed by the fetus, Tregs are important for
successful implantation, and that Tregs must recognize fetal antigens to create an immunosuppressive
environment.

Seminal Fluid
The affects of seminal fluid on the female reproductive tract have been well studied in mice. A
response that resembles an inflammatory event occurs with the production of cytokines such as LIF, IL-6,
and granulocyte colony stimulating factor (GM-CSF) from E2 primed epithelial cells that recruit
additional innate and adaptive immune cells (Robertson et al., 1998; Tremellen et al., 1998). Within hours
of mating, the numbers of MΦ, DCs, neutrophils, T cells and granulocytes within the uterine endometrial
stroma and lumen are increased (McMaster et al., 1992; Robertson et al., 1998; Tremellen et al., 1998).
This transient inflammatory response to seminal fluid recruits additional immune cells to the female
reproductive tract and is seen in other species including sheep (Scott et al., 2006).
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When the female is receptive to mating around ovulation, DCs are abundant in the endometrial
tissue (Robertson et al., 1996; Blois et al., 2007a). The addition of seminal fluid at coitus further recruits
APCs to endometrial tissues (Robertson et al., 1996) as a result of seminal fluid inducing expression of
the chemokines CCL2, CCL3, CCL5, CCL20, CCL22, and CXCL10 (Robertson et al., 1998). The DCs in
the endometrial tissue normally have a tolerogenic phenotype (Blois et al., 2007a), which will be
maintained as long as cytokines such as GM-CSF, IL-4, and IL-10 are produced by uterine tissue and
dominate the local cytokine environment (Robertson et al., 2000). The importance of seminal fluid is
shown by in vitro studies in which seminal fluid is able to direct the differentiation of DCs into a
tolerogenic phenotype that then produce higher amounts of IL-10 and TGFβ, and can induce Treg
differentiation (Remes et al., 2012). Within uterine tissues, tDCs will phagocytose spermatozoa, soluble
antigens and apoptotic somatic cells in the seminal fluid deposited during coitus. Seminal fluid induces
production of PICs in the female reproductive tract, which causes the DCs to traffic to the draining lymph
nodes after uptake and processing of antigen or to interact with local Treg cells in the uterus. Both of
these actions by DCs lead to the activation and expansion of clonal subsets of Treg cells that express
TCRs that are specific to seminal fluid antigens (Moldenhauer et al., 2009a; Robertson et al., 2013). The
P4 from the CL stabilizes the Treg cell pool, and, if conception is successful after mating, apoptotic
placental and fetal cells from tissue remodeling provide further alloantigens to be cross-presented to T
cells by maternal DCs, increasing the number of Treg cell clones specific to paternal alloantigens
(Robertson et al., 2013). While seminal fluid and the conceptus share antigens, it is unlikely that all
paternal antigens that will be expressed by the conceptus are presented to Tregs during initial Treg cell
priming. Therefore, the notion of “bystander tolerance” mediated by Treg cells (Shevach et al., 2002;
Corthay, 2009; Shevach, 2009; Kahn and Baltimore, 2010) is important during pregnancy meaning that a
selection of paternal antigens that will be expressed by the conceptus are presented and used to generate
Treg cell clones that then proliferate and generate an overall immune suppressive environment at the fetomaternal interface. Because Tregs are suppressive in an antigen independent manner once activated, so
they are able to regulate the uterine immune environment without having been presented every paternal
antigen that will be expressed during gestation.
Seminal fluid also may affect steroidogenesis. In mice, exposure to seminal fluid is associated
with increased numbers of MΦs in the CL (Gangnuss et al., 2004), and these innate immune cells seem to
play a critical role in remodeling events required to sustain steroidogenic function (Care et al., 2013).
Administration of seminal fluid to pigs at ovulation also has been associated with an increase in CL MΦs
along with increased steroidogenic function and increased circulating plasma P4 (O’Leary et al., 2006).
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Not only is P4 critical for maintenance of pregnancy and embryo development, this hormone has direct
positive effects on Treg cell differentiation, proliferation and suppressive function (Mao et al., 2010).

Transforming growth Factor Beta
After being deposited into the female tract as a component of seminal fluid, TGFβ is activated by
acidic vaginal pH, enzymes originating in the male or female tract, or through conformational changes
induced by interaction with epithelial cell docking proteins (Robertson et al., 2002). This cytokine has a
role stimulating the post-coital inflammatory response, inducing maternal immune tolerance to seminal
antigens, preventing immunity to sperm, and priming an appropriate maternal immune response to
embryo implantation because many seminal antigens will be expressed by the conceptus (Robertson et al.,
2002). Interacting with uterine and/or cervical epithelial cells, TGFβ upregulates several PICs and
chemokines leading to recruitment and activation of leukocytes including neutrophils, MΦs, and DCs
(McMaster et al., 1992; Robertson et al., 1992a; Robertson et al., 1996) Also a component in seminal
fluid, PGE aids in recruitment of leukocytes through promotion of CXCL8 expression (Denison et al.,
1991). TGF-β is involved in the induction and maintenance of Treg function (Clark et al., 1997;
Gabrysová et al., 2011). Tregs are generated in the lymph nodes beginning at mating and then circulate in
the blood to be sequestered into the endometrium in a chemokine-dependent manner prior to implantation
(Zenclussen et al., 2005; Robertson et al., 2009; Guerin et al., 2011; Shima et al., 2012; Robertson et al.,
2013). Uterine NKs also colonize the uterine lining at or shortly after implantation and their production of
TGF-β may help with the generation and maintenance of Treg cells (Vacca et al., 2010). Both E2 and P4
upregulate the expression of uNK cell chemokines CXCL10 and CXCL11 in the endometrium (Sentman
et al., 2004). TGFβ is expressed by the endometrium and maternal lymphomyeloid cells (Clark et al.,
1997; Simpson et al., 2002; Gabrysová et al., 2011) and is involved in preparing the uterus for
implantation by inducing expression of LIF (d’Hauterive et al., 2005) and GM-CSF (Robertson et al.,
2002), which results in leukocyte recruitment (Tremellen et al., 1998). TGFβ also reduces IL-6
production (d’Hauterive et al., 2005) and inhibits Th1 responses (Eriksson et al., 2004).
TGFβ is a potent cytokine in its ability to limit inflammation and modify innate and adaptive
immunity; however, its effects are dependent on context (Sporn, 1999) and the presence of other
cytokines in the local environment. TGFβ acting on resting cells usually results in them being turned
on/activated, whereas, inflammatory cells that are already active respond to TGFβ by being inhibited by
the cytokine (Sporn, 1999). TGFβ can suppress activated MΦ functions (Bogdan and Nathan, 1993; Chen
and Wahl, 2002), suppress NO production (Vodovotz et al., 1993), influence T cell differentiation
(Gorelik et al., 2002), and suppress effector T cell proliferation, cytokine responses, and cytotoxic effects
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by inhibiting granzyme-B and the transcription factors for Th1 (T-bet) and Th2 (GATA3) (Gorelik and
Flavell 2000; Heath et al., 2000; Gorelik et al., 2000; Chen et al., 2003; Lin et al., 2005; Thomas and
Massaqué, 2005).
TGFβ also suppresses cell proliferation by suppressing c-Myc and the cell cycle inhibitors
p15INK4b and p21CIP1 (Wahl et al., 2004). IL-2 can perturb the inhibitory influence of TGFβ (Chen and
Wahl, 2002). IFNγ is another cytokine that can alter TGFβ functions. By enhancing expression of
inhibitory Smad7, IFNγ can block TGFβ signaling (Nakao et al., 1997; Strober et al., 1997). TGFβ can
directly inhibit IFNγ and IL-2 production by T cells or indirectly by affecting the ability of APCs to
activate Th1 cells by suppressing CD40 expression, suppressing IL-12 production by APCs, and/or
inhibiting IL-12 from activating Jak-Stat pathways (Strober et al., 1997; Bright and Sriram, 1998;
Gortham et al., 1998). These examples of complex immunregulatory circuits demonstrate that the balance
of pro and anti-inflammatory cytokines and how they interact will influence the generation and
maintenance of Treg cells and tolerance at the feto-maternal interface.
Injecting TGF-β into the vaginal tracts of female mice of abortion-prone matings that have a
suboptimal Treg response to the male ejaculate promotes pregnancy success and is shown to recruit Treg
cells to the vaginal tract (Clark et al., 2008). Seminal fluid has been shown to be the key regulator of the
uterine Treg cell population by stimulating proliferation of Tregs and thus increasing the pool of available
Treg cells and by promoting recruitment of Tregs from the circulation to the implantation site (Guerin et
al., 2011). During copulation, sperm and seminal plasma are deposited into the female genital tract where
they interact with resident MΦs and DCs. Being APCs, the MΦs and DCs pick up paternal alloantigen
and carry it to the draining lymph nodes where stimulatory DCs can activate αβ T cells to become
effectors of rejection or tolerogenic DCs will activate Tregs (Clark and Chaouat et al., 2012). TGFβ in the
seminal fluid is important for polarizing the DCs encountering paternal antigens into a tolerogenic
phenotype, so that they induce Tregs in the lymph nodes. This is achieved by regulating which
costimulatory molecules and cytokines are expressed by DCs (Robertson et al., 2002). DCs matured in
vitro with TGFβ express low levels of the T-cell costimulatory molecules CD80, CD86, and CD40 and
can exert a tolerant function in vivo (Lu et al., 1997). Once Treg cells have been activated and
proliferated they will leave the lymph node and enter the circulation. Seminal fluid and sperm are also
responsible for increasing the expression of the Treg chemokine CCL19 by glandular and luminal
epithelial cells in the uterus. CCL19 interacts with the CCR7 receptor on Tregs to recruit and retain Tregs
in peripheral tissues, in this case the uterus (Guerin et al., 2011). Other types of T cells that can cause fetal
rejection also localize to the uterine lining but their function is kept in check by tDCs via IDO and the
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tryptophan metabolite 3-hydroxyanthranillic acid (3HAA) (can induce T cell apoptosis) along with TGFβ
promoting Treg activity (Clark and Chaouat et al., 2012). Insufficient tDCs and/or increased amounts of
stimulatory DCs can lead to fetal rejection.

Interleukin-10
Interleukin-10 (IL-10) is a critical anti-inflammatory cytokine involved in immune tolerance at
the feto-maternal interface and controlling response to PAMPs. IL-10 inhibits COX-2 transcription
induced by LPS (Niiro et al., 1995), thus limiting PGE2 production. This occurs through inhibition of
STAT5 through suppression of LPS induced GM-CSF production (LPS->GM-CSF->STAT5->COX-2)
(Yamaoka et al., 1998) and by preventing LPS activation of ERK2 and p38 MAPK in monocytes (Nirro
et al., 1998). IL-10 blocks upregulation of TLR4 in response to LPS or PICs (Muzio et al., 2000), limiting
the inflammatory response to LPS. IL-10 can inhibit MHC class II antigen expression on monocytes
through inhibition of the transport of mature, peptide loaded MHC class II molecules to the plasma
membrane (Koppelmann et al., 1997). IL-10 inhibits expression of co-stimulatory molecules, CD54
(ICAM), CD80, and CD86 by monocytes (de Waal Malefyt et al., 1991; Ding et al., 1993; Willems et al.,
1994; Koppelmann et al., 1997). IL-10 also will affect MHC class II and co-stimulatory molecules
expression by DCs as well as the cytokines produced by the DC (Moore et al., 2001). These effects will
be detrimental to the ability of the APC to present antigen/stimulate T cells. T cell “activation” in the
presence of IL-10 induces CD4+ T cells to become anergic in an antigen specific manner (Caux et al.,
1994; Groux et al., 1996) that is not reversible with IL-2 or stimulation of CD3 and CD28 (Groux et al.,
1996). These anergic cells will no longer react to the antigen they are specific for and can act as
suppressor cells by competing with other antigen-activated T cells for IL-2 (Wan and Flavell, 2006).
IL-10 inhibits the activation of NFκB in activated monocytes/macrophages and the production of
cytokines (IL-1α, IL-1β, TNFα, IL-6, IL-12, IL-18, GM-CSF, M-CSF, LIF, PAF) and chemokines
(MCP1, MCP-5, Mip-1α, Mip1β, Mip-3α, Mip-3β, RANTES, MDC, IL-8, IP-10, MIP-2) by innate
immune cells that recruit monocytes, DCs, neutrophils, and T cells (Moore et al., 2001; Akdis et al.,
2011).
IL-1 and TNFα tend to have synergistic effects on inflammatory pathways inducing additional
inflammatory mediators such as chemokines, PGs, and platelet activating factor (PAF). By inhibiting
production of these two cytokines, IL-10 has significant anti-inflammatory effects. In addition, IL-10
enhances production of IL-1Ra (Moore et al., 2001), an endogenous blocker of IL-1 effects. IFNy induces
IP-10 expression, which attracts Th1 cells, while IL-10 inhibits IFNγ activated STAT molecules, which
may occur through upregulation of suppressor of cytokine signaling 3 (SOCS3) (Cassatella et al., 1999;
Ito et al., 1999; Yamaoka et al., 1999). By interfering with downstream IFNγ signaling, IL-10 suppresses
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Th1 recruitment (Moore et al., 2001). The importance of IL-10 mediating the cytokine environment at the
feto-maternal interface is shown by IL-10 null mice being more susceptible to LPS induced fetal loss as a
result of increased expression of TNFα, IL-6, IL-1, and IL-12 compared to LPS treated control mice
(Robertson et al., 2007).

Galectin-1
Galectins are a family of β-galactoside-binding proteins involved in immunoregulatory functions.
After release from a cell, galectins crosslink β-galactoside-containing cell-surface glycoconjugates,
leading to changes in cell signaling, adhesion, and cell survival (Rabinovich et al., 2002). Gal-1
recognizes and binds multiple glucose-β1-4-N-acetylglucosamine (LacNAc) units located on branches of
N-Linked or O-linked glycans (Rabinovich and Toscano, 2009).
Galectin-1 is expressed in reproductive tissues including the myometrium, decidua of the uterus,
and invasive extravillous trophoblast (Phillips et al., 1996; Maquoi et al., 1997; Rabinovich, 1999; Sasaki
et al., 2004; von Wolff et al., 2005; Kallikourdis et al., 2007; Blois et al., 2007b; Ramhorst et al., 2012;
Than et al., 2012; Tirado-González et al., 2013) where it may play a role in controlling inflammation by
triggering apoptosis of infiltrating effector T cells and reducing production of PICs (Rabinovich et al.,
2002). It is produced by Tregs, MΦs, and uNKs located at the fetomaternal interface (Rabinovich et al.,
1998; Koopman et al., 2003; Kopcow et al., 2008). Expression by the placenta is likely involved in cell
adhesion and invasion of the trophoblast, but gal-1 also plays an important role in maternal tolerance to
placental alloantigens (Than et al., 2012).
With regard to modulating effector functions by other T cells, gal-1 interacts with surface
glycoproteins on T cells and specifically CD45, CD43, and CD7 are involved in gal-1 induced apoptosis
(Pace et al., 1999). Gal-1 inhibits production of IL-2, IFNγ, and TNFα from activated T cells and IL-12
from infected MΦs; decreases release of AA and PGE2 production from MΦs; decreases PLA2 induced
edema, neutrophil extravasation and mast cell degranulation; and causes cell-cycle arrest and/or apoptosis
of activated peripheral T cells, and infected MΦs (Perillo et al., 1995; Blaser et al., 1998; Rabinovich et
al., 1999; Vespa et al., 1999; Rabinovich, 2000; Rabinovich et al., 2000; Rabinovich et al., 2002). Gal-1
influences T cell physiology and survival by initiating signal transduction events including ERK-2
phosphorylation, calcium influx, activation of the transcription factor AP-1, and downregulation of the
anti-apoptotic protein BCL-2 (Vespa et al., 1999; Rabinovich et al., 2000). Binding of gal-1 to a T cell
alone or with antigen stimulation causes partial phosphorylation of TCR-zeta and generation of inhibitory
pp21zeta (Chung et al., 2000). Galectin-1 limits membrane reorganization and causes cross-linking events
that limit the size of lipid raft clusters at the TCR contact site and raft-associated protein tyrosine
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phosphorylation. Because of these gal-1 actions, functions in the T cell that need only partial TCR
signals, like apoptosis, can occur but functions that require co-stimulation or tyrosine phosphorylation,
like IL-2 production, are blocked (Chung et al., 2000) meaning that the T cell cannot be activated or
induced to proliferate.
Galectin-1 has been reported to be important for the generation of feto-maternal tolerance through
involvement in the generation of tDCs and Tregs. Blois et al (2007b) showed that gal-1 deficient mice had
higher rates of fetal loss during allogenic matings but not syngeneic matings. Treating gal-1 deficient
mice with recombinant Gal-1 prevented fetal loss and restored tolerance. This was associated with a shift
towards a Th2 dominant cytokine profile at the fetomaternal interface which is known to be crucial for
successful pregnancy (Wegmann et al., 1993; Blois et al., 2007b). Galectin-1 expression may be regulated
by P4 as Blois et al (2007b) reported that treatment with the P4 derivative dydrogesterone increased gal-1
expression that was correlated with expansion of Treg cells and DCs with a regulatory phenotype in the
myometrium and decidua of stress-challenged pregnant mice. P4, and gal-1 may work in a reciprocal
manner as treatment with gal-1 prevented the stress-induced decrease in P4 and in fact increased systemic
P4 levels higher than amounts measured in non-stressed pregnancies (Blois et al., 2007b). Choe et al
(1997) also reported that gal-1 is under steroid hormone control, and uterine expression is particularly
high around the time of implantation in the mouse.
Galectin-1 control over T helper cytokine profiles may be due to susceptibility of the different
subsets to Gal-1 induced apoptosis (Motran et al., 2008). Signaling and subsequent cell death by gal-1 is
dependent not only on clustering and segregation of CD45 with CD3 and CD43 with CD7 on the target
cell (Pace et al., 1999), but on the glycosylation status of the glycoproteins (Nguyen et al., 2001; Amano
et al., 2003; Hernandez et al., 2006; Toscano et al., 2007). Th1 and Th17 cells express the surface glycans
that Gal-1 binds to cause apoptosis, Th2 cells, however, are protected from Gal-1 through differential
sialylation of their cell surface glycoproteins (Toscano et al., 2007; Kopcow et al., 2008; Rabinovich and
Ilarregui, 2009; Ramhorst et al., 2012b). Galectin-1 also will induce activated CD8+ T cells to undergo
apoptosis (Kopcow et al., 2008).
Recombinant gal-1 induces DCs to have a tolerogenic phenotype. The tDCs then promote
expansion of Tregs characterized by production of IL-10. Tregs play an essential role in the generation of
feto-maternal tolerance by influencing the types of cytokines produced and suppressing proliferation of
CD25- T cells. Tregs are generated in an antigen specific manner and create an overall
immunosuppressive local environment where that antigen is expressed. This is important at the fetomaternal interface because the mother needs to tolerate the paternal antigens expressed by the fetus
(Aluvihare et al., 2004; Sasaki et al., 2004; Somerset et al., 2004; Kallikourdis et al., 2005) The
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importance of Tregs was shown when feto-maternal tolerance failed to be generated in mice depleted of
Tregs or deficient in IL-10, even with the addition of Gal-1. This result also demonstrates that one of the
mechanisms of Gal-1 in generating tolerance is through generation of Tregs (Blois et al., 2007b;
Ramhorst et al., 2012b) and inducing production of IL-10 from T lymphocytes (van der Leij et al., 2004).
Regulatory T cells also produce Gal-1 and expression is upregulated upon TCR activation. It
plays a role in the suppressive function of Treg cells as anti-gal-1 antibody reversed the suppressive
function of human and mouse Tregs in vitro and Tregs isolated from gal-1 null mice also had reduced
suppressive capabilities (Garín et al 2007). Tregs use the molecule to control other types of T cells (Garín
et al., 2007). Gal-1 inhibits cytokine production from Th1 and Th17 cells, induces cytokine production
from Th2 and Treg cells and inhibits adhesion and transendothelial migration of effector T cells (Norling
et al., 2008; Rabinovich and Ilarregui, 2009; Ramhorst et al., 2012b).
Galectin-1 expression is increased during an inflammatory response (Ilarregui et al., 2009) and
expression has been shown to be induced by NF-κB (Toscano et al., 2011). A regulatory mechanism to
control the inflammatory response is built in by gal-1 being able to inhibit activation of NF-κB (Toscano
et al., 2011).

Dendritic Cells
The phenotype of DCs is important because they can either be immunogenic and cause fetal loss
or promote immune tolerance at the feto-maternal interface (Kämmerer et al., 2003; Miyazaki et al., 2003;
Blois et al., 2005; Arck et al., 2007), which is dependent on the signals they receive and the cytokines
they produce when presenting antigen. tDCs are either immature, maturation resistant, or alternatively
activated DCs (activated after exposure to corticosteroids or anti-inflammatory cytokines). These cells
express MHC molecules, inhibitory molecules, low levels of co-stimulatory molecules (CD40, CD0,
CD86), have low production of PICs, produce IL-10, and do not synthesize Th1 polarizing cytokines (IL12p70) (Arck et al., 2007). tDCs not only play an important role in the generation of Tregs but are
involved in the shift towards a predominantly Th2 cytokine profile at the feto-maternal interface
(Miyazaki et al., 2003).
The low ratio of co-stimulatory to inhibitory signals makes it so that when tDCs present antigen,
there is inadequate co-stimulation to activate and cause proliferation of effector T cells (instead they
undergo apoptosis or become anergic), but tDCs can cause the generation and expansion of Treg cells
(Morelli and Thomson, 2007). Treg cells are end-stage effector cells that arise from differentiation away
from the alternative Th17 effector pathway, and this is influenced by TGF-β and IL-6. While IL-6
influences activated CD4+ T cells to become Th17 cells, TGF-β plus IL-2 can prevent IL-6 from
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converting iTregs cells into Th17 type T cells by down-regulating IL-6 receptor expression (Zheng et al.,
2008). While the polarization of naïve CD4+ cells into T help cell subsets is generally viewed as
irreversible, this may not be true for Treg and Th17 cells. These two T helper cell subsets are less stable
and have greater plasticity in switching between the two phenotypes if environmental conditions change
(Zhou et al., 2009). This means an infection or other insult that increases PICs can result in a shift from
Treg cells to Th17 cells that would be detrimental to pregnancy.
Ilarregui et al (2009) reported that Gal-1 induces DCs to produce IL-27 which subsequently
promotes DCs to be tolerogenic, to produce IL-10, and to cause the generation of induced T regulatory
type 1 (Tr1) cells (lack FOXP3 expression) that also produce IL10 to regulate T cell function. The
importance of IL-27 from DCs in causing the differentiation of naïve CD4+ T cells into IL-10 producing
Tr1 cells was reported by Awasthi et al (2007); TGFβ was also reported to amplify the generation of Tr1
cells by IL-27.
Interleukin-27 producing tDCs were generated from interaction with Tregs, most likely in
response to gal-1 produced by the Tregs (Awasthi et al., 2007; Garín et al., 2007). The cytokine induces
the transcription factors AhR and c-Maf, which bind together to promote transactivation of the IL-10 and
IL-21 promoters. The DC then uses these cytokines to cause the generation of Tr1 cells (Apetoh et al.,
2010). IL-21 has also been shown to induce IL-10 synthesis via STAT3 phosphorylation, and can mediate
IL-27 induced IL-10 production, modifying the plasticity of committed Th17 cells (Spolski et al., 2009.)
IL-27 promotes the differentiation of IL-10 producing Treg cells while inhibiting generation of Th17 cells
by inhibiting IL-17 secretion and other molecules associated with the function and maintenance of a Th17
phenotype (Murugaiyan et al., 2009).
Activated Th cells exposed to gal-1 increase expression of the surface-bound immunomodulatory
molecules CD25, CTLA-4, and PD-1, produce IL-10, and stop producing IFNγ and IL-17, essentially
turning them into Tr1 cells (Cedeno-Laurent et al., 2012). Gal-1 treated cells had increased
phosphorylation of STAT1 and STAT3, which have already been established as being associated with Tr1
formation (Wang et al., 2011). IL-10 production in response to gal-1 was associated with expression of
the transcription factors c-Maf, AhR and Jun-B (mediates IL-10 expression in Th2 cells (Wang et al.,
2005)) (Cedeno-Laurent et al., 2012). C-Maf has already been identified as a crucial transcription factor
in Tr1 cell differentiation (Pot et al., 2009). Th1 and Th17 cells have been seen to be susceptible to gal-1
mediated apoptosis at concentrations >7μM (Toscano et al., 2007), thus there may be two consequences
to Th1 and Th17 exposure to gal-1 depending on the exposure amount. Consequence 1 is IL-10 synthesis
during differentiation or after commitment to Th subtypes through the c-MAF/AhR/IL-21 pathway
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(Cedeno-Laurent et al., 2007) and consequence 2 is cell death at high concentrations (Toscano et al.,
2007). IDO expression by tDCs can also induce apoptosis of activated effector T cells (Th1 and Th17)
and is involved in promoting Treg generation through the generation of 3-hydroxyanthranillic acid, a
tryptophan metabolite (Morelli and Thomson, 2007).

Progesterone
Progesterone is produced by the CL and by the placenta to varying degrees depending on the
species. The steroid hormone is known to have immunosuppressive affects and plays a role in modulating
the immune environment in the uterus. P4 has genomic and non-genomic effects with non-genomic effects
being mediated by G-protein coupled receptors and genomic effects being mediated by two isoforms of
its nuclear receptor (PR-A and PR-B) that act as transcription factors (Li et al., 2004; Mulac-Jericevic and
Conneely, 2004; Arck et al., 2007). In the peri-implantation uterus, P4 has been reported to regulate
several genes including amphiregulin (in the EGF superfamily), Hox-A10 and Hox-A11 (homeobox gene
family), histidine decarboxylase (histidine->histamine), calcitonin, immune response gene-1 (Irg-1),
Muc1, Indian hedgehog, and gal-1 (Choe et al., 1997; Arck et al., 2007). Progesterone can influence
cytokine production as well as immune cell function.
In pregnant women, P4 causes the production of P-induced blocking factor (PIBF) that mediates
some of progesterone’s immunological effects (Arck et al., 2007). PIBF activates the JAK/STAT pathway
activating STAT6, which then causes transcription of SOCS-3. SOCS-3 will bind to the IL-12R,
inhibiting IL-12 signaling and preventing IL-12 activation of STAT4 (Kozma et al., 2006), thus
influencing T cells towards a Th2 phenotype and blocking a Th1 phenotype. PIBF therefore, leads to TH2
dominant cytokine production (Szekeres and Wegmann, 1996) and blocks NK cell activation because of
the reduced IL-12 production (less Th1 cells) (Szekeres-Bartho et al., 1996). In sheep, the P4 induced
immunoregulatory molecule is not PIBF but instead a member of the serine proteinase inhibitor family
called uterine serpin. This molecule is also secreted from the endometrium of goats, cattle, and pigs and
has been reported to block lymphocyte proliferation in vitro (Liu et al., 1999; Peltier et al., 2000).
Murine studies have shown that CD4+ T cells contain the nuclear PR, and P4 reduces effector
activity of these cells through binding of its nuclear receptor and repressing transcription of IFNγ (Hughes
et al., 2013). Also, through interaction with its nuclear receptor, P4 has been shown to promote the
generation of murine induced Treg cells in vitro that have suppressive functions with regards to
generation of effector T cells and inflammation in vitro and in vivo (on target T cells) (Lee et al., 2012).
P4 suppresses mTORC1 signaling which is needed for the generation of Th1 and Th17 cells; in its
absence, Treg cells are produced (Haxhinasto et al., 2008; Lee et al., 2012). P4 also leads to the expansion
of the Treg population during murine pregnancy (Mao et al., 2010).
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Culture of human peripheral blood mononuclear cells (PBMCs) from pregnant women with P4
resulted in reduced production of IFNγ and TNFα, while increasing production of IL-4 (Lissauer et al.,
2015). P4 is a potent inducer of Th2 cytokines (Piccinni et al., 1995; Miyaura and Iwata, 2002) including
IL-4 which mediates P4 stimulated LIF (Piccinni et al., 1998) and M-CSF (Piccinni et al., 2001)
producing T cells. LIF is critical for implantation as it mediates uterine receptivity (Rosario and Stewart,
2016) while M-CSF is important for pregnancy development (Piccinni et al., 1998; Piccinni et al., 2001;
Song et al., 2009). The Th2 cytokines, IL-4 and IL-10, can inhibit development and function of Th1 cells
and MΦs, which is important as IL-12 and IFNγ downregulate LIF and a Th1 response promotes allograft
rejection (Piccinni et al., 1998; Piccinni et al., 2001).
Progesterone can regulate mature DC function and DC-stimulated proliferation of T cells in a
receptor-mediated manner (Butts et al., 2007). Treatment of LPS activated mature bone marrow derived
dendritic cells (BMDCs) with P4 did not alter antigen take up by DCs, but suppressed production of the
PICs TNFα and IL-1β without affecting IL-10 production. Treatment with P4 also down regulated
expression of the co-stimulatory molecule CD80 by DCs and inhibited DC-stimulated T cell proliferation
(Butts et al., 2007). As the major APC in the uterus, reduced PIC production and decreased expression of
co-stimulator molecules by DCs will limit Th1 responses and T cell responses to fetal antigen.
Acting through the GC and P4 receptors, P4 can downregulate innate immune responsivity of MΦs
by modulating TLR signaling (Jones et al., 2008; Su et al., 2009). The downregulation is associated with
the suppression of NF-κB activation and enhancement of SOCS1 expression leading to a decrease in NO,
IL-6, and IL-12 production (Miller et al., 1996; Su et al., 2009).
Mucin-1 expression is induced by E2 and expressed in humans by the syncytiotrophoblast at the
feto-maternal interface and by the extravillous trophoblast cells invading the decidua (Jeschke et al.,
2002). Mucin-1 is thought to control the correct placement and timing of implantation. Blastocyst
implantation is proposed to be regulated by a uterine barrier consisting of a high density of Muc-1 at the
epithelial cell surface that inhibits blastocyst adhesion (Aplin et al., 2001). Downregulation of Muc-1
expression by the uterine epithelium at the implantation site during the window of implantation allows for
blastocyst adhesion. This may be regulated by P4 antagonizing Muc1 expression (Brayman et al., 2006).

Complement
The complement system is part of the innate immune response and is involved in killing
pathogens, inflammation, production of PICs, chemotaxis of inflammatory cells, opsonisation and
clearance of immune complexes (Molina, 2005; Murphy 2012). Proper control of complement in the
uterine environment is necessary to prevent inflammation and embryo loss since inappropriate
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complement activation results in loss of maternal-fetal tolerance (Xu et al., 2000; Mellor et al., 2001;
Caucheteux et al., 2003; Mao et al., 2003). There are 3 complement pathways that differ in how the
pathway initiates, but all converge at the formation of C3 convertase. The classical pathway is initiated
when complement proteins bind antigen-antibody complexes; the lectin pathway is initiated when
mannose-binding lectin binds to mannose residues in microbial proteins and polysaccharides, and the
alternative pathway is initiated when complement fragments bind directly to the microbial cell wall. The
pathways end with the formation of the membrane attack complex, which is inserted into the wall of a
target cell resulting in it being lysed. During the complement cascade some complement fragments have
other effects rather than being involved in formation of the convertases or membrane attack complex.
These complement fragments (C3a, C3b, C4a, C5a) have effects such as opisonization of target cells,
causing degranulation of mast cells, basophils, and eosinophils, extravasation and chemotaxis of
leukocytes to the inflammatory site, aggregation of platelets, release of hydrolytic enzymes from
neutrophils, and increased expression of complement receptors by neutrophils (Murphy, 2012).
Murine studies have shown the role of complement deposition in fetal loss, abnormal placental
development and the importance of complement regulation in the uterine environment to prevent
complications (Xu et al., 2000; Wu et al., 2000; Mao et al., 2003). Girardi et al (2006b) reported that C3
deposition in the decidua of mice was associated with increased necrotic tissue, fetal debris, and
infiltration of inflammatory cells such as neutrophils and monocytes. Xu et al (2000) demonstrated that
deficiency in the complement regulatory protein Crry (complement receptor 1-related gene/protein y) in
mice results in fetal loss due to spontaneous C3 deposition in the placenta at the fetomaternal interface
and embryos being invaded by polymorphonuclear cells. Complement fragments cause increased
production/release of PICs, such as TNFα (Girardi et al., 2006b). Increased TNFα levels at the fetomaternal interface can lead to fetal loss as TNFα can reduce inner cell mass proliferation, induce
trophoblast apoptosis and restrict trophoblast invasiveness (Hunt et al., 1989; Yui et al., 1994; Pamofer et
al., 1994a; Pampfer et al., 1994b; Silver et al., 1994; Pampfer et al., 1995). Fetal loss in Crry deficient
mice was attributed to C3 activation because Crry null mice pups were born only if they were on a C3
deficient background (Xu et al., 2000) Crry is a membrane bound protein that inhibits the deposition of
activated C3 and C4 on the surface of autologous cells and has been shown to be expressed in
trophoblasts and maternal decidual tissues. While Crry is specific to mice, other complement regulatory
proteins that have been found in high levels in human placentas, such as decay accelerating factor
(DAF/CD55) and membrane cofactor protein (MCP/CD46) may have a similar role in other species
(Caucheteux et al., 2003).
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Female mice of abortion prone matings were reported to have increased complement activation
that was associated with impaired placental vascularization and a deficiency in the number of trophoblast
giant cells (Girardi et al 2006a). Trophoblast giant cells mediate implantation and invasion of the decidua
by the conceptus; efficient numbers of these cells leads to placental failure (Kraut et al., 1998; Cross et
al., 2005). Placental development requires angiogenic growth factors, VEGF and placenta growth factor
along with expression of their receptors (Lam et al., 2005). By binding to the tyrosine kinase receptors
VEGFR-1 (Flt-1) and VEGFR-2, VEGF promotes placental development and invasiveness (Ferrara et al.,
2003). The VEGFR-1 can be alternatively spliced to produce a secreted form of the receptor (soluble
sVEGFR-1/sFLT-1) that lacks the cytoplasmic and transmembrane domains of the receptor but retains the
ligand binding domain (Kendall and Thomas, 1993). This secreted form of the receptor is actually antiangiogenic by binding and sequestering circulating VEGF and placental growth factor, preventing the
molecules from interacting with their endogenous receptors (He et al., 1999). Impaired placental
vascularization in abortion prone mice matings in Girardi et al’s study (2006a) was found to be due to
C5a produced during the complement cascade inducing infiltrating monocytes to produce sVEGFR-1 that
then bound VEGF inhibiting its activity during placental development. Thus, complement can affect the
pro-angiogenic functions of uterine MΦs impairing pregnancy success.

Bacterial Infections and the Innate Immune System
Although there are numerous mechanisms in place to generate and maintain maternal tolerance to
the fetus (Trowsdale and Betz, 2006), an acute or chronic uterine infection during pregnancy that
activates the immune system to clear the infection can also result in disruption of maternal tolerance and
ultimately fetal loss (Mor, 2008; Koga et al., 2014). Infection induced loss is most likely to occur during
the early phases of pregnancy when maternal tolerance is still being generated. Paternal alloantigens
presented during a uterine infection are likely to be presented in the presence of PICs, which will favor
activation of inflammatory/effector T cells instead of Tregs, which can result in fetal rejection (Trowsdale
and Betz, 2006).
A uterine infection will cause inflammation by signaling innate immune cells through PAMPs
and DAMPs; LPS even increases expression of the IFNγ and TNFα receptors heightening the
inflammatory response. This can result in a shift in cytokine expression, a switch from tolerogenic to
immunogenic DCs, a loss in Treg cell function, and uNKs to become cytotoxic, ultimately resulting in
fetal loss. Exposure to a PAMP or DAMP can also cause MΦs, trophoblast cells, and endothelial cells to
up-regulate surface expression of a membrane pro-thrombinase (Fibrinogen-like protein 2/mFGL2) that
will activate thrombin and result in fibrin deposition, vascular thrombosis, and inflammation. Once
thrombin is activated there is positive feedback for further activation. Thrombin will activate complement
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component 5 which will spilt into C5a and C5b (Clark and Chaouat et al., 2012). C5a will then act as a
chemoattractant to bring in additional innate immune cells and cause release of inflammatory mediators
(Murphy, 2012). The combination of polymophonuclear leukocytes recruitment by endothelial cells and
C5a, inflammation, and fibrin deposition will impair the vascular supply to the placenta and cause fetal
loss (Clark and Chaouat et al., 2012).
DC maturation results in upregulation of surface expression of MHCII, CD80, CD86, CD40,
CCR7, and production of cytokines like IL-12 and TNFα. Maturation occurs in response to DAMPs,
PAMPs, and PICs (Morelli and Thomson, 2007). Monocyte derived DCs that mature in the presence of
PGE2 are induced to migrate to secondary lymph nodes (Luft et al., 2002). This effect maybe mediated by
PGE2 altering CCR7 signal transduction (Scandella et al., 2004). This chemokine receptor responds to the
ligands CCL19 and CCL21, which are expressed in lymphoid organs (Scandella et al., 2004). An
infection that increases PICs and PGE2 will result in DCs traveling to lymph nodes to present antigen
while producing Th1 polarizing cytokines.
Regulatory T cells control NK cell proliferation, secretory function, and cytotoxic activity in a
TGFβ dependent manner involving downregulation of the NKG2D receptor (receptor on the surface of
NK cells, cytotoxic CD8+ cells, and γδ T Cells; ligand binding leads to perforin-mediated cytotoxicity),
insufficient quantity of Treg cells can result in an overabundance of NK cell activity (Ghiringhelli et al.,
2005a). Treg cells, however, cannot suppress NK cell function when the IL-2Rγ chain (cytokine receptor
sub unit that is a part of the receptors for IL-2, IL-4, IL-7, IL-9, IL-15, or TLR4 is activated (Ghiringhelli
et al., 2005a). This means that with an acute infection or LPS exposure, Tregs will be unable to prevent
NKs from proliferating and having cytotoxic activity. With regards to pregnancy, a uterine infection will
likely convert specialized uNK cells into cytotoxic NKs that behave similarly to their peripheral
counterparts resulting in pregnancy loss.
Infection can be a stressful event and can involve the activation of the hypothalamic-pituitaryadrenal (HPA) axis. High levels of GCs exert adverse effects on the uterus and fetus and inhibit LH, E2
and P4 secretion (Magiakou et al., 1997). Stressful events during pregnancy can also challenge the
immune suppressive environment of the uterus leading to pregnancy loss (Arck et al., 1995).
Allogenically mated mice exposed to stress early in gestation causes a decrease in P4 (Joachim et al.,
2003), increased secretion of PICs (Blois et al., 2004b), migration of inflammatory cells to the fetomaternal interface (Blois et al., 2005), and decreased Treg cells and gal-1 (Blois et al., 2004b; Blois et al.,
2007b), thus resulting in a switch from an anti-inflammatory to a pro-inflammatory environment.
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The trophoblast expresses PPRs that sense bacteria, viruses, dying cells, and damaged tissue in
the surrounding environment (Abrahams et al., 2005; Mor et al., 2005, Costello et al., 2007). In response
to PAMPs and DAMPs, the trophoblast will secrete cytokines that will act on immune cells (MΦs, DCs,
Tregs, NK cells) in the uterus and recruit additional immune cells (Fest et al., 2007). Immune cells in the
pregnant uterus tend to have a specialized phenotype: NK cells are not cytotoxic, DCs are tolerogenic, T
cells are regulatory; however, infections can cause them to lose that phenotype. While they were
promoting fetal tolerance, with an infection, they switch to functions that promote fetal rejection (Murphy
et al., 2005; Fest et al., 2007; Mor, 2008). The trophoblast can respond to PICs in addition to producing
them, and an increase in PICs can change trophoblast resistance to Fas-mediated apoptosis leading to
embryonic death (Abrahams et al., 2004). There are 3 major ways for a viral or bacterial infection to gain
access to the uterus: through the maternal circulation, by ascending into the uterus from the lower
reproductive tract (most common), or by descending into the uterus from the peritoneal cavity (Deb et al.,
2004; Espinoza et al., 2006).

Inflammation
Inflammation is a mechanism to restore homeostasis in response to infection or injury but also
after physiological changes in tissue architecture like ovulation or parturition (Medzhitov, 2008; Sheldon
et al., 2014). Classical signs of inflammation are redness, swelling, heat, and pain. There are seven groups
of inflammatory mediators: vasoactive amines, vasoactive peptides, complement fragments, lipid
mediators, cytokines, chemokines, and proteolytic enzymes (Medzhitov, 2008). Vasoactive amines, such
as histamine and serotonin, are released from granules in mast cells causing increased vascular
permeability and vasodilation or vasoconstriction depending on the situation. Vasoactive peptides
(substance P, fibrinopeptide A, fibrinopeptide B, fibrin degradation products) cause vasodilation and
increased vascular permeability directly or by causing histamine release from mast cells. Fragments
generated during the complement pathways (C3a, C4a, C5a) trigger the synthesis of cytokines,
chemokines, and adhesion molecules, promote granulocyte and monocyte recruitment and cause mast cell
degranulation (granule contents then affect vasculature) (Medzhitov, 2008; Dinarello, 2010). Lipid
derivatives (eicosanoids, platelet-activating factors, resolvins) are produced from phospholipids located in
cell membranes.
Activated PLA2 releases arachidonic acid (AA) from membranes to be turned into eicosanoids.
Cyclooxygenases (COX 1 and COX2) turn AA into PGs and thromboxanes while lipoxygenases turn AA
into leukotrienes (LTs) and lipoxins (LXs) (Medzhitov, 2008). Some prostaglandins cause vasodilation
(PGE2 and PGI2), and PGE2 is hyperalgesic and causes fever (Higgs et al., 1984). Lipoxins along with
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resolvins and protectins produced from dietary omega-3 fatty acids inhibit inflammation and aid in the
resolution of inflammation and tissue repair (Serhan, 2007).
Cytokines (interleukins, interferons, adipokines, tumor necrosis factors, mesenchymal growth
factors) can be separated into groups based on their primary function: cytokines that are mostly
lymphocyte growth factors, ones that are mostly pro-inflammatory, ones that are mostly antiinflammatory, or cytokines that polarize the immune response to antigen. Cytokines activate endothelium
and leukocytes, cause fever, resistance to viral infections, lead to elevated white blood cell counts, and
induce the acute phase response. Chemokines are responsible for controlling leukocyte extravasation and
chemotaxis of additional immune cells to the affected area (Dinarello, 2007; Medzhitov, 2008).
Proteolytic enzymes (elastin, cathepsins, matrix metalloproteinases) degrade extracellular matrix and
basement membrane proteins, which is important for allowing leukocytes to move through the area and
during tissue remodeling (Medzhitov, 2008).
The beginning of the inflammatory response is characterized by pro-inflammatory mediators
(PIMs) (IL-1β, IL-6, TNFα, IL-8, PGE2) that attract and activate immune cells like neutrophils and MΦs
to remove the pathogen and damaged cells. After the pathogens have been cleared, mediators like IL-10
(suppresses IFNγ, IL-1, TNFα, IL-6) and resolvins are released to stop the inflammatory reaction and to
repair any damaged tissue (Dinarello, 2007; Sheldon et al., 2014). While inflammation is an important
mechanism for restoring tissue homeostasis and is an important part of the innate immune system, chronic
inflammation has adverse effects.

Infection
Infection is an important trigger for inflammation that is harmful to pregnancy and can lead to
embryonic loss. There are PRRs located at the maternal-fetal interface (expressed on immune cells,
trophoblast, epithelial cells, stromal cells) that recognize and bind PAMPs, which are unique to the
surface of microorganisms (Martinon et al., 2009; Schroder and Tschopp, 2010; Murphy, 2012). Binding
of these receptors to pathogen molecules results in the activation of anti-pathogen responses, such as the
synthesis and secretion of chemokines, PICs, antimicrobial peptides, and acute phase proteins (APPs)
(Wira et al., 2005; Akira et al., 2006; Davies et al., 2008; Medzhitov, 2008; Koga et al., 2014). PAMPs
are typically molecules that are vital for microbial survival; therefore, they are unlikely to change because
that would be detrimental to the microbe. Examples include bacterial structural components, such as LPS
and peptidoglycan, and viral nucleic acids. PAMPS can be specific to classes of microbes and their
invariance makes them a good way of alerting the innate immune system of a microbe’s presence
(Martinon et al., 2009).
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Toll like receptors (TLRs) are one family of innate immune system receptors with 10 members,
some of which are located in the endosome and some are displayed on the cell surface. The TLRs that
respond to bacteria are TLR2, which forms heterodimers with TLR1 and TLR6 and recognizes bacterial
lipopeptides, and TLR4, which recognizes the gram negative bacterial cell wall component, LPS in
complex with CD14 and MD2 (Chow et al., 1999; Saito et al., 2000; Abrahams, 2008; Takeuchi and
Akira, 2010). LPS is an endotoxin located in the cell walls of gram-negative bacteria and consists of
mostly carbohydrates and lipids. LPS has a hydrophilic core of repeating polysaccharides attached to an
O-specific chain and the hydrophobic lipid-A domain (Raetz, 1993). The core region is conserved
between different types of gram negative bacteria, whereas, the O-specific chain of repeating
polysaccharides has some structural diversity. The lipid A region is the portion recognized by other cells
and is responsible for LPS-induced biological responses (Rietchel et al., 1994). Endotoxins are constantly
shed into the bacteria’s environment, released after gram negative bacteria are ingested by phagocytes and
degrade in vacuoles, and released when the bacterium lyse or disintegrate (Deb et al., 2004). The
endotoxin can then interact with local host cells and/or travel in the blood to cause a variety of responses
(Deb et al., 2004). In the circulation, LPS is bound to lipoproteins or LPS-binding proteins (LBP).
Not only are neutrophils, MΦs, and DCs able to respond to PAMPs and DAMPs but other nonimmune cells also have PRRs. Endometrial epithelial and stromal cells express the TLR4/CD14/MD2
receptor complex and respond to LPS by secreting IL-6, CXCL8, and PGE2 (Herath et al., 2006; Herath et
al., 2009b; Cronin et al., 2012). In response to binding its ligand, TLRs initiate production and release of
PICs or type I interferons (IFN) and IFN-inducible proteins (Akira and Hoshino, 2003; Koga et al., 2014).
TLRs responding to bacterial components with the help of MYD88 stimulate IL1R associated kinases
(IRAK4/IRAK1), which activate TNFR associated factor 6 (TRAF6) which catalyzes a complex
consisting of TGFβ activated kinase 1 (TAK1) and members of the TAK1 binding protein (TAB) family.
This complex can activate the MAPK pathway (JNK, ERK1/2, p38) leading to activation of the
transcription factor AP-1 or it can activate the IKK complex (IKKα, IKKβ, IKKγ) causing
phosphorylation and ubiquitination of IκB. Ubiquitination of IκB causes degradation of the protein which
releases NF-κB from the complex allowing it to translocate into the nucleus. In the nucleus, the
transcription factors AP-1 and NF-κB activate transcription of PIMs including cytokines (IL-1α, IL-1β,
IL-6, TNFα), chemokines (CXCL8, CXCL1), and lipid mediators (PLA2, PGHS, PGES). On the other
hand, endosomal TLR4 recognizes viral envelope glycoproteins and signals in a MyD88 independent
pathway that involves Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF). TRIF then
either leads to activation of NF-kB for PIC production or IFN regulatory factor-3 (IRF-3) for type I IFN
and IFN-inducible genes production (Takeuchi et al., 2000; Yamamoto et al., 2003).
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Prostaglandins are inflammation mediators and are produced in a cell-specific manner. Activation
of the transcription factor NF-κB by IL-1 or TNFα leads to COX2 gene expression and the production of
PGE2 (Dinarello, 2007). Monocytes/MΦs produce large amounts of PGE2 and PGF2α upon stimulation
while neutrophils produce moderate amounts of PGE2, and mast cells produce PGD2. The enzyme 5-LOX
is expressed by mast cells, monocytes, MΦs, and granulocytes and converts AA into the 4-series LTs and
hydroxyl and hydroperoxy derivatives (5-HETE and 5-hydroperoxyeicosatetraenoic acid (5-HPETE))
(Calder, 2003).
Prostaglandin E2 is involved in acute inflammation by inducing fever, lowering pain thresholds,
promoting local vasodilation/vascular permeability and by promoting local attraction/activation of
neutrophils, MΦs, and mast cells (Calder, 2003; Dinarello, 2010; Kaliński, 2012). However, PGE2 also is
considered an immunosuppressive product of inflammation. PGE2 can induce IL-10 production and can
reduce levels of PICs, chemokines, and adhesion molecules reducing nonspecific and chronic
inflammation (Dinarello, 2010; Kaliński, 2012).
Not only does PGE2 recruit cells to the local inflammatory site, but it also can affect their
function. With regards to NK cells, PGE2 can suppress their ability to respond to IL-12 and IL-15 (Joshi
et al., 2001; Walker and Rotondo, 2004), which results in suppressed cytolytic function (Bankhurst, 1982;
Goto et al., 1983), and inhibit NK cell production of IFNγ, which is used to help DC cells induce Th1 and
cytotoxic T cell responses (Mailliard et al., 2005). PGE2 can reduce phagocytosis and release of
lysosomal enzymes by granulocytes (Smith, 1977).
PGE2 is a potent suppressor of T cell function. PGE2 increases intracellular cAMP levels, which
then suppresses IL-2, IFNγ, and TNFα production (Dinarello, 2007; Dinarello, 2010). PGE2 not only
inhibits IL-2 production (Walker et al., 1983) but also the expression of the IL-2 receptor and JAK3
needed for IL-2 responsiveness by T Cells (Rincón et al., 1988, Kolenko et al., 1999), thus suppressing T
cell activation and proliferation. DCs that mature in the presence of PGE2 are characterized with a
phenotype of impaired ability to induce cytotoxic T lymphocytes, Th1, and NK cell mediated immunity
(Kaliński et al., 1998; Kaliński et al., 1999; Gustafsson et al., 2008) but instead promote Th2 responses
(Kaliński et al., 1999). PGE2 is able to suppress production of the Th1 polarizing cytokine IL-12 in
monocytes (van der Pouw Kraan et al., 1995) and DCs (Kaliński et al., 1997; Kaliński et al., 1998) and
can suppress IL-12 receptor expression and responsiveness (Wu et al., 1998). More directly, PGE2
inhibits Th1 IFNγ production but does not affect Th2 cytokines, IL-4 and IL-5, by CD4+ T cells (Betz
and Fox, 1991; Snijdewint et al., 1993). PGE2 can cause development of Th17 cells through suppression
of IL-12, which is inhibitory to Th17 polarization and by enhancing IL-23, which promotes Th17
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polarization (Kahyrullina et al., 2008). The PG also increases IL-17 production and augments IL-6
production (Calder, 2003; Dinarello, 2007; Dinarello, 2010). While Th17 cells are inflammatory, PGE2
also promotes the development of Tregs from naïve T cells (Baratelli et al., 2005) and the interaction of
DCs with Tregs (Muthuswamy et al., 2008), which may promote Treg expansion (Banerjee et al., 2006).
PGE2 can also affect chemokine expression at the inflammatory site so that pro-inflammatory type MΦs,
cytotoxic T lymphocytes, NK cells, and Th1 cells are not attracted to the area (McIlroy et al., 2006;
Gustafsson et al., 2008; Muthuswamy et al., 2008; Van Elssen et al., 2011), but Th2 and Tregs cells are
attracted (McIlroy et al., 2006; Muthuswamy et al., 2008).
Neutrophils are usually the first responders to arrive at the site of an invading pathogen (Sadik et
al., 2011). They are recruited from the vasculature to the site of pathogen invasion to aid in containing
and clearing the pathogen (Chiang et al., 2012). To get neutrophils to the inflammation site they must be
“captured” by the vascular endothelium, transverse into the tissue, and then migrate to the inflammation
site (Sadik et al., 2011). Neutrophils phagocytose pathogens and destroy them in phagocytic vacuoles
using protease enzymes housed in granules (Segal, 2005). Due to their destructive nature they can
potentially cause tissue damage; therefore, recruitment and activity of neutrophils must be regulated.
There are several chemoattractants that have been identified to recruit neutrophils to the site of infection
including CXCL8, IL-17, IL-37, leukotriene B4 (LTB4), platelet activating factor (PAF), and complement
components C5a and C3a (Sadik et al., 2011). Neutrophils are made in the bone marrow and will move
out into the periphery in response to the hematopoietic cytokine G-CSF during acute inflammation.
PAMPs and DAMPs will activate tissue resident sentinel cells (MΦ, mast cells) or stromal cells to release
PIMs and neutrophil chemoattractants (chemokines and lipid mediators (LTB4 and PAF)) (Arancibia et
al., 2007; Borregaard, 2010; Williams et al., 2011).
In order for neutrophils to exit the blood stream and migrate to the injury/inflammation site,
adhesion molecules must be displayed by the endothelial cells neighboring the area. Neutrophils will
engage in a sequence of physical interactions with endothelial cells that can be referred to as the
leukocyte adhesion cascade (Williams et al., 2011) and includes rolling, activation, adhesion
strengthening, and then diapedesis (Murphy, 2012); events that are orchestrated by PGE2, leukotrienes,
adhesion molecules, and chemokines (Calder, 2003; Phillipson et al., 2006; Wegmann et al., 2006; Lou et
al., 2007; Borregaard, 2010; Sadik et al., 2011; Murphy, 2012). Lipid mediators such as LTB4 usually act
at the start of neutrophil recruitment and at the local site of inflammation as they are rapidly produced but
have a short half-life. Chemokines, on the other hand, are produced slower (as they are often regulated
transcriptionally and their release is subject to post-translational regulation) and have a longer half-life
making them suited to be used later in recruitment cascades and at longer distances (Sidak et al., 2011). In
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tissue, the main job of neutrophils is thought to be phagocytosis; however, in peripheral tissues they can
release chemokines, cytokines, and lipid mediators (Scapnin et al., 2000; Kasama et al., 2005;
Borregaard, 2010) contributing to biological mediator production at the inflammation site. While a single
neutrophil cannot produce the same quantity of mediators as other immune cells (ex: MФ) due to their
sheer number at the inflammation site their mediator production is significant (Kasama et al., 2005; Chou
et al., 2010). In producing these mediators, neutrophils can recruit additional neutrophils to the site, aid in
orchestrating the progression of an acute inflammatory response from a predominantly neutrophilic
infiltrate to a monocytic one (Soehnlein et al., 2009), and participate in the resolution of inflammation
through the production of specialized pro-resolving mediators (SPMs) through sequential steps involving
endothelial cells and MΦs in addition to neutrophils (Serhan and Savill, 2005; Ariel et al., 2006;
Borregaard, 2010). When MΦs phagocytosis apoptotic neutrophils they decrease their production of IL23, this leads to a decrease in production of IL-17 from Th17 cells and consequently less G-CSF is
produced from fibroblast and endothelial cells in the area to stimulate neutrophil production in the bone
marrow (Borregaard, 2010).
Murine Treg cells have been reported to express several TLRs including TLR 4, 5, 7, and 8
(Caramalho et al., 2003) and respond to the TLR4 ligand LPS in vitro. When cultured with LPS, murine
Tregs cells proliferated, had increased survival, and increased suppressor function (Caramalho et al.,
2003). Activation of Tregs by microbial PAMPs does not stop the immune system from clearing an
infection, but it may limit the magnitude of the immune response to protect against host damage and
targeting self-antigens (Hori et al., 2002). The balance between effector and regulatory cells depends on
the antigens being presented, thus with the onset of acute infection a high amount of nonself peptides are
presented resulting in activation of naïve responder cells. As the pathogen is dealt with and the debris is
cleared, the predominant type of antigen being presented shifts towards self-antigen being presented to
Tregs. Activated Tregs can then work to control inflammation, restore homeostasis, and prevent the
activation of naïve, autoreactive T cells by self-antigen presented in an inflammatory context (Caramalho
et al., 2003).
Ligation of PAMPs to TLRs on DCs leads to maturation of the APCs characterized by
upregulation or MHCII and the co-stimulatory molecules CD80 and CD86, and the production of
cytokines (Murphy, 2012). LPS matures DCs and stimulates them to produce PICs including IL-6, which
has been shown to allow activation and function of pathogen specific effector T cells even in the presence
of Tregs cells (IL-6 signaling allows effector T cells to overcome the suppressive effect of Treg cells)
(Pasare and Medzhitov, 2003).
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While the response of the innate immune system to a pathogen is not specific to the type of
invader (inflammation, phagocytosis, complement), the adaptive immune system tailors its response to
the type of pathogen (bacteria, virus, parasite) through subsets of T helper cells with different functions
and through CD8+ T cells and B cells with antigen specific receptors (Murphy, 2012). The different T
helper cell subsets are under the control of distinct lineage specifying genes that are activated in response
to 1) CD4+ TCR recognizing antigen presented by an APC, 2) interaction between co-stimulatory
molecules between the T cell and APC, 3) specific cytokines released by the APC (Murphy, 2012). An
APC producing IL-12 and IFNγ when presenting antigen to a naïve CD4+ T cell will cause the
transcription factors STAT4 and T-bet to become activated leading to a Th1 cell that will produce IL-2
and IFNγ while aiding in virus elimination. An APC producing IL-4 and IL-2 will cause the transcription
factors STAT6 and GATA3 to be produced by a naïve CD4+ T cell turning it into a Th2 call that will aid
in eliminating parasites and produce the cytokines IL-4, IL-5, and IL-10. Naïve CD4+ cells are polarized
towards a Th17 phenotype in the presence of IL-17, IL-6, IL-21, and IL-23 from the APC which activate
the transcription factors STAT3 and RORγt. Th17 cells are a pro-inflammatory T helper cell subset that
produce IL-17 that recruits neutrophils to the site of infection. Treg cells are polarized in response to the
cytokines TGFβ and IL-2 from the APC and the transcription factors STAT5 and Foxp3. Tregs have
suppressive functions and produce TGFβ and IL-10 (Reiner, 2007; Murphy, 2012) Tregs can switch to a
Th17 phenotype in the presence of PICs (Koenen et al., 2008), but this switch can be suppressed by IDO
(Baban et al., 2009).

Fever
Fever is an upward resetting of an individual’s temperature “set point” (threshold for the
activation of thermal responses) in response to infection (Cooper et al., 1964). Recognizing PAMPS,
leukocytes release endogenous pyrogens that affect the hypothalamic temperature sensors leading to a rise
in the temperature set point. The individual is then in a hypothermic state since body temperature is below
the new temperature set point. Effector mechanisms are activated to elevate body temperature including
increased metabolic heat production, decreased heat loss by decreasing skin blood flow and evaporative
heat loss, and behavioral responses such as seeking an area of warmer temperature (Kluger, 1978).
The major mediator of fever is PGE2 produced by brain vascular endothelial cells (Stitt, 1986;
Engstrӧm et al., 2012; Wilhelms et al., 2014). The lipid effector is produced in response to pyrogenic
cytokines and activates neurotransmitters that raise core body temperature (Evans et al., 2015). Pyrogenic
cytokines (IL-1, IL-6, and TNFα) are produced in response to bacterial products, toxins, or the microbes
themselves at the site of infection and travel through the circulation to the brain vascular where they are
either actively transported across the blood-brain barrier or through passive transport cross into the brain
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through fenestrated capillaries in the circumventricular organs (Netea et al., 2000; Evans et al., 2015).
LPS may also be able to induce fever by stimulating PIC production by endothelial cells in
circumventricular organs (Netea et al., 2000). Pathogenic stimuli also cause peripheral PGE2 production
by hematopoietic cells that can travel through the blood-brain barrier and initiate a fever response (Netea
et al., 2000; Evans et al., 2015).
The cytokines IL-1 and TNFα are produced initially, and both cytokines can then stimulate IL-6
production. All 3 cytokines work to stimulate PGE2 production (Netea et al., 2000; Evans et al., 2015).
The systemic or locally produced pyrogenic cytokines act on brain endothelial cells to induce synthesis of
the enzymes COX-2 and prostaglandin E synthase 1 resulting in PGE2 production (Engstrӧm et al., 2012;
Wilhelms et al., 2014). IL-1 receptors mediating COX2 induction, and, thus, PGE2 synthesis, have been
identified on brain endothelial cells within the median preoptic nucleus region of the hypothalamus and
signal via the p38 MAPK and c-Jun pathway (Konsman et all, 2004; Ching et al., 2007). Il-6 binds to IL6Rα on brain endothelial cells inducing COX2 expression and PGE2 synthesis via the STAT3 signaling
pathway (Eskilsson et al., 2014). To induce fever, PGE2 binds to the PGE2 receptor 3 (EP3) expressed by
thermoregulatory neurons in the median preoptic nucleus region of the hypothalamus (Ushikubi et al.,
1998; Lazarus et al., 2007). Neurons expressing EP3 trigger the sympathetic nervous system to release
noradrenaline which increases thermogenesis in brown adipose tissue and reduces passive heat loss in
extremities by inducing vasoconstriction. Acetylcholine also is released, which increases overall
metabolic rate and stimulates muscle myocytes to induce shivering (Hasday et al., 2014; Evans et al.,
2015).
In moderation, an elevation in body temperature is beneficial in that it inhibits bacterial growth,
increases bactericidal activity of innate immune cells, causes leukocyte mobilization, and stimulates acute
protein synthesis, allowing the host to clear the infection and survive (Kluger, 1978; Netea et al., 2000).
Specifically, fever-range temperatures increases neutrophil recruitment to local sites of infection and
enhances respiratory burst, a bacteriolytic mechanism of neutrophils (Evans et al., 2015). Phagocytic
activity of MΦs and DCs are increased with heat as well as their response to pathogens through
upregulation of TLR2 and TLR4. Heat also increases expression of MHC I, MHC II, and co-stimulatory
molecules (CD80 and CD86) by mature DCs and augments secretion of Th1 polarizing cytokines (IL-12,
TNFα) and CC-chemokine receptor 7 (CCR7) dependent migration through afferent lymphatics to
draining lymph nodes; thus increasing their potential to sense pathogens and then present antigen to naïve
T cells.
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Several chemokines contain binding sites within their promoter regions for heat-inducible
transcription factor heat shock factor protein 1 (HSF1) including chemokines that recruit neutrophils, NK
cells, monocytes, CD4+ and CD8+ T cells (CXCL8, CXCL9, CXCL10, CXCL11, and CXCL12) (Hasday
et al., 2014), suggesting fever aids in infiltration of immune cells to infection sites. Heat also functions to
increase release of immunomodulatory molecules such as cytokines, NO, and heat shock protein 70
(Evans et al., 2015). While febrile temperatures initially increase PIC production by MΦs at the
inflammatory site, heat also dampens cytokine production after MΦs become activated. This is a result of
elevated temperature reducing transcription of genes for PICs through repressive activities of the HSF1.
In addition, there is reduced recruitment of NF-κB to promoter regions of cytokine encoding genes and
reduced cytokine mRNA stability (Evans et al., 2015).

Acute Phase Response
An acute phase response (APR) is a nonspecific reaction with the goal of restoring homeostasis
(Ceciliani et al., 2002; Murata et al., 2004; Gruys et al., 2005; Cray et al., 2009). The APR is part of the
innate immune response and can be activated by infection, stress, and inflammation (Murata et al., 2004;
Cray et al., 2009). Local response to these triggers is production of PICs that act at the level of the central
nervous system (CNS), autonomic nervous system (ANS) and the adrenal gland. PICs acting at the level
of the CNS on the HPA axis leads to behavior changes like disinterest in social activities as well as
anorexia, adipsia, and lethargy (Tracey, 2002; Gruys et al., 2005; Karrow, 2006). Activation of the ANS
can modulate the APR by depressing the release of the cytokines by inflammatory cells and by affecting
hypothalamic responses (Karrow, 2006). Cortisol released from the adrenal gland works systemically to
cause leukocytosis and alter acute phase protein (APP) production.
Systemic effects that compose the APR include fever, leukocytosis, increased cortisol, decreased
thyroxine concentrations, metabolic changes in lipolysis, gluconeogenesis, and muscle catabolism,
decreased serum iron and zinc concentrations and changes in APP levels. There can be decreases in the
APPs albumin and transferrin (negative APPs), while there can be increases in the APPs C-reactive
protein (CRP), serum amyloid A (SAA), haptoglobin (Hp), alpha-1-acid glycoprotein (AGP),
ceruloplasmin (Cp), and fibrinogen (positive APPs). APPs are synthesized primarily by hepatocytes when
stimulated by the PICs IL-6, IL-1, IFN-γ, or TNF-α and then released into the bloodstream (Heinrich et
al., 1990; Petersen et al., 2004; Murata et al., 2004; Gruys et al., 2005) but also can be made by other
tissues including the endometrium (Chapwanya et al., 2013). APPs have various functions such as
proteinase inhibitors, enzymes, metal-binding proteins, transport proteins, and coagulation factors. These
functions are important in mediating immune function, pathogen trapping, preventing replication of the
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pathogen, tissue repair, and remodeling (Ceciliani et al., 2002; Murata et al., 2004; Petersen et al., 2004;
Karrow, 2006; Cray et al., 2009; Thatcher et al., 2010).
There are major, moderate, and minor APPs. Major APPs have low serum concentrations
(<1µg/L) in healthy animals that increase by 100-1000 fold when activated while moderate APPs increase
by 5-10 fold when activated (Eckersall and Bell, 2010). Major APPs tend to show an early and large
increase in concentration with a rapid decline while moderate APPs tend to require more time to increase
and return to normal values. There can be species specific production and response of APPs. The major
APPs in both cows and sheep are haptoglobin (Hp) and serum amyloid A (SAA) (Cray et al., 2009;
Lecchi et al., 2012; Chapwanya et al., 2013).
The APR prevents microbial growth while some APPs opsonize microorganisms and activate
complement, scavenge cellular remnants and free radicals, neutralize proteolytic enzymes, or modulate
the immune response (Gruys et al., 2005). Activities of SAA include being chemotaxic to monocytes,
polymorphonuclear cells, and T cells, scavenging potentially dangerous oxidized cholesterol, and
opsonization of bacteria (Petersen et al., 2004; Hari-Dass et al., 2005; Cray et al., 2009). Haptoglobin
binds free hemoglobin reducing iron availability for bacterial growth and prevents pro-oxidant activity of
hemoglobin on tissues (Allison, 1958; Eaton et al., 1982; Petersen et al., 2004; Cray et al., 2009).
Upon activation of the immune system the PICs IL-1, IL-6 and TNF-α are produced. All 3
cytokines have autocrine activities, stimulating their own production. In addition, IL-1β and TNFα
stimulate each other and both stimulate IL-6. IL-6 then inhibits the secretion of TNFα and IL-1β (κ;
Ceciliani et al., 2002). These cytokines activate the HPA axis as seen by increases in CRH, ACTH, and
GCs (Heinrich et al., 1990; Turnbull and Rivier, 1999). Tκα works by synergistically enhancing IL-1
induced ACTH and/or GC secretion (Turnbull and Rivier, 1999), and both amplify and prolong the
inflammatory response by activating surrounding cells to release more IL-1 and inflammatory mediators
including eicosanoids, NO, and ROS (Tracey, 2002). In addition, IL-1β and IL-6 work together to induce
the fever response associated with the APR. GCs inhibit the production of all 3 cytokines to prevent
overproduction; however TNFα has the greatest sensitivity to this suppression while IL-6 is fairly
resistant to this suppression. IL-6 acts synergistically with GCs to stimulate hepatic APP production
(Heinrich et al., 1990; O’Conner et al., 2000; Ceciliani et al., 2002; Murata et al., 2004) and to down
regulate cytokine production by monocytes and MΦs (Baybutt and Holsboer, 1990; Ceciliani et al., 2002;
Murata et al., 2004).
The APR involves activation of the HPA axis and production of GCs which can have antiinflammatory effects through regulation of gene transcription. Binding to intracellular steroid receptors,
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the ligand-receptor complex migrates into the nucleus to bind to specific DNA sequences that oppose the
function of the transcription factors AP-1 and NF-κB. This will prevent transcription of pro-inflammatory
genes such as TNF-α, pro-IL-1β, and IL-6. Reduced TNF-α and IL-1β affects normal downstream actions
of these cytokines such as expression of the enzymes COX2 and iNOS as well as expression of
intracellular adhesion molecule-1 (ICAM-1). GCs also suppress expression of IFNγ and inflammatory
genes for cytokines involved in T cell growth and T helper cell polarization (IL-2, IL-4, IL-15, IL-17).
While decreasing expression of PICs, GCs increase expression of anti-inflammatory molecules, like IL-10
and the IL-1 type 2 decoy receptor (Dinarello, 2010).
Acute phase proteins are considered a nonspecific diagnostic tool; while measurements cannot be
used as a marker for a particular disease, APP levels provide evidence that an individual has subclinical
inflammation or an infection and can be used in prognosis and in monitoring response to therapy
(Petersen et al., 2004; Gruys et al., 2005; Eckersall and Bell, 2010). APPs have been used as biomarkers
for monitoring inflammation, infection, and trauma in humans for decades (Eckersall and Bell, 2010) and
in recent years have progressively been used as biomarkers in veterinary medicine in companion and farm
animals (Petersen et al., 2004; Murata et al., 2004; Cray et al., 2009; Eckersall and Bell, 2010).

Inflammasome
Due to its highly pro-inflammatory nature and potential to damage host cells extra precaution is
taken when activating IL-1β. In order for IL-1β to be synthesized, processed to its active form and
secreted by MΦ, the cell must respond to two distinct stimuli and an inflammasome must form (Meylan et
al., 2006; Sutterwala et al., 2006). NOD-like receptors (NLRs) are a family of PRRs that are mostly
expressed in the cytosol; NALP3 is a member of the NLR subfamily NALP (Martinon et al., 2009). Upon
activation, the NALP3 inflammasome forms from a combination of the NALP3 protein, CARDINAL.,
ASC (apoptosis-associated speck-like protein containing a CARD (caspase recruitment domain)), and
caspase-1. The NALP3 protein (also known as cryopyrin) is composed of an N-terminal pyrin domain
(effector domain), carboxy-terminal ligand-sensing leucine rich repeats (LRRs), the central nucleotide
domain NACHT (nucleotide-binding and oligomerization domain) (mediates oligomerization), and a
NACHT-associated domain (NAD) (Meylan et al., 2006; Martinon et al., 2009). The adaptor molecule,
ASC controls the activation of caspase-1 which cleaves two members of the IL-1 family of ligands, proIL-1β and pro-IL-18 into their biologically active, secreted forms (Meylan et al., 2006; Sutterwala et al.,
2006; Dinarello, 2007; Dinarello, 2009; Schroder and Tschopp, 2010). Caspases are cysteine proteases
that initiate or execute functions involved in inflammation or cell death, therefore, their function is tightly
controlled by being synthesized as inactive zymogens that have to be activated by proteolytic cleavage
(Martinon et al., 2009; Schroder and Tschopp, 2010)
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The first signal needed to get IL-1β produced is an inflammatory signal recognized by a TLR,
such as LPS binding to TLR4. Downstream of the TLR, NF-κB will be activated leading to transcription
of the IL-1β gene, which is then translated into an immature pro-form of the cytokine (Meylan et al.,
2006; Sutterwala et al., 2006). The second necessary signal is one that will activate the inflammasome to
form allowing caspase-1 to cleave the cytokine into its mature form which can then be secreted. The
NALP3 inflammasome responds to some PAMPs such as peptidoglycan and its degradation products,
bacterial RNA, and small antiviral compounds (Martinon et al., 2004; Kanneganti et al., 2006; Schroder
and Tschopp, 2010). The NALP3 inflammasome also responds and becomes activated in response to
DAMPs that cause K+ efflux resulting in low intracellular concentrations of potassium (Perregaux and
Gabel, 1994; Meylan et al., 2006; Mariathasan et al., 2006; Pétrilli et al., 2007; Schroder and Tschopp,
2010). This occurs when extracellular ATP binds the P2X7 receptor or in response to NAD+, bacterial
toxins, or uric acid crystals (Perregaux and Gabel, 1994; Solle et al., 2001; Shi et al., 2003; Kahlenberg
and Dubyak, 2004; Martinon et al., 2006; Kanneganti et al., 2006; Kawamura et al., 2006).
Lipopolysaccharide does not activate the NALP3 inflammasome (Martinon et al., 2004;
Mariathasan et al., 2006), however, in combination with DAMPs that do, LPS leads to the production of
mature IL-1β (Meylan et al., 2006; Mariathasan et al., 2006; Sutterwala et al., 2006). TLRs agonists (ex:
LPS) induce pro-cytokine synthesis and DAMPS (ex: extracellular ATP) stimulate caspase-1-dependent
cleavage and secretion of the active form of IL-1β and IL-18 (Mariathasan et al., 2006; Sutterwala et al.,
2006). ATP induced K+ efflux through P2X7 signaling causing an increase in intracellular Ca2+ may also
be necessary for activation of active phospholipase C and calcium dependent PLA2 needed for exocytosis
of IL-1β containing lysosomes (Andrei et al., 2004). Phospholipases act on phospholipids in membranes
to produce lipid metabolites that are involved in the final stages of membrane fusion (Goñi and Alonso,
2000; Brown et al., 2003).
It was suggested that TLR signaling might also be required for expression of some of the
inflammasome components, since although ATP was required for caspase-1 activation, ATP by itself
without LPS priming did not activate caspase 1 (Mariathasan et al., 2006; Sutterwala et al., 2006). Indeed,
Bauernfeind et al (2009) reported that NF-κB activation by TLR agonists or PICs (TNFα) is required for
gene transcription of Nlrp3. The necessity of an extracellular signal that leads to NF-κB activation to get
transcription of NLRP3, pro-IL-18 and pro-IL-1β combined with a host danger signal to activate NLRP3
allowing for inflammasome assembly may provide insurance that IL-1β and IL-18 are produced when
pathogenic bacteria are present and not in response to commensal bacteria (Meylan et al., 2006;
Bauernfeind et al., 2009). Caspases also have functions related to forms of cell death. At low levels of
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caspase-1 activation, the protease functions to stimulate cell survival responses and control intracellular
growth in addition to forming active PICs. However, if activation of caspase-1 crosses a threshold level
the MΦ undergoes pyroptosis, a form of cell death characterized by rapid plasma-membrane rupture and
release of proinflammatory intracellular contents (Bergsbaken et al., 2009). With this form of cell death
caspase-1 is responsible for the formation of pores in the plasma membrane that results in loss of control
of cellular ionic gradients, a net increase in osmotic pressure, water influx that causes the cell to swell and
ultimately osmotic lysis that releases inflammatory intracellular mediators (Fink and Cookson, 2006;
Bergsbaken et al., 2009). Neutrophils are able to process the IL-1β precursor independent of caspase-1
using other enzymes. In these cells, proteinase-3 can cleave pro-IL-1β into its active form (Guma et al.,
2009; Joosten et al., 2009).
Primary sources of IL-1β are innate immune cells including tissue MΦs, blood monocytes, and
DCs, however, NK and B lymphocytes can also produce the cytokine (Dinarello, 2009). IL-1β induces
gene expression and synthesis of COX2, PLA2, and iNOS resulting in production of PGE2, NO, and
platelet activating factor (PAF). These mediators are involved in fever, lowered pain threshold,
vasodilation, and hypotension (Dinarello, 2009). IL-1β also induces the expression of adhesion molecules
by mesenchymal and endothelial cells to aid in the infiltration of immune cells into the inflammatory area
(Dinarello, 2009). Cytokines exist in “cascades” and tend to act in a synergistic fashion (Dinarello, 2010).
In general, PICs will function to induce other PICs, feedback to induce each other and stimulate further
expression of themselves to increase inflammatory cytokine expression. IL-1β will stimulate production
of other cytokines (IL-6, IL-17) and APPs (Dinarello, 2009). IL-1β is involved in IL-17 production by
stimulating production of IL-6 and IL-23; Th17 polarizing cytokines that activate STAT3 which then
induces the Th17 transcription factor RORγt (Dinarello, 2009; Murphy, 2012). IL-17 is chemoattractant
to neutrophils and MΦs and has also been shown to stimulate the production and release of IL-1β from
primary human blood monocytes (Dinarello, 2009; Dinarello, 2010; Murphy, 2012).
Inflammasomes are also responsible for cleavage of pro-IL-18 into its mature form, another PIC.
IL-18 in conjunction with IL-12 induces IFNγ production by other immune cells and naïve T cells to
polarize towards a Th1 phenotype. With regards to IFNγ production, IL-18 and IL-12 signaling leads to
activation of transcription factors that induce transcription of IFNγ. Working through a signaling pathway
with similar components to TLR signaling, IL-18 activates MyD88, IRAK (IL-1 receptor-associated
kinase) proteins, and TRAF6 (TNF receptor-associated factor) to activate p38 MAP, AP-1 and cause
translocation of NF-κB into the nucleus. IL-12 leads to activation of STAT4 and AP-1 (Robinson et al.,
1997; Nakanishi et al., 2001). These transcription factors bind the promoter region of IFNγ and together
cause gene transcription (Nakanishi et al., 2001). Th1 (but not Th2) cells express IL-18Rα (Robinson et
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al., 1997; Yoshimoto et al., 1998; Xu et al., 1998) and IL-18 induces cell proliferation of Th1 cells in
addition to acting as a costimulant molecule to augment production of IL-2, IL-2Rα, and GM-CSF
production by these cells (Robinson et al., 1997; Yoshimoto et al., 1998). IL-18 (along with IL-2) in the
absence of IL-12 cause naïve T cells to polarize towards a Th2 phenotype and production of IL-4 and IL13 (Nakanishi et al., 2001).
Because IL-1 and IL-18 have such potential to cause host damage with their inflammatory nature,
not only is their production/activation tightly regulated but there are specific mechanisms to control their
function once they have been secreted to prevent runaway inflammation. IL-1Ra is a receptor antagonist
that binds the IL-1 receptor with greater affinity than IL-1, thus reducing IL-1β function. IL-18 binding
protein (IL-18BP) is an endogenous neutralizer of IL-18 activity as it has greater affinity for IL-18 than
the IL-18 receptor has for the cytokine (Novick et al., 1999; Dinarello, 2009).

Lipopolysaccharide
Lipopolysaccharide (LPS) is a component of gram negative bacteria cell walls and is a PAMP for
host immune cells to recognize pathogens. LPS will directly activate monocytes/ MΦs to produce PICs
(TNF-α, IL-1β, IL-6, IL-8), eicosanoids (PGE2), NO, and MMPs (Calder, 2003). LPS will induce the
expression of adhesion molecules (ICAM-1, VCAM-1, E-selectin) by endothelial cells and leukocytes
which are needed for the movement of cells into the inflammatory/infected site (Calder, 2003). The
cytokines and eicosanoids produced will regulate the whole-body response to infection/injury (fever, pain
sensitivity) (Calder, 2001). While infections need to be cleared to protect the host, over activation of the
PRR pathways and production in PICs is detrimental to pregnancy. Neutralization of LPS or blockage of
TLR4 signaling has been shown to prevent fetal loss in murine pregnancy (Friable et al., 2011).
Endotoxins can decrease embryo cleavage rates, blastocyst formation and impair implantation,
resulting in embryonic loss (Deb et al., 2004). LPS mediates its biological effects mostly through PICs.
While inflammatory cytokines and growth factors play a role in blastocyst development and implantation,
the quantity and timing of their expression must be tightly controlled, any disturbance in the level of
expression at the feto-maternal interface can cause embryonic loss (Deb et al., 2004; Agrawal et al.,
2013a). Cell adhesion molecules, cytokines, growth factors, endometrial epithelial integrins, MMPs, PGs,
and COX-2 are important for successful implantation playing roles in tissue remolding and regulation of
trophoblast invasion. Expression of these molecules by uterine and trophoblast cells is regulated by
cytokines and growth factors (IGF, TGF, IL-1, IL-6, TNF) (Lim et al.,, 1999; Bischof et al., 2000; Dey et
al., 2004).

50

The antifertility effects of LPS can be attributed to modulation of the synthesis and secretion of
cytokines and growth factors at the feto-maternal interface altering preimplantation embryonic growth
and development along with appropriate inflammatory reactions at the implantation site. Epithelial and
stromal cells have been shown to respond to LPS in vitro by phosphorylation of MAPK and nuclear
translocation of NF-κB, secretion of PGF2α, PGE2, IL-6, CXCL8, and increased expression of
antimicrobial peptides (MUC1, lingual antimicrobial peptide, tracheal antimicrobial peptide) (Herath et
al., 2006; Davies et al., 2008; Cronin et al., 2012). Changing the levels and timing of production of
implantation relevant cytokines can lead to preimplantation embryonic loss or implantation failure (Deb
et al., 2004). For example, IL-1 α and β binding to their receptors on the uterine endometrium trigger
integrin expression during implantation (Simón et al., 1998) and IL-1 stimulates production of
endometrial LIF, which is important for implantation (Dimitriadis et al., 2005; Agrawal et al., 2013a).
Altered production of cytokines can accelerate or delay the uterine transition to the receptive state
disrupting coordination between embryonic and uterine development. This can mean a receptive uterus
and an implantation competent blastocyst do not occur at the same time. In addition to altering uterine
receptivity, LPS effects can make the developing blastocyst incompetent for implantation (Deb et al.,
2004). Endotoxin is known to induce embryonic death (Giri et al., 1990) and has been shown to increase
DNA damage in preimplantation embryos associated with a decrease in heat shock proteins (HSP 90,
HSP70, HSP60), decrease embryo cleavage rate, decrease blastocyst formation, and induce degeneration,
fragmentation, and developmental arrest of the preimplantation embryo (Dumoulin et al., 1991; Randall et
al., 1991; Dostál et al., 1996; Jaiswal et al., 2006; Jaiswal et al., 2013).
Mediated by PICs, LPS can inhibit steroidogenesis, increase PG production, and cause luteolysis
of the CL (Bagavandoss et al., 1990; Gorospe et al., 1992; Telleria et al., 1998). PG production can result
in embryonic death by acting as an abortifacient and/or causing luteolysis of the CL and loss of P4
production (Deb et al., 2004). Among other actions, P4 regulates uterine receptivity for blastocyst
attachment and coordinates uterine-embryo interactions (Paria et al., 2002). In the mouse, LPS (given on
day 0.5 p.c. ) decreased serum P4 while increasing serum E2 and this higher E2/P4 ratio during
preimplantation led to unsuccessful pregnancy. The change is steroid levels may have prevented the
uterus from becoming receptive or prevented the blastocysts from developing to the stage where they
could implant (Agrawal et al., 2011) In addition, LPS given to mice was shown to alter the mRNA
expression of both the P4 and E2 receptor in embryos and the uterus on preimplantation days which will
affect the ability of the hormones to regulate implantation (Agrawal et al., 2013b). E. Coli endotoxin
infusions (1.0 or 2.5 μg/kg over 6 hours) to first trimester cows caused an increase in PGF2α followed by a
drop in P4 and pregnancy loss (Giri et al., 1990).
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Bacterial Infections during Pregnancy
The female reproductive tract has several anatomical barriers to block ascending microbes from
reaching the uterus including the vulva, vagina, cervix, the stratified squamous epithelium of the vagina,
and the columnar epithelium of the endometrium. As a second line of defense, the mucosa of the
reproductive tract contains antimicrobial peptides and mucosal glycoproteins to neutralize bacteria and
prevent them from reaching the epithelium and causing infection. The bovine endometrium contains the
antimicrobial peptides β-defensins, lingual antimicrobial peptide, and tracheal anti-microbial peptide
(Davies et al., 2008; Chapwanya et al., 2013). Gene expression for APPs has also been found in the uterus
and may be involved in protection against infection (Lecchi et al., 2012; Chapwanya et al., 2013),
however, the major producer of APPs is the liver in response to PICs. The female reproductive tract also
contains the complement system which is involved in opsonization of infected cells to mark them for
phagocytosis and killing of infected cells (Sheldon et al., 2014). If microbes surpass all the passive
defense systems in the reproductive tract the result is infection.
Apoptosis inducing cytokines, such as TNFα and IFNγ can cause pre-implantation embryonic
loss or impair embryo development. TNFα has been seen in vitro to increase the percentage of apoptotic
mouse blastomeres (Fabian et al., 2007) and IFNγ inhibits the embryotrophic factor GM-CSF (Robertson
et al., 1992b). GM-CSF is produced by epithelial cells lining the oviduct and uterus around the time of
conception in response to seminal fluid and is required for normal blastocyst development and fetal
viability (Robertson, 2007; Sharkey et al., 2007). GM-CSF in the mouse has been reported to promote
blastocyst formation and increase the number of viable blastomeres by inhibiting apoptosis and the stress
response and facilitating glucose uptake (Robertson et al., 2001; Chin et al., 2009). With regards to
generating fetal tolerance, GM-CSF plays a role in upregulating MHC-II and the co-stimulatory
molecules CD80 and CD86 on APCs like DCs and macrophages and a deficiency in the cytokine impairs
Ag presentation and T cell response to Ag (Moldenhauer et al., 2010). Paternal antigen must be processed
and bound to an MHC II molecule to be presented to T cells by APCs and the co-stimulatory molecules
are critical for stabilizing the peptide-MHC-TCR interaction to generate strong Ag-specific T cell
responses (Murphy, 2012). Inadequate expression of these molecules by APCs in the reproductive tract
after coitus will negatively impact Treg cell generation specific to paternal antigens and fetal tolerance.
Therefore, a uterine infection around the time of conception is likely to prevent a successful pregnancy.

Omega-3 Polyunsaturated Fatty Acids
Omega-3 poly-unsaturated fatty acids (PUFA) are known to have anti-inflammatory effects for
several reasons. They can effect eicosanoid production by displacing AA in cellular membranes (Jaudszus
et al., 2013) reducing the availability of substrate for production of inflammatory PGs and LTs or by
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competing with AA for the COX and lipoxygenase (LOX) enzymes. Alterations in the fatty acid
composition of membranes can also modify membrane fluidity, lipid raft formation, and cell signaling.
Inflammation is associated with LTs, PGs, and polymorphonuclear neutrophil (PMN) recruitment to the
inflammatory site. Resolution of inflammation is associated with lipoxin (LX) biosynthesis and decreased
PMN infiltration (Levy et al., 2001). During inflammation, AA can go through the COX pathway to
produce PGs or the LOX pathway to produce LTB4. LTB4 increases vascular permeability, is a
vasoconstrictor, enhances local blood flow, is chemoattractant to leukocytes, induces release of lysosomal
enzymes, enhances ROS generation and production of PIC (TNFα, IL-1β, IL-6). (Calder, 2003; Afonso et
al., 2012).
Omega-3 FAs inhibit AA metabolism by COX1 and shift the vascular balance to higher levels of
PGI2 by coupling endothelial COX2 with PGI synthase (PGIS) (Norris and Dennis, 2012; Dennis and
Norris, 2015). Possible physiological responses of PGI2 binding to the IP receptor include decreased
platelet aggregation, hyperalgesia, vasodilation, increased IL-10 levels, and decreased TNFα levels
(Shinomiya et al., 2001; Dennis and Norris, 2015). Omega-3 PUFAs can also shunt AA from the
inhibited COX pathway into the 5-LOX pathway which produces LTs (involved in inflammation) as well
as lipoxins, resolvins, protectins (resolve inflammation) (Dennis and Norris, 2015). Omega-3 PUFAs also
modulate inflammation independent of eicosanoid production by altering gene expression of PICs and
adhesion molecules (on endothelial cells and leukocytes) (Calder, 2003; 2011). Omega-3 PUFAs can be
made into eicosanoids by the PTGS and LOX enzymes but these molecules have anti-inflammatory
effects and have been termed specialized pro-resolving mediators (SPMs) (Bannenberg and Serhan, 2010;
Serhan and Petasis, 2011). Cytoplasmic phospholipase A (cPLA2) acts on phospholipids to release free
PUFA, including AA, EPA, and DHA. A diet with high amounts of ω-3 PUFAs will result in cellular
membranes with more ω-3 PUFAs and less AA which will affect the PUFA released by cPLA2 and the
subsequent eicosanoids produced, whether pro-inflammatory PGs and LTs or anti-inflammatory SPMs.

Resolution of Inflammation and Specialized Pro-Resolving Mediators
Specialized pro-resolving mediators (SPMs) (di- and trihydroxylated metabolites of long chain
PUFAs) are eicosanoids and docosanoids produced by LOX, COX, and cytochrome P450 enzymes
working alone or in combination. SPMs include LXs (metabolites of the ω-6 FA AA), resolvins (Resolvin
E series: COX2 derived metabolites of the ω-3 FA, EPA; Resolvin D series: 15-LOX derived metabolites
of the ω-3, DHA; Resolvin Dn-3DPA: 15-LOX derived metabolite of the ω-3 FA, DPA; Resolvin T: COX2
derived metabolite of the ω-3, DPA), protectins (15-LOX derived metabolites of the ω-3, DHA), and
maresins (MΦ mediators in resolving in inflammation; MaR1 and MaR2 derived from DHA) (Serhan,
2007; Serhan et al., 2014;Weylandt, 2016).
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Special pro-resolving mediators are produced at specific temporal intervals to resolve
inflammation and aid in the return to a state of homeostasis (Bannenberg and Serhan, 2010). SPMs
accelerate bacterial clearance (Chiang et al., 2012), promote recruitment and activation of monocytes,
promote neutrophil clearance (efferocytosis: “phagocytic clearance of apoptotic cells before they undergo
secondary necrosis”), inhibit neutrophil diapedesis, inhibit PIC expression, and turn on anti-inflammatory
cytokine expression (Schwab et al., 2007; Serhan and Petasis, 2011; Colas et al., 2014; Serhan, 2014;
Serhan et al., 2014; Dennis and Norris, 2015). The process of efferocytosis increases SPM biosynthesis
by PMN, including the resolvins D2, and E2 (Norling et al., 2011). Apoptotic PMNs phagocytosed by
MΦs induce generation of SPMs (LXA4, RvE1, PD1) by the MΦ which further increases phagocytic
activity and regulates chemokine/cytokine production (↑IL-10, ↓IL-6 and IFNγ) (Schwab et al., 2007).
Maresin 1 (MaR1), is produced by MΦs when its biosynthetic pathway is activated during phagocytosis,
it functions to reduce neutrophil migration and increase phagocytosis by MΦs (Serhan, 2007; Serhan and
Petasis, 2011). MΦs with the M2 phenotype produce the SPMs MaR1 and lipoxin A4 (LXA4) and lower
amounts of LTB4 and PGs compared to M1 MΦs (Serhan and Chiang, 2013), fitting with M2 MΦ’s role
of tissue repair and inflammation resolution.
The transiently and temporal specific production of SPMs is brought about by the activation of
the biosynthetic pathways to produce SPMs through interaction of inflammatory leukocytes with
endothelial cells, epithelial cells, and MΦs at the inflammation site (Bannenberg and Serhan, 2010). The
switch in production of LT to LX (pro-inflammatory to resolution) is mediated by first-phase eicosanoids.
PGE2 and LTB4 are produced during inflammation, LTB4 recruits neutrophils to the inflammatory site
whereas PGE2 sets up the resolution phase by amplifying LX expression. PGE2 (and PGD2) accomplishes
this by increasing gene expression for 15-LOX (which produces LXA4) through a mechanism that
increases intracellular cAMP, initiating RNA processing of the 15-LOX transcript in PMNs, and
inhibiting expression of 5-LOX (Levy et al., 2001). As neutrophils migrate into the tissue they will
encounter PGE2 that initiates phenotypic changes by regulating gene expression (Levy et al., 2001). Once
15-LOX is transcribed, activity may need to be induced by secondary exposure. Once active, neutrophils
will produce LXs instead of LTs from AA and resolution will be initiated (Levy et al., 2001).
Lipoxin A4 has been shown to inhibit neutrophil chemotaxis but enhance MΦ chemotaxis and
stimulate MΦ phagocytosis of apoptotic neutrophils (Lee et al., 1989; Mitchell et al., 2002). LXA4 has
also been shown to increase IL-10 which then inhibits TNFα (Souza et al., 2007). Both LTs and LXs are
produced from AA in the LOX pathway. The PMN chemokine, LTB4, is produced from the 5-LOX
pathway and also influences release of neutrophil granule products and superoxide anions (Borgeat and
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Naccache, 1990). Lipoxins are a separate class of LOX generated eicosanoids that oppose the functions of
LTs by working in an autocrine manner to regulate leukocyte function (Levy et al., 2001).
Resolvins are produced and act locally by binding to G-protein coupled receptors to elicit their
biological actions in the picogram-nanogram range (Serhan and Petasis, 2011; Chiang et al., 2012).
Resolvin E1 (RvE1) binds to the ChemR23 receptor on monocytes and DCs reducing DC migration,
decreasing IL-12 production, and enhancing macrophage phagocytosis (Arita et al., 2005; Ohira et al.,
2010). RvE1 also interacts with the BLT1 receptor. BLT1 is also the receptor for LTB4, signaling
neutrophil survival, chemotaxis of neutrophils, and NF-κB activation. RvE1 blocks LTB4 from binding to
the BLT1 receptor, thus stopping neutrophil infiltration and attenuating NF-κB activation. RvE1-BLT1
interaction also promotes apoptosis of PMNs and clearance of apoptotic cells by macrophages (Arita et
al., 2007; El Kebir et al., 2012).
Special pro-resolving mediators also function through control of microRNAs to change leukocyte
activity (Li et al., 2013). Binding to GPR32 ALX/FPR2, resolvin D1 (RvD1) upregulates miR-208a
which increases IL-10 production. RvD1 also upregulates miR-219 causing decreased 5-LOX expression
and thus decreased production of LTB4 while increasing 15-LOX expression and production of protectin
D1 (Recchiuti et al., 2011; Krishnamoorthy et al., 2012; Fredman et al., 2012).
Resolvins and protectins have been seen to control the magnitude and duration of inflammation in
animal disease models (Schwab et al., 2007), to regulate inflammatory pain (Xu et al., 2010) and to
increase animal survival (Serhan and Chiang, 2013). Resolution of an E. Coli infection in mice was
associated with elevated levels of host protectin D1, resolvin D5 and D1 that enhanced bacterial killing
and SPMs given to mice decreased the amount of antibiotics needed for microbial clearance (Chiang et
al., 2012). Exogenous LXA4 was reported to increase survival in a sepsis rat model by decreasing levels
of PIMs through reduction of NF-κB phosphorylation in MΦs. In addition, LXA4 decreased blood
bacterial load by increasing recruitment of MΦs to phagocytosis the bacteria (Walker et al., 2011). LXs
have also been reported to stimulate the production of bactericidal peptides by mucosal epithelia (Canny
et al., 2002). Human Th2 cells have been reported to produce protectin D1 that reduces T cell migration,
promotes T cell apoptosis, and decreases TNFα and IFNγ (Ariel et al., 2005). Exogenous protectin D1,
along with RvE1 and LXA4 upregulate CCR5 expression on leukocytes that bind chemokines and
facilitate leukocyte clearance and resolution of inflammation (Ariel et al., 2006). Dietary omega-3 PUFA
in humans has been shown to be associated with increased plasma SPMs and Colas et al (2014) also
reported increased phagocytosis of E. Coli in whole blood collected from volunteers that had taken
capsules containing essential fatty acids (Mas et al., 2012; Colas et al., 2014).
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The role of RvD1 in inflammation resolution was examined in a LPS-induced acute lung injury
murine model (Wang et al., 2011; Liao et al., 2012). Pretreating mice with RvD1 before LPS increased
survival, inhibited LPS induced recruitment of PMNs and mononuclear leukocytes and IL-6 and TNFα
production in bronchoalveolar lavage fluids. RvD1 reduced the LPS-increase in COX-2, iNOS, NO,
PGE2, and adhesion molecules. These affects are thought to be mediated at least in part through RvD1
interacting with the LXA4 receptor and inhibiting the MAPK and NF-κB pathways (Wang et al., 2011).
Liao et al (2012) also reported reduced leukocyte counts, TNFα and IL-6 in bronchoalveolar lavage fluids
of mice treated with RvD1 before LPS. Based on staining they also reported reduced LPS-induced lung
inflammation with RvD1. Their conclusion was RvD1 works at least in part by suppressing IκBα
degradation and NF-κB nuclear translocation by a pathway partly dependent on PPARγ activation (Liao
et al., 2012), although RvD1 has not been shown to directly interact with PPARγ (Krishnamoorthy et al.,
2010)
Resolvin D2 (RvD2) promotes inflammation resolution by limiting PMN infiltration, enhancing
phagocytosis of bacteria, and stimulating efferocytosis through binding of the GPR18 receptor (Chiang et
al., 2015). Spite et al (2009) studied the role of RvD2 in inflammation resolution during microbial
infection. They concluded that RvD2 reduces PMN infiltration to the inflammation site by affecting
leukocyte-endothelial interactions by reducing platelet activating factor induced surface expression of
adhesion molecules (L-selectin and integrin beta 2) by PMNs (Spite et al., 2009). In addition, RvD2
stimulates local NO production at levels that have anti-adhesive effects instead of pro-inflammatory
effects (Kubes et al., 1991; Spite et al., 2009) RvD2 also reduced complement (C5a) mediated PMNendothelial interactions and C5a stimulated extracellular superoxide generation. When they examined the
effects of RvD2 in a murine sepsis model using cecal ligation and puncture they reported RvD2 reduced
the amount of live aerobic bacteria in the blood and peritoneum 12 hours after the procedure. The amount
of leukocytes and specifically PMNs that infiltrated into the peritoneum was significantly reduced. RvD2
promoted phagocyte-dependent bacterial clearance and in vitro was seen to enhance MΦ phagocytosis.
While enhancing bacterial clearance, RvD2 also reduced PICs (IL-6, IL-1β, IL-23, IL-17, TNF-α), the
chemokine CXCL2 (secreted by monocytes and MФ, recruits polymorphonuclear leukocytes), and PIMs
(PGE2 and LTB4) (Spite et al., 2009). Lastly, this group reported that when human PMNs were preincubated with RvD2 before incubation with E. coli, the neutrophils had enhanced E. coli phagocytosis
that was associated with an increase in intracellular ROS (Spite et al., 2009).
Docosapentaenoic acid (DPA) is a 22 carbon PUFA with 5 double bonds and exists as two
isomers, a ω-3 (22:5n-3) and as a ω-6 (22:5n-6) (Weylandt, 2016). The body can turn alpha-linolenic acid
(ALA) (18:3 n-3) into EPA. EPA and AA can be converted into DPA; elongation of EPA (20:5n-3) will
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give the ω-3 isomer of DPA (22:5n-3) while elongation followed by desaturation of AA (20:4n-6) will
give the ω-6 isomer of DPA (22:5 n-6). Elongation of EPA (20:5n-3) followed by desaturation provides
DHA (22:6n-3). (Dalli et al., 2013). Derivatives of both DPA isomers have been reported to have proresolving effects with regards to inflammation (Weylandt, 2016).
With regards to the ω-6 isomer, using the MΦ cell line RAW 265.7, the DPA derivatives (17S)hydroxy-docosapentaenoic acid (17-HDPAn-6) and (10,17S)-dihydroxy-docosapentaenoic acid (10,17HDPAn-6) and the DHA derivative 17(R/S)-hydroxy-docosahexaenoic acid (17-HDHA) were reported to
increase phagocytosis by the MФ, decrease gene expression of TNFα and inducible NO synthase while
increasing expression of the IL-1ra, suggesting polarization of MФ towards a M2 phenotype and
inflammation resolution (Chiu et al., 2012). Derivatives of the ω-3 isomer of DPA include protectin D1,
the D series resolvins (RvD) and the maresins (MaR). Mice given an intraperitoneal injection of zymosan
(binds TLR2) after an intravenous injection of n-3 DPA derived products had reduced neutrophil
recruitment, decreased IL-6 and decreased MCP-1 levels (measured in exudates) compared to mice
receiving only zymosan (Dalli et al., 2013). In vitro studies showed that human neutrophils incubated
with n-3 DPA products had reduced adhesion to TNFα activated endothelial cells and reduced chemotaxis
towards an CXCL8 gradient while incubation of human MФ with n-3 DPA products before addition of
zymosan increased phagocytosis (Dalli et al., 2013).
The newly discovered 13-series DPA n-3 resolvins (RvT1, RvT2, RvT3, RvT4) also have antiinflammatory activities. They are produced by transcellular biosynthesis, where COX2 in endothelial cells
produces the intermediate 13-HDPA which is then converted to RvT1, RvT2, RvT3, and RvT4 by
lipoxygenation in neutrophils (Dalli et al., 2015). RvTs increased phagocytosis of E. coli, efferocytosis of
apoptotic neutrophils and the production of ROS by human MΦs in vitro. Human Neutrophils exposed to
RvT2 also had increased phagocytosis of E. coli and produced more ROS. RvTs blocked components of
the inflammasome in MΦs, decreasing caspase-1 and IL-1β expression (Dalli et al., 2015).
Administration of RvTs 2 hours after intraperitoneal E. coli inoculation in mice dose-dependently
increased survival rates. Administration of RvTs right before inoculation protected mice from
hypothermia, limited neutrophil recruitment to the inflammation site, increased bacterial phagocytosis,
reduced MФ inflammasome activity (as seen be reduced expression of caspase-1 and IL-1β levels), and
reduced systemic PGD2 and PGE2 levels (Dalli et al., 2015). The reduced PGs could be due to RvTs
regulating inflammasome activity, as some types of inflammasomes have been reported to produce
eicosanoids in response to TLR activation (von Moltke et al., 2012).
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Jones et al (2013a) reported that feeding pregnant rats a diet supplemented with ω-3 PUFAs
increased maternal plasma ω-3 PUFAs, increased placental ω-3 PUFAs, reduced placental oxidative
stress, and increased placental and fetal growth. Supplementation with ω-3 PUFAs also resulted in
increased levels of LOX15b expression (enzyme driving initial step in resolvin and protectin formation)
LOX5 expression (enzyme for final stages of resolvin production), resolvins, protectins, and their
precursors in the labyrinth zone of the rat placenta (Jones et al., 2013b), demonstrating that the placenta is
capable of producing SPMs and production can be increased with dietary ω-3 PUFA. Increases in
placental resolvin and protectin levels may enable the placenta to better handle/resolve inflammation in
response to an inflammatory challenge like infection.
The biosynthesis of PUFA derived lipid mediators increases and changes with time. PGs and LTs
are produced first to initiate inflammation but as time goes on there is increased recruitment of noninflammatory monocytes and MΦs and lipid class switching to SPMs that promote resolution (Serhan and
Petasis, 2011). Dietary ω-3 PUFAs can increase the amount of available ω-3 PUFAs and accelerate the
switch from pro-inflammatory PG and LT production to inflammation resolving SPMs.
Resolution of inflammation is now considered a coordinated program of events initiated a few
hours after the response begins. Acute inflammation is characterized by infiltration of granulocytes, with
neutrophils being the first responders, followed by monocytes that mature into M1 MΦs in the
inflammatory environment that then effect the functions of resident MΦs (Serhan and Savill, 2005).
Resolution of inflammation involves stopping neutrophil infiltration into the inflammatory site, increasing
monocyte/MΦ recruitment to the site to phagocytosis the pathogen and apoptotic neutrophils without
increasing inflammatory mediator release, and the return of the tissue mononuclear cell population
(lymphocytes and macrophages) to pre-infiltration numbers and phenotypes (M2 MФ) (Walker et al.,
2011).
Even as the inflammatory response is being initiated, signaling pathways to terminate the
response are being programmed. When granulocytes enter tissues they promote the switch of AA-derived
PGs and LTs to LXs, which initiate the termination sequence. The lipid mediators being produced depend
on the types of cells being encountered in the environment; neutrophils can interact with other leukocytes,
platelets, endothelia, mucosal epithelia, interstitial cells, and fibroblasts (Serhan and Savill, 2005). PGE2
and PGD2 produced at the inflammatory site switch on transcription of enzymes needed to make
eicosanoids from AA other than PGs and LTs (Levy et al., 2001). Neutrophils respond to PGs by
transcribing the gene for 15-LOX which leads to the temporal production of LXs from AA (Levy et al.,
2001).
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Lipoxins halt neutrophil infiltration into inflammatory sites (Serhan et al., 1995) by reducing
vascular permeability (Takano et al., 1998), promoting nonphlogistic infiltration of monocytes (Maddox
and Serhan, 1996), stimulating MΦ to ingest apoptotic neutrophils (Godson et al., 2000) and reducing DC
motility and IL-12 production (Aliberti et al., 2002). LXs initiate the termination sequence but they are
not the only players, resolvins and protectins are formed from ω-3 PUFAs that are also involved in
stopping neutrophil infiltration and neutrophil apoptosis (Serhan and Savill, 2005). As MΦs clean up the
area by phagocytosing apoptotic cells they are stimulated to release anti-inflammatory (IL-10) and
reparative mediators and stop producing PIM (TNFα, IL-1β, IL-8, GM-CSF, TxB2, LTC4) (Voll et al.,
1997; Fadok et al., 1998; Byrne and Reen, 2002). The process of phagocytosing apoptotic cells stimulates
the production of TGFβ, PGE2, and PAF which may mediate the decrease in PIC production as the
addition of these factors to LPS stimulated cells decreased cytokine production (Fadok et al., 1998).
TGFβ has been shown, in vitro and in vivo studies, to be released by these MΦs which can then suppress
proinflammatory signaling from TLRs (Byrne and Reen, 2002). Phagocytosing apoptotic cells inhibits
MΦs from killing resident tissue cells (Duffield et al., 2001) and triggers VEGF secretion that is involved
in repair of endothelial and epithelial damage that occurred during the inflammatory response (Golpon et
al., 2004).
The mechanisms of: PGs signaling lipid class switching in neutrophils, the production of SPMs,
cell contact between apoptotic neutrophils and MΦs resulting in phagocytosis and release of antiinflammatory cytokines and reparative mediators links mechanisms of inflammation resolution with
tissue repair and cell clearance. Phagocytosis of apoptotic cells also stimulates MΦs to emigrate and the
departure of M1 MΦs from the response site to local lymph nodes signals the end of the antiinflammatory program (Bellingan et al., 1996).

Peroxisome Proliferator-Activator Receptors
Peroxisome proliferator-activator receptors (PPARs) are nuclear receptors and ligand activated
transcription factors that form heterodimers with retinoic acid receptors (Dinarello, 2010; Lian et al.,
2015). PPARs have roles in development and differentiation as well as modulation of fat and glucose
metabolism and the inflammatory response (Clark et al., 2000; Feige et al., 2006; Dinarello, 2010; Li et
al., 2014; Lian et al., 2015). Ligands for the receptors include naturally occurring FAs and eicosanoids
(Forman et al., 1995). Specfically, PPARγ is activated by PUFAs as well as the bioactive metabolite of
prostaglandin D2, 15deoxyΔ12,14 Prostaglandin J2 (15dPGJ2) and 15-HETE (Forman et al., 1995;
Bensinger and Tontonoz, 2008). PPAR agonists reduce expression of several PICs, chemokines, and
adhesion molecules and effect T cell proliferation (including in the placenta) by interfering and inhibiting
other transcription factors (AP-1, NF-κB, NFAT (nuclear factor of activated T Cells) (IL-2 transcription),
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STATs (STAT3-IL-6 transcription)) by physically interacting with them in a process termed transrepression (Ricote et al., 1998; Clark et al., 2000; Lappas et al., 2002; Genolet et al., 2004; Feige et al.,
2006; Szanto and Nagy, 2008; Dinarello, 2010; Li et al., 2014; Lian et al., 2015). Therefore, another way
for ω-3 PUFAs to have anti-inflammatory effects is through upregulation and signaling through PPARγ.
In addition to its role in lipid metabolism, PPARγ controls inflammation through inhibition of
inflammatory gene expression including IL-1β, TNFα, IL-6, CXCL8, COX-2, VCAM-1, NOS, MMP,
and APPs (Ricote et al., 1998; Jiang et al., 1998; Jackson et al., 1999; Takano et al., 2000; Wang et al.,
2001). PPARγ also prevents the release of PICs, matrix metalloproteinase activity and vascular smooth
cell migration (Bensinger and Tontonoz, 2008; Szanto and Nagy, 2008). By inhibiting transcription of
monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2 in MΦs, Peroxisome proliferatoractivator receptor γ can inhibit MΦ recruitment to inflammatory sites (Szanto and Nagy, 2008). PPARγ
can regulate the response of MΦs, and T cells to inflammatory stimuli as well as influence the
polarization of Th1 versus Th2 cells (Genolet et al., 2004). Peroxisome proliferator-activator receptor γ
decreases IL-2, INFγ, and TNFα production by Th1 cells and increases IL-4, IL-10, and GATA3
production by T2 cells (Genoler et al., 2004).
There are several endogenous agonists including prostacyclin in addition to many synthetic
ligands for PPARγ (Dinarello, 2010). Dasu et al (2009) investigated the anti-inflammatory effects of the
synthetic PPARγ agonist pioglitazone on human blood monocytes in vitro when exposed to TLR 2 and
TLR 4 ligands after pretreatment with pioglitazone. Compared to control, the PPARγ agonist reduced
gene expression of TLR2 and TLR4 in addition to reducing TLR ligand-induced binding activity of NFκB, and the amount of PICs and MCP-1 secreted from the cells. In mice treated with pioglitazone for 10
days, peritoneal MΦs had reduced expression of TLR2 and TLR4, a decrease in MyD88 dependent
signaling, a decrease in NF-κB DNA binding activity, and reduced serum levels of PICs and MCP-1
(Dasu et al., 2009). These in vitro and in vivo studies show that activation of PPARγ has antiinflammatory effects by reducing TLR signaling resulting in reduced PIC production. N-3 PUFAs are
endogenous nuclear receptor ligands that activate PPARs and feeding mice ω-3 PUFAs has been show to
increase expression of PPARγ associated with a reduction in inflammation and disease severity (Li et al.,
2014; Lian et al., 2015). Li et al (2014) used the cecal ligation and puncture sepsis model in mice fed fish
oil or a control diet. After the procedure, fish oil fed mice had lower plasma TNFα, and IL-6, and lower
PGE2 and TNFα in peritoneal lavage fluid. In addition, it was reported that in fish oil fed mice the DNAbinding activity of PPARγ was increased as well as the mRNA expression of IκBα while NF-κB p65
DNA binding activity and iNOS protein levels were reduced in the liver (Li et al., 2014).
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With regard to MΦs, PPARγ promotes alternative activation of the cells (M2 MΦ) by increasing
expression of target genes involved in M2 MΦ function and preventing MΦs from being activated in
response to PIMs (Genoler et al., 2004; Bensinger and Tontonoz, 2008). Classical MΦs are activated by
PICs and infectious agents and produce PIMs. M2 MΦ develop from monocytes in response to IL-4 and
have a suppressive phenotype characterized by diminished production of PICs and the ability to inhibit T
cell proliferation and promote inflammatory resolution (Szanto and Nagy, 2008). PPARγ increases MΦ
production of CXCL8 and IL-1Ra and decreases MΦ production of IL-1β, IL-6, IL-12, IL-15, TNFα,
iNOS, IP-10, RANTES, and MIP-1α (Genoler et al., 2004). PPARγ activation in MΦ inhibits their
response to LPS or IFNγ (Ricote et al., 1998). These actions of PPARγ may be due to PPAR stimulating
the breakdown of inflammatory eicosanoids through induction of β-oxidation or through the ability to
transrepress other transcription factors such as NF-κB, AP-1, and STAT (Takano et al., 2000; Wang et al.,
2001; Daynes and Jones, 2002). DHA, a fatty acid ligand of PPARγ, induces mRNA expression and
nuclear translocation of the transcription factor in MΦs (Chang et al., 2015). In a PPARγ dependent
manner, DHA polarizes MΦ to a M2 phenotype but the transcription factor does not seem to account for
DHA’s ability to inhibit LPS-induced classical macrophage activation (M1) (Chang et al., 2015).
With regard to DCs, activation of PPARγ leads to reduced ability to be stimulated by TLR
agonists, reduced capacity to stimulate T cell proliferation, and inhibition of production of IL-12, IL-15,
IL-6, TNFα, CXCL10 (IP-10), and CCL5 (RANTES); PICs/cytokines for Th1 polarization and
chemokines for Th1 cell recruitment (Faveeuw et al., 2000; Gosset et al., 2001; Appel et al., 2005). With
regards to co-stimulatory molecule expression, PPARγ activation reduces CD80 expression but induces
CD86 expression, a situation that favors Th2 polarization over Th1 polarization of naïve T cells (Genolet
et al., 2004). CCR7, the chemokine receptor involved in DC migration, is also reduced with PPARγ
activation, limiting DC migration to lymph nodes. Altogether, PPARγ activation in DCs will result in less
antigen presentation to naïve T cells, a shift towards Th2 versus Th1 polarization, a reduction in Th1
recruitment, and reduced inflammation. Stimulation of human monocyte-derived DCs with PPARγ
agonists decreased secretion of the Th1 promoting cytokine IL-12 when cells were also stimulated with
LPS or CD40L compared to DCs only stimulated with LPS or CD40L (Gosset et al., 2001). The PPARγ
agonists also down regulated synthesis of IL-10 and RANTES, chemokines that attract Th1 lymphocytes
(Gosset et al., 2001), suggesting PPARγ may regulate DCs function so that DCs do not cause naïve CD4+
T cells to differentiate into Th1 cells and do not recruit Th1 cells to the infection/inflammatory site.
Peroxisome proliferator-activated receptors are expressed by trophoblast cells, in which they have
roles in placental development and function (Barak et al., 2008). PPARγ specifically has been reported to
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have a role in trophoblast differentiation and maturation, in regulating the thickness of the
spongiotrophoblast layer, affecting the labyrinthine vasculature, enhancing fatty acid uptake and
expression of fatty acid transport proteins (Schaiff et al., 2007; Barak et al., 2008; Wieser et al., 2008). A
diet high in ω-3 PUFAs, ligands for PPARγ, may increase the anti-inflammatory potential of the uterine
environment.

Dietary Supplementation with Omega-3 Polyunsaturated Fatty Acids
A diet high in ω-3 PUFA can be anti-inflammatory for several reasons. First, the ω-3 PUFAs will
partially replace the ω-6 PUFA AA in cell membranes which will lead to reduced production of AAderived mediators. Eicosanoids are produced from FAs liberated from membrane phospholipids. AA is
converted into 2-series PGs, thromboxanes, and 4-series LTs; by reducing the amount of AA in
membranes there is less substrate to be turned into these mediators (Calder, 2003). The PUFAs will also
compete for the COX and LOX enzymes and EPA has been reported to competitively inhibit oxygenation
of AA by COX (Obata et al., 1999). Ω-3 PUFAs can also suppress cytokine-induced expression of COX-2
and 5-LOX gene expression (Curtis et al., 2000; Curtis et al., 2002), limiting the production of
eicosanoids. Altering the FA composition of cell membrane phospholipids can influence membrane
activities and cellular responses (Calder, 2003). The FA composition of phospholipids will effect
membrane fluidity (Stubbs and Smith, 1984) which affects the activity of membrane-bound proteins such
as receptors, transporters, and enzymes (Murphy, 1990), which will influence how an inflammatory cell
responds to a stimulus (Grimble, 1998). Membrane phospholipids are used to produce the intracellular
signals DAG, inositol phosphate, and ceramide; the FA composition of the substrate phospholipids can
influence the production of these signals by phospholipase enzymes and signal transduction pathways
(Miles and Calder, 1998).
Omega-3PUFAs will suppress production of PICs and modulate adhesion molecule expression by
controlling gene expression of these factors (Calder, 2003). Suppling EPA and DHA in culture inhibited
IL-1β and TNFα production by monocytes (Calder, 1997) and the production of IL-6 and CXCL8 by
venous endothelial cells (de Caterina et al., 1994; Khalfoun et al., 1997). Feeding fish oil to mice
decreased circulating levels of TNFα, IL-1β, and IL-6 after an LPS challenge compared to mice fed
safflower oil (Sadeghi et al., 1999). With regards to adhesion molecules, human venous endothelial cells
cultured with EPA or DHA had decreased surface expression of E-selectin, ICAM-1, and VCAM-1 when
stimulated with cytokines or LPS (de Caterina et al., 1994) and had diminished adhesion of ligandbearing monocytes (de Caterina and Libby, 1996). Monocytes cultured with EPA also displayed less
surface ICAM-1 when stimulate with IFNγ (Hughes et al., 1996). The decrease expression of VCAM-1
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on the surface of endothelial cells was shown to be due to DHAs effect of gene expression of the adhesion
molecule (de Caterina et al., 1994).
In cultured bovine chondrocytes, EPA, DHA, and ALA decreased cytokine induced expression of
COX-2 (but not COX-1), IL-1α, and TNFα (Curtis et al., 2000). Adding EPA, DHA, or ALA to cultured
explants of human osteoarthritic cartilage decreased cytokine induced upregulation of COX-2, 5-LOX, 5LOX activating protein (FLAP), IL-1α, IL-1β, TNFα, MMP-3, and MMP-13 expression (Curtis et al.,
2002). Gene expression of COX-1, 12-LOX, and 15-LOX were not affected by the ω-3 PUFAs but these
genes were not induced by the cytokines anyway (Curtis et al., 2002).
The transcription factor NF-κB is involved in inducing expression of several inflammatory genes
including COX-2, ICAM-1, VCAM-1, E-selectin, TNFα, IL-1β, NOS, MMPs, and APPs (Christman et
al., 1998; Chen et al., 1999; Calder, 2002). This transcription factor is located in the cytosol of resting
inflammatory cells as an inactive heterodimer. When stimulated, a signaling cascade activates the IκB
kinase (IκK) protein complex which phosphorylates the inhibitory subunit of NF-κB (IκB). IκB then
dissociates from the rest of the inactive NF-κB trimer (Karin and Ben-Neriah, 2000; Karin and Helhase,
2000) and is degraded while the remaining NF-κB heterodimer translocates into the nucleus to bind to
response elements of target genes regulating transcription. Ω-3 PUFA may regulate gene expression by
limiting NF-κB activation. When the MΦ cell line RAW264.7 was cultured with EPA and then stimulated
with LPS, the cells produced less TNFα mRNA and protein, and less PGE2 which was associated with
reduced NF-κB activity (Lo et al., 1999).
Feeding fatty acids to cows after the post-partum period of immune-suppression and uterine
involution may have benefits to future pregnancy. Specific fatty acids could suppress the biosynthesis of
inflammatory molecules reducing residual inflammatory responses in the uterus to subclinical
endometritis and preventing PGF2α production and luteolysis (Thatcher et al., 2010).
The unsaturated fatty acid oleic acid (18:1 n-9) can be made by animal tissues, however, linoleic
acid (18:2 n-6) and ALA (18:3n-3) are considered dietary essential as the required desaturases to produce
these FAs are not present in animals (Abayasekara and Wathes, 1999) Linoleic acid (20:4 n-6) undergoes
elongation and desaturation to form differential n-6 products, such as dihomo-γ linolenic (20:3 n-6) and
AA (20:4n-6). ALA (18:3 n-3) undergoes elongation and desaturation to form n-3 products such as EPA
(20:5n-3) and DHA (22:6n-3). AA can be used to produce eicosanoid products, different series of PGs
(PGF1, PGF2, PGF3), thromboxanes, and LTs (Dennis and Norris, 2015) ALA is found as a component of
chloroplast lipids and is high in linseed oil from the flax plant (Linum usitatissimum) (Sergent, 1997).
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The diet of ruminants contains predominantly unsaturated fatty acids but upon ingestion, dietary
lipids are extensively hydrolyzed in the rumen and the unsaturated fatty acids are biohydrogenated by
rumen microbes to more saturated products (Wonsil et al., 1994). Supplementation of nonprotected fats
can decrease dry matter intake (DMI) and reduce digestibility of non-lipid energy sources in ruminants
due to changes in ruminal fermentation, gut motility, palatability, release of gut hormones, and oxidation
of fat in the liver (Allen, 2000). Both amount and form of a fat supplement matter when it comes to rumen
health, DMI, and digestibility. Flaxseed (Linum usitatissimum) on a dry matter (DM) basis contains 20%
crude protein (CP), 18% neutral detergent fiber (NDF), and 40% ether extract. It is rich in ALA (18:3n-3),
averaging 18% of the total seed weight and constituting 53% of the total fatty acids (Mustafa et al., 2002).
Being an oilseed, the high level of PUFAs in flaxseed can negatively affect ruminal fiber digestion
(Palmquist and Jenkins, 1980).
Gonthier et al (2004) using a Latin square design fed lactating Holstein cows a control diet with
no flaxseed at a 64:36 forage: concentrate ratio (DM basis) or flaxseed (12.6 % dietary DM) added as a
topdressing at a 55:45 forage: concentrate ratio (DM basis) in 3 different forms (raw, micronized, and
extruded). The study reported that flaxseed supplementation improved post-ruminal organic matter and
total-tract digestibility (expressed as a percent of passage to duodenum and percent of intake,
respectively) compared to a diet with no flaxseed, with no harmful effects on rumen function. Schroeder
et al (2014) using a Latin Square design fed Holstein steers basal diets of 47% concentrate, 30% corn
silage, 17% alfalfa hay and 6% beet pulp shreds. The concentrate portion contained either 7.5% linseed
meal (control), 10% whole flaxseed, 10% rolled flaxseed, or 10% ground flaxseed. Dry matter intake was
similar between diets and treatments had no effect on apparent or true OM digestion in the rumen. Large
intestine, small intestine, and total-tract digestibilities were similar for the treatments. There was no
change in protein digestion with the addition of flaxseed supported by no differences in duodenal CP flow
(bacterial., apparent feed, or total), ileal CP flow, fecal CP output, microbial efficiency, or CP digestibility
(apparent ruminal., true ruminal., small intestine, large intestine, or total tract) (Schroeder et al., 2014).
Gonthier et al (2004) reported a reduction in microbial CP flow to the duodenum and microbial
efficiencies (true and apparent) with flaxseed supplementation suggesting flaxseed can reduce ruminal
microbial growth. However, ruminal digestion of CP was not affected by diet and post-ruminal CP
digestibility (percentage of passage to the duodenum) and total tract CP digestibility were greater with the
flaxseed diets (Gonthier et al., 2004). Flaxseed had no effect on total-tract neutral detergent fiber (NDF)
or acid detergent fiber (ADF) digestion at the level of 10% of dietary DM and no differences in NDF and
ADF intake, duodenal flow, ileal flow, fecal output, or digestibility were detected in the Schroeder et al
study (2014). Gonthier et al (2004) reported the addition of flaxseed (12.6% of dietary DM) decreased
ruminal ADF digestibility, increased post-ruminal ADF digestibility and had no effect on total tract ADF
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digestibility (expressed as a percentage of intake). Flaxseed tended to increase post-ruminal and total tract
digestibilities of DM, OM, NDF, and gross energy (Gonthier et al., 2004). Gonthier et al (2004) reported
reduced microbial efficiency with raw, micronized, and extruded (12.6% of diet DM) flaxseed compared
to the control diet without flaxseed but Schroeder et al (2014) feeding flaxseed at 10% DM reported no
change in microbial efficiency (g of microbial N/kg of OM truly fermented). Schroeder et al (2014)
reported no effect of feeding flaxseed on ruminal pH, ammonia, or volatile fatty acid (VFA)
concentrations (total, individual, acetate: propionate, or acetate: butyrate: propionate) indicating similar
fiber digestion and ruminal fermentation with the different diets. Consistent with this, Gonthier et al
(2004) reported no difference in average ruminal pH, NH3N, or total VFA. In the Gonthier et al (2004)
study there was a decrease in the molar proportion of acetate and an increase in the molar proportion of
propionate when feeding flaxseed which decreased the acetate: propionate ratio. The authors stated that it
was not clear whether the differences in molar proportions of the two VFAs was due to flaxseed
supplementation or differences in forage level, as the 3 flaxseed diets had a different forage: concentrate
ratio than the control diet. Lower acetate and greater propionate proportions with the addition of oilseeds
to ruminant diets tends to relate to lower ruminal fiber digestion fitting with the reported reduction in
ruminal ADF digestibility (expressed as a percentage of ADF intake) with the flaxseed diets compared to
control (Gonthier et al., 2004).
Petit et al. (2002) fed primiparous lactating Holstein cows one of 3 total mixed diets with a fat
supplement based on either whole flaxseed (FLA; 10.4% DM), Megalac (MEG; 3.8% DM), or
micronized soybeans (SOY; 17.7% DM). Cows fed the whole flaxseed had higher milk production than
those fed MEG, higher milk protein percentage than those fed MEG or SOY, and higher levels of ALA in
their milk compared to MEG cows. Cows fed flaxseed had a lower DM digestibility compared to the
SOY group, and lower ether extract, ADF and NDF digestibility compared to the SOY and MEG groups.
Analyzing blood collected from the cows, FLA cows had reduced levels of NEFAs, total cholesterol
(mg/100ml) and HDL cholesterol (mg/100mL) compared to the other two diets. With regards to the fatty
acid profile in the blood samples, compared to the SOY and MEG groups, the FLA cows had lower levels
of palmitate (16:0) but higher levels of stearic (18:0), ALA (18:3 n-3), and EPA (20:5 n-3) with a reduced
omega-6/omega-3 ratio (Petit et al., 2002).
Petit and Côrtes (2010) fed multiparous Holstein dairy cows one of four iso-net energy total
mixed rations that contained either 21g/kg DM calcium salts of palm oil (CON), 72 g/kg DM whole
flaxseed (WHO), 72 g/kg DM ground flaxseed (GRO), or 36 g/kg DM whole flaxseed and 36 g/kg DM
ground flaxseed (MIX). The GRO group had reduced DM intake compared to the other 3 diets and might
have been due to disturbances in rumen function, this diet contained the largest amount of flaxseed with a
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disturbed seed coat leaving the oil unprotected from rumen microbes. The CON group had reduced milk
lactose compared to the 3 flaxseed diets while milk fat and CP showed no differences between diets.
Among long chain fatty acids, ALA results in high rates of gluconeogenesis which ruminants use for
lactose production. Increased gluconeogenesis with flaxseed supplementation may explain the increase in
milk lactose in the 3 diets containing flaxseed. With regards to the fatty acid milk profile, all 3 flaxseed
diets decreased the amount of palmitate (16:0), increased the amount of stearic acid (18:0), oleic acid
(18:1 cis 9), ALA (18:3 cis 9,12,15), increased the level of mono unsaturated fatty acids, long chain fatty
acids, and omega-3 fatty acids, while decreasing the level of saturated fatty acids and the omega6/omega-3 ratio. The GRO and MIX diets also significantly increased the levels of poly-unsaturated fatty
acids while the WHO and MIX diets significantly decreased the omega 6 FA levels compared to CON
(Petit and Côrtes, 2010).
Scholljegerdes and Kronberg (2008) using a Latin Square design fed Angus Heifers hay without a
supplement or supplemented with 0.91 kg/d (3.2% of added dietary fatty acids, DM basis) of whole
flaxseed, or 1.82 kg/d (5.8% of added dietary fatty acids, DM basis ) of whole flaxseed on a DM basis. In
agreement with Gonthier et al (2004), Scholljegerdes and Kronberg (2008) reported an increase in
apparent lower tract OM digestibility (% of duodenal flow) with the addition of flaxseed to the diet,
however, the apparent total-tract OM digestibility (% of intake) did not differ with the diets.
Scholljegerdes and Kronberg (2008) reported that flaxseed supplementation increased the apparent lower
tract and total-tract N digestibility indicating whole flaxseed does not impair ruminal N metabolism and
that N escaping ruminal degradation is available in the small intestine. There were no differences in
duodenal or fecal NDF flow and flaxseed had no effect on ruminal, lower tract, or total-tract NDF
digestibility (Scholljegerdes and Kronberg, 2008). Going from the control diet to 0.91 kg/d to 1.82 kg/d
of flaxseed, molar proportions of acetate decreased while molar proportions of propionate, isobutyrate,
isovalerate, valerate increased, and the acetate: propionate ratio decreased. Ruminal pH, NH3, total VFAs,
and butyrate levels were unaffected by diet. Flax feeding increased intestinal supply of ALA, mono
unsaturated fatty acids and PUFAs which may increase tissue supply of unsaturated fatty acids
(Scholljegerdes and Kronberg, 2008).
Côrtes et al. (2010) using a Latin square design fed lactating Holstein cows isonitrogenous and
isoenergetic diets: a control diet without flaxseed (CON), a diet (on a DM basis) with 4.2% whole
flaxseed (FLA), a diet with 1.9% calcium salts of flaxseed oil (SAL), or a diet with 2.3% whole flaxseed
and 0.8% calcium salts of flaxseed oil (MIX) fed ad libitum. Diets did not affect DMI, digestibility, milk
production, milk concentrations of protein, lactose, urea N, or total solids. Feeding whole flaxseed did not
affect rumen pH, concentration of ammonia N, total VFA, the ratio of acetate: propionate, or molar
66

proportions of specific VFAs (Côrtes et al., 2010). Feeding FLA increased the percent of 18:0, and longer
chain fatty acids in ruminal fluid. With regard to milk, the percent of 16:0 was decreased with FLA
compared to CON, the percent of long chain fatty acids were increased compared to CON and the FLA
milk had higher levels of ALA but was not high enough to be significant. The milk ratio of n-6:n-3 was
also decreased with the FLA diet compared to CON (Côrtes et al., 2010).
Oba et al. (2009) used a crossover design and fed primiparous Holstein cows unprocessed whole
flaxseed (WF) or rolled flaxseed (RF) at 100 g Kg-1 of dietary DM. DMI, milk yield, and milk
composition were similar between diets. Apparent total tract digestibility of ether extract was lower for
WF than RF and excretion of ALA in feces was greater with WF than RF. However, concentration of
ALA in milk was not different between diets and both diets increased ALA in milk (3x) compared to
before the study when cows were fed sunflower seed instead of flaxseed. Results suggest that both WF
and RF increase the absorption of ALA to a similar extent despite the lower digestibility of WF. This may
be due to reduced lipolysis in the rumen or fatty acid biohydrogenation of WF since the fatty acids are
protected by an intact seed coat. This idea is supported by a decreased concentration of vaccenic acid (a
fatty acid intermediate formed during biohydrogenation) in milk fat with the WF diet. While dry-rolling
flaxseed breaks the seed coat and allows for better access (increased digestibility) to the fatty acids, it also
allows for increased biohydrogenation in the rumen, therefore, does not necessarily improve absorption of
ALA (Oba et al., 2009). When feeding the unprocessed WF, intact WF appeared in the feces, however,
comparing the ether extract in excreted flaxseed to flaxseed before it was ingested there was a 76%
reduction in ether extract suggesting that the fats present in flaxseed were able to be utilized by cattle
even though the seed coat appeared intact (Oba et al., 2009). Mesgaran et al (2012) fed lactating dairy
cows either ground flaxseed, whole flaxseed or extruded soybeans, in a Latin square design, up to 9% of
diet DM with no differences in regards to DMI, body weight, body condition score, or milk yield. There
was no difference between diets in plasma NEFAs or BHB. The ground flaxseed diet increased the levels
of ALA, monounsaturated FAs and PUFAs in the milk. Increases in unsaturated FAs in milk when fed a
flaxseed diet suggests sufficient quantities of PUFAs in the flaxseed survived bio-hydrogenation in the
rumen to be transferred to milk fat (Oba et al., 2009; Mesgaran et al., 2012) and is likely to be available
for use by other tissues and incorporation into the plasma membranes of various cells.
Wachira et al. (2000) using a Latin square design fed wether lambs 4 iso-energic and isonitrogenous diets based on dried grass and provided similar fat levels (60g/kg DM) from 4 different
sources. One diet included Megalac (a calcium soap of palm oil) (control; palmitic acid 16:0), one diet
provided whole flaxseed (ALA, 18:3 n-3), one provided fish oil (EPA 20:5 n-3; DHA 22:6 n-3) and the
last diet provided whole flaxseed plus fish oil (50:50 mix on an oil weight basis). Wethers were fed
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1.2kg/day. With the flaxseed diet, duodenal flow of ALA was double compared to the control diet and
also had higher duodenal flow of 18:0 and trans 18:1 FAs. The increase in duodenal flow of the 18:0 and
trans 18:1 FAs is likely to be a result of biohydrogenation by rumen microbes and in fact the flaxseed diet
had a 92.4% biohydrogenation rate of ALA compared to 80.2 % with the control diet. The fact that the
whole flaxseed had 24.4 g/kg DM of ALA compared to 4.5 g/kg DM in the control diet allowed for
increased apparent small intestine fatty acid digestibility (duodenum to rectum) of ALA with the whole
flaxseed diet. This study incorporated the whole flaxseed into a pellet which damaged the seed coat and
provided the rumen microbes access to the fatty acids (Wachira et al., 2000). Had the flaxseed been fed
intact, there would have been less biohydrogenation and potentially even greater ALA reaching the small
intestine. Feeding whole flaxseed compared to control did not affect whole tract (mouth to rectum)
digestibility of DM, OM, CP, NDF, total FAs, or gross energy. The flaxseed diet compared to control did
not affect ruminal fluid pH, molar proportions of acetate, propionate, or butyrate, or the ratio of ketogenic
to glucogenic acids (acetate + butyrate/propionate) (Wachira et al., 2000). The control diet had a lower
duodenal flow of ammonia-nitrogen but a higher flow of non-ammonia nitrogen while microbial nitrogen
flow was similar between the control and flaxseed diets. The flaxseed diet compared to control had a
higher proportion of OM truly digested in the rumen (Wachira et al., 2000).
Soder et al. (2012) using a Latin Square design supplemented ground flaxseed in a orchardgrass
diet (70 g of total DM) at the level of 0% (70g of herbage), 5% (5g flaxseed + 65g herbage), 10% (10g
flaxseed + 60g herbage), and 15% (15g flaxseed + 55g herbage). With increasing flaxseed
supplementation, apparent DM, OM, and NDF digestibilities decreased, whereas true DM and OM
digestibilities were not affected (Soder et al., 2012). Flaxseed included in the diets was ground breaking
the seed coat and allowing the oil to be released in the rumen which may have impacted the rumen
microbes and nutrient (OM, DM, and NDF) digestibility. While ruminal pH and total VFAs were not
affected by the flaxseed, molar proportions of acetate and propionate increased while butyrate and
valerate decreased with increasing flaxseed supplementation resulting in a decreasing acetate: propionate
ratio with increasing flaxseed supplementation. Ammonia-N concentration, apparent CP digestibility, and
microbial N synthesis were not affected by diets (Soder et al., 2012).
An in vitro study (Maia et al., 2007) reported that growth of ruminal bacteria are affected by
PUFAs which could influence ruminal fermentation, although different species have different levels of
sensitives and different PUFA are more damaging than others. Ranking the PUFA tested on toxicity to
bacterial growth, the most toxic was EPA, followed by DHA, ALA, and finally linoleic acid (Maia et al.,
2007). ALA is toxic for the 3 predominant cellulolytic species responsible for fiber digestion
(Fibrobacter succinogenes, Ruminococcus albus, and Ruminococcus flavefaciens) by disrupting cell
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integrity (Maia et al., 2007). PUFA may be directly toxic to methanogens that use hydrogen for CH4
production. With less methanogens there may be more free hydrogen which can inhibit growth of
cellulolytic bacteria and impair fiber digestion (Soder et al., 2012). However, microbial N-flow was not
changed by increasing supplementation of flaxseed in Soder et al’s (2012) study suggesting that if there is
a reduction in methaogenic and cellulolytic bacteria that other microbial species are compensating. When
feeding whole seeds the fatty acids are protected by the seed coat minimizing PUFA toxicity to rumen
bacteria and biohydrogenation by the bacteria, potentially increasing their availability in the small
intestine.

Omega-3 PUFAs and Benefits to Reproduction
Fat supplementation in rumen diets is used to increase the energy density of the diet and to utilize
the properties of specific fatty acids. Several studies using different strategies of fat supplementation have
reported benefits in health, reproduction, and production of ruminants (Staples et al., 1998; Santos et al.,
2008; Silvestre et al., 2011a; Greco et al., 2015; Rodney et al., 2015). The benefits are not just due to
increased energy provided by the FAs but by the properties of the specific FAs in the diet (Staples et al.,
1998). Altering the lipid content of the diet can shift the FA profile of tissues and alter tissue physiology
(Calder, 2012). Indeed, feeding high amounts of omega-3 FAs to cows resulted in a higher proportions of
omega-3 FAs in the endometrium concurrent with a lower proportion of AA (Burns et al., 2003; Bilby et
al., 2006c). Reduced amounts of available AA limit the PG response to a stimulus (Mattos et al., 2002).
Thus, most research investigating the effect of dietary FAs on uterine biology focus on changing the
endometrial FA profile to reduce the proportion of PG precursors (ex: arachidonic acid) and thus control
the amount the 2 series PGs that can be produced. Because PGF2α is luteolytic in ruminants, limiting the
amount of PGF2α should protect the CL and P4 production from the CL (Ribeiro et al., 2016c). In general.,
studies using dietary FA supplementation report benefits with regards to reproduction (Rodney et al.,
2015) with the benefits occurring not only from additional energy but from non-caloric effects of FAs
(Santos et al., 2008). Non-caloric effects include altering the FA profile at the maternal-fetal interface
(limiting series 2 prostaglandin precursors), immune modulating functions, altered follicle development,
changes in oocyte quality, and improved uterine environment (Ribeiro et al., 2016c).
Postpartum diseases in cattle are a major factor in reproductive failure with cows suffering
inflammatory diseases having impaired hypothalamic-pituitary-ovarian axis function, impaired conceptus
development, and increased rates of embryo loss (Ribeiro et al., 2016b). Not only is an inflammatory
environment not conducive to conceptus development but prostaglandins are mediators of an
inflammatory response. Since the precursors of prostaglandins are FAs, in a pro-inflammatory
environment not only will there be an increase in inflammatory prostaglandins but a change in tissue lipid
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content. During elongation, the conceptus needs lipid for energy as well as for incorporation into new cell
membranes as cells proliferate. Therefore, an inflammatory environment is not only hostile to an embryo
but will limit the amount of lipid available for embryo growth. Dietary supplementation of FAs not only
provides energy for the dam and embryo but depending on the type of FAs added to the diet, the amount
of inflammatory prostaglandins produced can be reduced and more lipid can be available for conceptus
growth.
Feeding fish meal, which is high in the omega-3 FAs EPA and DHA improved pregnancy per AI
in lactating dairy cows (Armstrong et al., 1990; Burke et al., 1997). When Silvestre et al (2011) fed
lactating dairy cows fish oil (high in n-3) or palm oil (no n-3; little n-6) around the time of breeding they
saw a reduction in pregnancy loss to first AI in their fish oil fed cows and an increase in pregnancy to
second AI. These two results together means fish oil improved the accumulated proportion of pregnant
cows after 2 postpartum inseminations (Silvestre et al., 2011). Feeding whole flaxseed (10.4 % DM),
which can be turned into EPA and DHA, to cows has been seen to increase first service pregnancy per AI
(Petit and Twagiramungu, 2006) and to reduce pregnancy loss (Ambrose et al., 2006 (rolled flaxseed 9%
DM); Petit and Twagiramungu, 2006).
The change in pregnancy success in cows fed PUFAs may be due to immune modulating
effects of PUFAs which have been seen to have beneficial effects with regards to inflammation (Calder
2006a,b; 2013a,b,c) and increased amounts of fatty acids are found in the uterus/placenta after
supplemented feeding. Therefore, feeding PUFAs may result in these fatty acids being able to have direct
effects on immune cells in the reproductive tract leading to alteration of the immune response in that area.
In the study that supplemented cows with fish oil, neutrophils isolated from blood samples taken around
the time of insemination had a highly attenuated production of TNF-α when stimulated with LPS while
the neutrophils from palm oil supplemented cows had a huge increase in TNF-α when stimulated with
LPS (Silvestre et al., 2011a; Silvestre et al., 2011b). Greco et al (2015) fed lactating dairy cows diets that
were formulated with a mixture of oils (fish, safflower, and palm) to produce diets with varying ratios of
n-6 to n-3 fatty acid concentrations and then evaluated their inflammatory response to an infusion of LPS
into one quarter of the mammary gland. Cows fed the lowest n-6/n-3 ratio (ate the most omega 3 fatty
acids) had the lowest level of IL-6 after LPS and had an attenuated increase in somatic cell count while
the cows fed the diet with the highest n-6/n-3 ratio had significantly higher haptoglobin levels in response
to LPS (Greco et al., 2015).
Vijay-Kumar et al. (2011) fed mice either a diet with fish oil (FO) or saturated fat (SF) before
2 LPS challenges 7 days apart (100ng of LPS followed by 500 ng of LPS). Mice fed the saturated fat diet
had higher mortality after the LPS challenges and lost more body weight. With regards to the PIC IL-1β,
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although not significant different, the FO mice had lower levels compared to the SF mice before LPS
challenge (100ng) and levels barely increased in FO mice in response to LPS challenge. In the SF mice,
there was an increase in IL-1β in response to LPS challenge and a significant difference in IL-1β levels
between FO and SF groups after LPS challenge. With regards to behavior, after the 100ng LPS challenge
the SF mice became reclusive and went to sleep while the FO mice displayed no abnormal behaviors.
After the 500ng challenge both groups were moribund, however, mice in the FO group recovered more
rapidly than the SF mice. (Vijay-Kumar et al., 2011).
Caughey et al. (1996) saw a decrease in TNFα, IL-1β, thromboxane B2, and PGE2 production
by mononuclear cells (in response to LPS stimulation) of male subjects that added flaxseed oil to their
diet for 4 weeks but subjects that added sunflower oil to their diet had no change in production of the
PIM. There was an association between PIM production and the EPA content of their cells where
cytokine production decreased as cellular EPA increased to ~1% of total fatty acids (Caughey et al.,
1996). These studies suggest that PUFAs, specifically ω-3 fatty acids, may dampen the inflammatory and
APR to bacterial components, which would be favorable during pregnancy when an immunosuppressive
environment in the uterus is needed for embryo survival.
A study that fed lactating dairy cows either calcium salts of fish oil (11% of C20:5n-3 + C22:6n3) or calcium salts of palm oil (47% c16:0) during the breeding period (30-80 days post-partum) found
that neutrophils (isolated at 80 days post-partum) cultured with LPS from cows supplemented with fish
oil produced significantly less TNFα than neutrophils isolated from cows supplemented with palm oil. In
addition, neutrophils isolated from cows fed fish oil contained significantly higher amounts of omega 3
fatty acids (C20:5n-3, C22:5n-3, C22:6n-3) giving them a lower n-6/n-3 fatty acid ratio than neutrophils
isolated from cows fed the palm oil (Silvestre et al., 2008). This suggests that neutrophils in the fish oil
fed cows were less inflammatory which could be beneficial when trying to establish a pregnancy,
especially in a dairy cow that may have subclinical endometritis.
In vitro, ALA was shown to have beneficial effects on embryo development with regards to the
percentage of cumulus-oocyte complexes that cleaved and made it to the blastocyst stage and improved
the quality of the embryos (Marei et al., 2009). A high proportion of embryonic losses precede or occur
during the period when the embryo inhibits uterine secretion of PGF2α, some of these losses may be due
to under-sized embryos the secrete insufficient IFN-τ to prevent endometrial secretion of PGF2α (Bilby et
al., 2006a). Pre-implantation embryonic loss can also be attributed to inflammatory mediators such as
TNFα, IL-1β, NO, and PGF2α, which would be present if the uterus has any bacterial contamination.
These PIM hinder embryonic development through damages to the oocyte or developing embryo (Hansen
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et al., 2004). Direct beneficial effects of ALA on the developing embryo (Marei et al., 2009) or through
anti-inflammatory effects could prevent early embryonic loss; a sufficiently developed embryo will be
able to secrete enough IFN-τ to prevent luteolysis.
Lian et al. (2015) fed male C57BL/6 mice a low (4.62and DHA and 2.8% EPA) or high (12.4%
DHA and 7.35% EPA) ω-3 PUFA diet in the form of fish oil (Menhaden Oil) for 4-12 weeks. After 12
weeks of feeding, the PUFA diets caused proliferation of hepatic natural (but not induced Tregs) Treg
cells (CD25+FOXP3+) increasing the percentage of Tregs among CD4+ cells (Lian et al., 2015). The
Treg cells also showed higher expression of molecules (CD103 (a TGFβ inducible surface integrin),
CTLA-4, CD62L) involved in their suppressive roles suggesting enhanced immune suppressive functions
of Tregs in the fish oil fed mice (Lian et al., 2015). Liver tissue from ω-3 PUFA fed rats had higher IL-10
and TGFβ expression (Lian et al., 2015), two cytokines that mediate Treg functions and are involved in
the generation and maintenance of Tregs (Asseman et al., 1999; Nakamura et al., 2001; Nakamura et al.,
2004; Wan and Flavell, 2006). The role of Tregs is to maintain peripheral tolerance, control
inflammation, and during pregnancy to prevent rejection of the allogenic fetus. This occurs through cellcell contact between the Treg and another immune cell (they can suppress the other T helper cell subsets)
and by Treg production of regulatory cytokines such as TGFβ and IL-10 (Nakamura et al., 2001; Bettelli
et al., 2006; Shevach, 2009). Lian et al (2015) administered Concanavalin A to mice after 6-8 weeks of
eating the ω-3 PUFA or control diets to elicit hepatitis and investigate beneficial effects of the diets. Mice
fed the fish oil had more hepatic Tregs and less liver damage as assessed by liver histology analysis. Fish
oil fed mice also had increased liver PPARγ and TGFβ (did not reach significance) expression and
decreased expression of PICs (IL-1β, IL-6, TNFα, IFNγ).
Upregulation of PPARγ by dietary ω-3 PUFAs may be mediating the increase in Treg cells as
Lian et al (2015) saw an increase in liver PPARγ along with increased liver Tregs when feeding mice fish
oil and Cipolletta et al (2012) knocked out PPARγ in mouse Treg cells and concluded that PPARγ was
critical for accumulation of visceral adipose tissue Tregs and for Treg phenotype. IL-10 and TGFβ are not
only produced by Tregs to mediate their suppressive functions (Asseman et al., 1999; Hara et al., 2001;
Nakamura et al., 2004; Wan and Flavell, 2006) but along with IL-2 are involved in polarization of naïve
CD4+ T cells to a Treg phenotype and maintenance of the phenotype (Wan and Flavell, 2006). TGFβ in
conjunction with IL-2 activate the transcription factors STAT5 and FOXP3 which polarize a naïve CD4+
into a Treg (Bettelli et al., 2006; Murphy, 2012). In a mouse model of atopic dermatitis, administration of
fermented fish oil (in drinking water) reduced skin inflammation due to increased expression of TGFβ,
IL-10, and FOXP3 as well as the number of Treg cells at the inflammation site (Han et al., 2012),
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suggesting the ω-3 PUFA increased Tregs by upregulating FOXP3 or TGFβ which then activated FOXP3
expression and the increased Tregs reduced inflammation in the fermented fish oil group.
Jaudszus et al. (2013) cultured human PBMCs with EPA or DHA and reported
immunosuppressive and pro-resolving effects of the ω-3 PUFAs. Intracellular levels of IL-2, TNF-α, and
IL-4 were reduced in T helper (Th) cells when incubated with either ω-3 PUFA, although EPA had a
greater effect. This anti-inflammatory effect of the ω-3 PUFAs involved PPARγ as a mediator as a
PPARγ antagonist reversed the effects. Levels of IFNγ were unchanged by the ω-3 PUFAs (Jaudszus et
al., 2013). With regards to pro resolving functions, the ω-3 PUFAs increased the population of IL-10
positive monocytes. Incorporation of EPA and DHA into cellular membranes was shown to be at the
expense of AA which resulted in a change in the lipid mediators produced. Cells stimulated with LPS
after incubation with the ω-3 PUFAs produced decreased amounts of PGE2, thromboxane B2, LTB4, and
12-HETE and instead 18-HETE (can be metabolized into the E-series resolvins) and RvD1 were
produced.
In summary, the above studies demonstrate that ω-3 PUFAs can influence the response to a
stimulus with regard to the type of PGs produced, the production of SPMs, the production of Tregs, and
the function of immune cells; all of which factor in to mediating inflammation and maternal tolerance
during pregnancy.

Statement of the Problem
Dairy cows have high rates of early embryonic loss, which influence production, profitability, and
culling rates. Parturition and the onset of lactation are associated with a state of negative energy balance
that suppresses the immune system. That combined with bacteria entering the reproductive tract during
parturition or into the mammary glands makes dairy cows highly susceptible to subclinical and clinical
infections. A subclinical bacterial infection can turn into a clinical infection under the influence of
progesterone, which is immunosuppressive, and be detrimental to successful pregnancy. While several
pro-inflammatory molecules are involved in immunological signaling, stimulating embryonic growth,
vascular remodeling of uterine arteries and implantation of the embryo, the timing and quantity of the
molecules must be tightly controlled. Immune cells at the maternal-fetal interface have specific
phenotypes that regulate maternal tolerance to fetal antigens and mediate vascular remodeling and
implantation. An infection will result in the production of inflammatory mediators that can act directly on
the developing embryo to impair development or cause apoptosis of embryonic cells. Inflammatory
mediators also will affect the phenotype of immune cells resulting in loss of tolerance to fetal antigen and
impaired vascular remodeling and implantation. Ultimately, infection during early pregnancy can result in
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embryonic loss. Dietary omega-3 polyunsaturated fatty acids have anti-inflammatory effects and may
have reproductive benefits. Using LPS to mimic a gram-negative bacterial infection, the objectives of this
study were to identify the immunological changes in response to LPS in early pregnancy in sheep that
could be detrimental to embryo survival, to examine whether dietary omega-3 polyunsaturated fatty acids
could modulate the immune response to LPS, and to examine whether Dorset and Suffolk ewes have
differential immunological responses to LPS.
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Chapter 2: Materials and Methods
Animals
The first study was conducted in the spring (May 2015) with 16 mature Dorset ewes (10 control,
6 flaxseed) with an average body weight of 66.5 ± 2.08 kg and the second study in the fall (AugustSeptember 2015) with 42 mature Dorset ewes (21 control, 21 flaxseed) with an average body weight of
70.96 ± 1.69 kg. Breed responses to LPS were compared in Fall 2015 between 21 mature Dorset ewes
with an average body weight of 71.78 ± 1.41 kg and 32 mature Suffolk ewes with an average body weight
of 76.73 ± 2.07 kg. For the fall experiments, ewes were divided into 4 groups in the fall experiments and
experimental days were a week apart for 4 weeks with the first and third experimental days using Dorset
ewes (half on the flaxseed supplement and half on the control supplement on both days) and the second
and forth experimental days using Suffolk ewes. All ewes in the breed study were given the control
supplement. Abbreviations used for the treatment groups are CP (control supplement + PBS), CL (control
supplement + LPS), FP (flaxseed supplement + PBS), and FL (flaxseed + LPS) for the supplement studies
and DP (Dorset + PBS), DL (Dorset + LPS), SP (Suffolk + PBS), and SL (Suffolk + LPS) for the breed
study. Ewes were synchronized for estrus with a 5-day controlled intravaginal drug releasing insert
(CIDR) (Pfizer, New York, NY) followed by injection of 4 cc of PGF2α (Lutalyse®, Pharmacia and
UpJohn, New York, NY) at CIDR removal. Dorset and Suffolk ewes were always in separate pastures.
With the supplement experiments, Dorset ewes were randomly divided into two groups on the day of
CIDR removal for supplement feeding. A fertile ram wearing a marking harness was placed with each
group on the day of CIDR removal, and marking by the ram was checked twice daily when ewes were
fed. Day of the first breeding was denoted as day 0 post coitus (dpc). Ewes were weighed on the day of
withdrawal of the CIDR, the day before the LPS challenge (~7 days on supplement), and at 25 dpc
(~27days on supplement); supplement s did not affect ewe weights. All ewes were housed at the WVU
Stewartstown Farm (WVU IACUC # 13-0404.3).
The day before the experiment (supplement started 7 days prior), ewes were weighed, sorted into
pens in the barn and given hay and water. Ewes were randomly assigned to receive either LPS (2.5 µg/kg)
or PBS (3 ml) on day 5/6 post coitus (dpc). At 8 am, a blood sample was collected before jugular
administration of LPS or PBS. This dose of LPS has been used in previous experiments (Elsasser et al,
2004; Graham, 2014; Nikpour, 2017). Jugular blood samples (~8 ml) were collected via venipuncture into
EDTA treated tubes and stored in coolers with ice packs until transported to the laboratory. In the spring,
samples were collected at 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, and 24 hours after LPS or PBS
injection. During the fall, samples were collected at 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 5, 6, 9, 12, and 24
hours after LPS or PBS injection. Rectal temperature was recorded right before treatment administration
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and at each whole hour blood collection. Observable changes in behavior and mucosal responses after
treatment (lethargy, coughing, vaginal discharge, nasal discharge, and inappetance) were recorded at each
blood collection. After the 24 hour sample, ewes were returned to pasture. Additional blood samples were
collected via venipuncture into EDTA treated tubes on 8/9, 15/16 and 25/26 dpc.
White blood cell counts in 20 μl of whole blood collected at the whole hour time points were
obtained using a Beckman Coulter Counter (Beckman Coulter, Pasadena, CA). Samples were then
centrifuged at 2500 rpm for 20 minutes, and plasma was collected and stored at -80. In the spring
supplement study, buffy coats were collected and pooled for each group at each time point (Flax + LPS,
Flax + PBS, Con + LPS, Con + PBS). In the fall, buffy coats were collected, and 2-3 samples at each time
point were randomly pooled for ewes recieving the same supplement and treatment giving 4 pooled
samples for each supplement with each treatment. For the breed study, buffy coats were collected, and 4
samples were randomly pooled within treatment for the Suffolk ewes and 2 to 3 samples were randomly
pooled within treatment for the Dorset ewes giving 4 pooled samples for each breed with each treatment
at each time point. Cells in the buffy coat were re-suspended in PBS, and any remaining red blood cells
were removed using ACK lysis buffer (Lonza catalog #10-584E) and washed with PBS. Buffy coat was
transferred to a polypropylene tube and homogenized in 1.5 ml RNA-bee (Tel-Test, Friendswood, TX)
and stored at -80 until RNA extraction.
Detection for pregnancy occurred 25 or 26 dpc via transrectal ultrasonography with a 7.5 MHz
transducer and Aloka 500 ultrasound console (Corometrics Medical Systems, Inc.Wallingford, CT) for
visualization of an embryonic heartbeat. Date of birth, number of lambs born and lamb sex were recorded
after lambing.
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Figure 1: Timeline outlining the steps of trial 1 (top) of the omega-3 PUFA study (Spring 2015) and the experiments
that occurred in Fall 2015 (trial 2 of the omega-3 PUFA study and breed study) (bottom) The only major difference
is the blood collection times on the experimental day.

Feed Manufacture
Feed was prepared in weekly batches at West Virginia University’s Pilot Feed Mill using a Davis
horizontal ribbon mixer (Bonner Springs, KS). The flaxseed supplement consisted of 45% sheep ration
and 55% whole flaxseed (Table 2 and 6) (Commodity Marketing Company, Canada) purchased from
Valley Point Feed (Albright, WV; Trial 1: Lot # DM1415; Trial 2: Lot # 15-0072), and ingredients for the
control supplement were stored at the Pilot Feed Mill. The control supplement consisted of 45% sheep
ration and a 55% mixture of cracked corn, soybean meal, and soybean oil (Table 2 and 6) formulated to
match the fat and protein in the flaxseed (Tables 1 and 5). All components of the flaxseed supplement
were added to the mixer and allowed to mix for at least 5 minutes before being transferred to feed bags
for storage. All components of the control supplement except the soybean oil were added to the mixer and
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mixed for 5 min. The soybean oil was then added, and the supplement was mixed for an additional 5
minutes. Control supplement was transferred to a plastic storage bin. Both supplement s were stored in
the feed mill and weighed out in buckets to take to the ewes. Ewes were kept on pasture, had access to
water ad libitum, and were randomly assigned to receive 0.24 kg per head twice a day of the respective
supplement beginning the afternoon CIDRs were removed until 25/26 dpc.
Samples of both supplements were analyzed (Tables 3, Tables 7) by the Rumen Fermentation
Profiling Laboratory at WVU. Ten attributes were compared between samples of the prepared flaxseed
and control supplement s (Table 5, Figure 10, Table 6, Figure 20). Attributes were compared by T-tests
and Bonferroni correction was used to control for multiple comparisons (10 attributes) between the
supplement s; differences with p<0.005 were considered statistically significant. In both trials, the
flaxseed supplement had a higher percentage of neutral detergent fiber (trial 1: control: 6.77 ± 0.28,
flaxseed: 19.70 ± 0.78, p=0.0001; trial 2: control: 10.48 ± 0.86, flaxseed: 21.39 ± 1.85, p=0.0002,) and a
lower percentage of non-fiber carbohydrate (trial 1: control: 41.58 ± 0.90, flaxseed: 33.39 ± 0.67,
p=0.0005; trial 2: control: 42.46 ± 0.89, flaxseed: 32.84 ± 1.33, p<0.0001).

Gene Expression
For RNA extraction, frozen homogenates (white blood cells in RNA Bee, Fisher Scientific,
Waltham, MA) were thawed for ~5 minutes in a 37oC water bath; 150 μL 24:1 chloroform/isoamyl
(Sigma-Aldrich, St. Louis, MO) was added to each tube, which was then shaken vigorously for 15
seconds and transferred to a microcentrifuge tube. Samples sat on ice for 5 minutes before being
centrifuged for 15 minutes at 4˚C and 14,000 x g. Following centrifugation, the aqueous (top) layer was
transferred to a new microcentrifuge tube, in which RNA was precipitated by the addition of an equal
volume of ice cold isopropanol to the sample, gently inverting the tube to mix the contents and incubating
on ice for 15 minutes. Samples were then centrifuged for 15 minutes at 14,000 x g at 4 oC resulting in the
formation of an RNA pellet. The RNA was washed twice with 1 ml 75% cold ethanol (centrifuged 10 min
at 14,000 x g at 4oC), dried under a vacuum and dissolved in ~20 μl ultrapure water. Quality and quantity
of RNA was assessed using Take3 microvolume plate (BioTek, Winooski, VT), and samples with an
OD260/OD280 ratio >1.8 were accepted.
Extracted RNA was diluted in 13 μl of DEPC-treated water to a total concentration of 1.8 μg, and
cDNA synthesis was conducted by making a master mix composed of 2.5 l of 2.5 mM dNTP (GE
Illustra, Buckinghamshire, UK), 5.0 l 5X reverse transcriptase buffer (Life Technologies, Burlington,
ONT Canada), 2.0 l 0.01 M Dithiothreitol (DTT) (Life Technologies, Burlington, ONT Canada), 0.5 l
RNasin (Promega, Madison, WI), and 2.0 l random hexamer primers (Life Technologies, Burlington,
ONT Canada). Master mix (12 μl) was added to each sample (13 μl) and then transferred to a 96 well
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plate. Using a T100 thermal cycler (Bio-Rad, Hercules, CA) samples were denatured at 70oC for 5
minutes and then chilled at 4oC for 5 minutes. SuperScriptTMII (1μl) (Life Technologies, Burlington, ONT
Canada) was then added to each sample. Reverse transcription reaction was conducted by heating to 37oC
for 60 minutes, 90oC for 5 minutes, and cooling to 4oC for 5 minutes using a T100 thermal cycler (BioRad, Hercules, CA). Quantity of cDNA was determined using Take3 microvolume plate (BioTek,
Winooski, VT). For trial 1 of the supplement study, samples were diluted 1:5 in DEPC water. For the Fall
experiments, samples were diluted to 4ng/μl in DEPC water. The RNA was stored at -20oC.
Primer design was based on mRNA sequences found in the NCBI database. For each candidate
gene, primers were selected using Primer3 software (Rozen and Skaletsky, 2000). Changes to the default
program settings included product range 80-120 bp, primer Tm 59-61oC, primer GC% 40-60, max selfcomplementarity 3, max 3’ self-complementarity 1, and max poly-x 3. Primers were purchased from
Integrated DNA Technologies (Coralville, Iowa); associated GenBank accession numbers and primer
sequences used in qPCR are shown in Table 4. All primers were used previously (Sommers, 2014; Jacobs
et al 2016) except NF-κB and SOD2 (Chauhan et al, 2014). The primer efficiency was derived (Sommers,
2014) from the slope of the regression line fitted to a subset of baseline-corrected data points in the loglinear phase using LinRegPCR (Ramakers et al, 2003). Efficiency for each primer was higher than (1+E)
= 1.96. The PCR products were visualized after agarose gel electrophoresis to confirm amplification of
only one product when the primers were first purchased (Sommers, 2014). Melting curve analysis resulted
in one well defined peak per reaction indicating only one amplified PCR product. Melting temperatures
(Tm) of products were consistent with theoretical Tm of the expected PCR products. Gene names and
primer sequences are in Table 4.
Quantitative PCR reactions were conducted using a Bio-Rad CFX96 system (Bio-Rad, Hercules,
CA). Samples were analyzed in duplicate, and the reaction was performed in a total volume of 20 μl
consisting of 10 μl SYBR GreenTM Select Master Mix (Life Technologies, Burlington, ONT Canada), 1.2
μl forward primer, 1.2 μl reverse primer, 5.6 μl DEPC-treated water, and 2μl diluted template cDNA. The
conditions for the qPCR reaction were 50o C for 10 minutes followed by initial denaturation at 95oC for 5
minutes, then 39 cycles of denaturation at 95oC for 10 seconds, and extension for 30 seconds at 60oC.
Relative fold changes in expression of candidate genes were obtained using the 2-ΔΔCt method (Livak and
Schmittgen, 2001). The obtained Ct values were used to calculate ΔCt values of the genes of interest [Ct
(test)-Ct (reference)]. The reference gene used for normalization was GAPDH. For trial 1 of the
supplement study, the ΔΔCt values were obtained in reference to the control supplement + PBS group
sample at each time point. For the fall experiments, the ΔΔCt values were obtained in reference to the
sample collected at CIDR removal. Graphical representation for each gene is based on fold changes.
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Assays
Progesterone concentrations were measured in 25 μl of plasma using an Immulite® 1000
Immunoassay System, a solid phase, competitive immunoassay using enzyme-labeled chemiluminescent
technology. Reportable range of the assay was 0.20-40 ng/mL with a sensitivity of 0.46 ng/mL. Control
samples were from an ovariectomized ewe (negative control) and an ovariectomized ewe injected with
progesterone (positive control). For trial 1, P4 concentrations were measured in plasma collected at hour
0 on 5/6 dpc, 9/10 dpc, and 25/26 dpc. For the fall experiments, P4 concentrations were measured in
plasma collected on days 8/9 and 25/26 dpc.
Plasma samples were pooled to measure cortisol, Hp, and SAA. For trial 1, plasma samples were
pooled for the time points 0, 0.5, 1, 1.5, 2, 2.5, 3, 6, 9, 12, and 24 hours post treatment among ewes
receiving the same supplement and treatment at each time point. For trial 2, plasma samples were
randomly pooled in groups of 2 to 3 samples within supplement and treatment (same groups as pooled
buffy coat for gene expression) giving 4 pooled samples for each supplement with each treatment at the
time points 0, 1, 2, 3, 6, 9, and 12 hours post treatment for cortisol and at the time points 0, 2, 6, 12, and
24 hours post treatment for Hp and SAA. For the breed study, plasma samples were randomly pooled in
groups of 4 samples within treatment for the Suffolk ewes and 2-3 samples within treatment for Dorset
ewes (same groups as pooled buffy coat for gene expression) giving 4 pooled samples for each breed with
each treatment at the time points 0, 1, 2, 3, 6, 9, and 12 hours post treatment for cortisol and at the time
points 0, 2, 6, 12, and 24 hours post treatment for Hp and SAA.
Concentrations of cortisol were measured using a solid phase competitive ELISA kit from
Immuno-Biological Laboratories, Inc (Minneapolis, MN; Catalog # IB79135) following manufacturer’s
instructions. The assay had a detection range of 0-800 ng/mL with a sensitivity of 2.5 ng/mL and an intraand inter-assay CV of 4.73 % and 11.78% respectively. Absorbance was read at 450 nm and raw
absorbance values for samples and standards were adjusted for blank absorbance. SAA was measured
using a sheep quantitative sandwich ELISA kit from mybiosource (San Diego, CA; Catalog #
MBS024559) following manufacturer’s instructions. The assay had a detection range of 3.12-100 μg/mL,
a sensitivity of 1.0 μg/mL, and intra- and inter-assay CV of 3.83% and 5.35% respectively. Absorbance
was read at 450nm. Hp was measured using a sheep double antibody sandwich ELISA kit from
mybiosource (San Diego, CA; Catalog # MBS564186) following manufacturer’s instructions. The assay
had a detection range of 0-1000 ng/mL with a sensitivity of 15.63 ng/mL and an intra- and inter-assay CV
of 3.51% and 16.41% respectively. Absorbance was read at 450 nm. Hp was analyzed in samples diluted
1:2000 (2 μl pooled sample into 198 μl diluent then 15 μl of diluted pooled sample into 285 μl diluent)
and reported as mg/mL.
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Statistics
Data were analyzed using JMP and SAS software (JMP®, Version Pro 12, Copyright ©2015;
SAS®, Version 9.3, SAS Institute., Cary, NC, Copyright © 2002-2010). Data that were not normally
distributed were log transformed before analysis and significance criterion alpha level was 0.05. Hourly
responses in rectal temperature, hourly change in temperature from hour 0, and white blood cells were
analyzed by repeated measures ANOVA. Main effects in the supplement experiments included
supplement (flaxseed or control), treatment (LPS or PBS), hour, all 2-way interactions and the 3-way
interaction. Main effects in the breed study included breed (Dorset or Suffolk), treatment (LPS or PBS),
hour, all 2-way interactions and the 3-way interaction. All results reported as mean ± SEM.
For trial 1 of the supplement study, cortisol, Hp, SAA, and gene expression (CXCL8, TLR4, NFκB, IL-6, TNFα, IFNγ, COX2, C3, MRC1, IL-10, PPARγ, FOXP3, SOD2) were measured in samples
collected at various time points, but samples were pooled within supplement and treatment giving only
one sample per group per time point. Therefore, time points served as trials for each group, and means
were analyzed by ANOVA for the main effects of supplement, treatment, and their interaction. The
Benjamini-Hochberg procedure was used to control the false discovery rate (FDR=0.10) with regard to
gene expression.
For the Fall experiments, Hp, SAA, cortisol, and fold change in gene expression (CXCL8, TLR4,
NF-κB, IL-6, TNFα, IFNγ, COX2, C3, MRC1, IL-10, PPARγ, FOXP3, TGFβ, SOD2) were analyzed by
repeated measures with irregular spacing ANOVA. When significant interactions were detected, least
square means comparisons were made by slicing with the effect Supplement *Treatment*Hour, slicing
supplement and hour (supplement study trial 2) or with the effect Breed*Treatment*Hour slicing breed
and hour (breed study). The Benjamini-Hochberg procedure was used to control the false discovery rate
(FDR=0.10) with regards to gene expression (CXCL8, TLR4, NF-κB, IL-6, TNFα, IFNγ, COX2, C3,
MRC1, IL-10, PPARγ, FOXP3, TGFβ, SOD2).
For mucosal responses and noticeable behavioral changes, the number of symptoms recorded for
each ewe was summed over time. Sickness symptoms, plasma progesterone at one time point, and the
number of lambs were analyzed by two-way ANOVA and Tukey’s HSD for the effects of breed (Dorset
or Suffolk) or supplement (Flaxseed or Control) and treatment (LPS, PBS) and their interactions. In trial
1, a T-test was used to compare plasma progesterone between the supplement s.
For the Fall experiments, using the average gestation length (148 days) and the lambing records
retrospectively, conception date was determined. For each ewe it was then decided based on that
determined mating date if she was pregnant with that lamb(s) during the experiment and thus did not
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experience embryonic loss or had a lamb from a mating that occurred after the experiment and could have
experienced embryonic loss.
For trial 2 of the supplement study, multiple contingency analyses with Pearson’s Chi-square
were used to examine the possible association between 1) pregnancy diagnosis by ultrasound and
treatment group (CP, CL, FP, FL); 2) pregnancy diagnosis by ultrasound and treatment (LPS, PBS); 3)
pregnancy diagnosis by ultrasound and supplement (flaxseed, control); 4) a ewe lambing as a result of the
mating that occurred before the experiment (no embryonic loss) and treatment (LPS, PBS); and 5) a ewe
lambing as a result of the mating that occurred during the experiment and supplement (flaxseed, control).
Logistic regression was conducted to examine if receiving LPS, eating flaxseed, or the interaction could
predict the odds of a ewe having a lamb as a result of the mating that occurred before the experiment. For
the breed study, multiple contingency analyses with Pearson’s Chi square were used to examine possible
associations between 1) pregnancy diagnosis by ultrasound and treatment group (DP, DL, SP, SL); 2)
pregnancy diagnosis by ultrasound and breed (Dorset, Suffolk); 3) the association between a ewe having a
lamb as a result of the mating that occurred during the experiment (no embryonic loss) and experimental
group (DP, DL, SP, SL); 4) the association between a ewe having a lamb as a result of the mating that
occurred before the experiment and breed (Dorset, Suffolk) and 5) the association between a ewe having a
lamb as a result of the mating that occurred before the experiment and treatment (LPS, PBS). Logistic
regression was conducted to examine if receiving LPS, breed, or their interaction could predict the odds
of a ewe having a lamb as a result of the mating that occurred before the experiment.

Chapter 3: Effects of Supplementing with Omega-3 Polyunsaturated Fatty Acids
on LPS Challenge in Early Pregnant Dorset Ewes
Introduction
Reproductive tract infections or immune responses outside of the reproductive tract can
compromise fertility (Hansen, 2011a). Cows with clinical or subclinical mastitis are less likely to become
pregnant and are more likely to experience pregnancy loss compared to healthy cows (Hansen et al.,
2004). Immune responses to bacterial infections include the release of bacterial products, ROS, cytokines,
and chemokines at the inflammation site that can travel systemically to act on the liver, hypothalamus,
pituitary, and reproductive tract resulting in impaired fertility (Hansen, 2011a). This immune response can
be mimicked in early pregnant sheep by systemically giving peptidoglycan-polysaccharide complex
(Holásková et al., 2004; Dow et al., 2010) or LPS (Graham, 2014).
Several cytokines, including pro-inflammatory ones, are critical for establishing and maintaining
early pregnancy and implantation. However, temporal-spatial secretion of these molecules is critical. Any
insult, like an infection, that alters the temporal-spatial secretion of cytokines could negatively affect
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reproduction. Binding of PAMPs to PRRs activates intracellular signaling (MAPKs, AP-1; NF-κB) that
leads to transcription/secretion of PICs (IL-1β, IL-6, and TNFα), chemokines (CXCL8), PGs, and
antimicrobial peptides (Taakeuchi and Akira, 2010; Norris and Dennis, 2012; Badinga et al., 2016).
Indeed, when Zarrin et al. (2014) injected 200μl of LPS, a gram negative bacteria PAMP, into udders of
cows, gene expression of IL-1β, IL-6, CXCL-8, IL-10, iNOS, TNFα, NF-κB, Hp, and SAA increased in
the tissue.
Microbial infections evoke inflammatory responses mediated by the infiltration of neutrophils,
phagocytes and other innate immune cells, and the production of cytokines and chemokines to eliminate
the infection before removing debris and resolving the inflammation. An infection that is not cleared, as
might occur in a post-partum dairy cow in NEB with a suppressed immune system, can lead to chronic
inflammation and damage of endometrial cells. Early responses of the uterus to pathogens involves
neutrophilic influx into the superficial endometrium and then into the lumen (Bondurant, 1999).
Neutrophils phagocytize bacteria with the aid of opsonins in the uterine fluid and attack the pathogens by
releasing toxic substances (ROS, reactive nitrogen species, proteinase 3, cathepsin G, elastase) (Cheville,
1988; Nathan, 2006). These effector molecules are not able to distinguish between host and microbial
targets, so damage to host tissue also occurs (Nathan, 2002). Besides neutrophils, other immune cells that
will be at the site of invading pathogens include macrophages, eosinophils, mast cells, and lymphocytes
(Bondurant, 1999). Activation of mast cells results in degranulation and release of chemotactic factors for
neutrophils and eosinophils, PIMs (histamine, cytokines, PGs) (Bondurant, 1999), proteases that can
activate the complement components C3 and C5 (Kéuther et al.,1998), and vasoactive substances
(Kéuther et al.,1998) that increase the permeability of small vessels allowing serum (containing
complement components and immunoglobulins) to leak into the superficial endometrial tissue and uterine
lumen (Bondurant, 1999). Damage to endometrial epithelial cells from PIMs will cause release of IL-1α
(a damage associated molecular pattern (DAMP)), further increasing the inflammatory response
(Medzhitov, 2008; Carneiro et al., 2016). Other DAMPs released from damaged or dead cells include
ATP and nucleic acids that are thought to bind PRRs and initiate an inflammatory response (Chen and
Nunez, 2010).
Chronic infection/inflammation in the endometrium will alter endocrine functions and can affect
transport of spermatozoa and the hormonal and cytokine milieu involved in implantation of the blastocyst.
Hill and Gilbert (2008) reported a reduction in trophoblast cells of bovine embryos cultured in media
conditioned with endometrial fluid collected from an inflamed endometrium. The trophoblast is the outer
layer of cells of the blastocyst that will be the fetal contribution to the placenta, and a reduction in the
number of trophoblast cells will have a negative impact on implantation, placentation, and embryonic
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survival. Endometrial cytokines produced during infection/inflammation may alter steroidogenesis in
luteal cells resulting in a lower secretion of progesterone than is necessary for pregnancy (Thatcher et al.,
2010). The PICs (TNFα, IL-1, and IFNγ) could act directly on the CL or indirectly hamper P4 production
through the induction of PGF2α production (Pate, 1995; Niswender et al., 2000; Petroff et al., 2001;
Erlebacher et al., 2004).
Cell membranes are composed of phospholipids, in which PUFA are key structural and functional
components (Calder, 2013). Phospholipids of cells involved in inflammation tend to have more AA than
ω-3 PUFA (Peterson et al., 1998; Healy et al., 2000), but the addition of fish oil (high in ω-3 PUFAs) to
the supplement of animals (Peterson et al., 1998; Mattos et al., 2004) or human volunteers (Rees et al.,
2006) resulted in an increase in EPA and DHA in cell membranes with a reduction in AA content in the
phospholipid pool. Norris and Dennis (2012) also reported that EPA supplementation to macrophages in
vitro increased membrane EPA and DPA while DHA supplementation increased membrane DHA levels.
In vivo studies have shown that ω-3 PUFAs decrease eicosanoid synthesis in the bovine uterus
(Mattos et al., 2004; Petit et al., 2004) while in vitro studies have shown that exogenous EPA inhibits
PGF2α production by cultured bovine endometrial cells (Mattos et al., 2003; Caldari-Torres et al., 2006;
Badinga et al., 2016). Effects of supplemental ω-3 PUFA could be due to a decrease in AA in cell
membranes and an increase in fatty acids that compete with AA for enzyme usage (Mattos et al., 2004).
In homeostatic conditions, PLA2 is mostly inactive, but, during infection or inflammation, PRRs
can activate PLA2 causing it to translocate to the perinuclear and endoplasmic reticular membranes. At
the membranes, PLA2 can release lipids to be used as substrates for other lipid mediators. PLA2 can
hydrolyze AA containing phospholipids releasing AA to be converted into pro-inflammatory eicosanoids
by COX enzymes, or PLA2 can release phospholipid-esterified ω-3 PUFAs (EPA, DPA, and DHA),
which can be turned into anti-inflammatory SPMs by COX and LOX enzymes working together (Norris
and Dennis, 2012; Dennis and Norris, 2015). The ω-3 PUFAs, are made from ALA; therefore, a
supplement high in ALA (like flaxseed) potentially provides an individual with more SPMs during an
inflammatory response and the ability to recover from that response faster.
When the macrophages in Norris and Dennis’s study (2012) were stimulated with a TLR4 agonist
or ATP, the media contained increased levels of the PUFAs that the macrophages were cultured with EPA
or DHA showing that ω-3 PUFA supplementation results in the FAs being incorporated into cell
membranes, which are then available for use in the eicosanoid pathways. The macrophages then used the
released FAs to produce COX metabolites. Cells supplemented with EPA or DHA produced lower levels
of AA derived COX-metabolites (PGE2, PGD2) and higher amounts of EPA-derived COX metabolites
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(PGD3, PGE3, and 5-HEPE) and DHA-derived COX metabolites, although COX-2 expression was not
changed by supplementation. While AA COX-metabolites decreased with supplementation, 5-LOX AA
metabolites (5-HETE) increased; 5-HEPE, the EPA version of 5-HETE, increased with EPA
supplementation, and DHA was metabolized by 5-LOX to 4-HDoHE and 7-HDoHE, suggesting that the
ω-3 PUFA inhibited the COX pathway and shunted the FAs to the LOX pathway (Norris and Dennis,
2012). End products of the LOX pathway have anti-inflammatory effects.
ATP activates P2X receptor cation channels, which leads to increases in intracellular Ca2+ and
translocation of cPLA2 to cell membranes to liberate stored phospholipids. Signaling through this receptor
allows both AA and EPA to be utilized. However, activation of cPLA2 through TLR4 does not result in
release of non-AA PUFAs. Long-term TLR4 activation leads to sPLA2 activation, which then contributes
to eicosanoid production during late-phase activation, which will release ω-3 PUFAs (Norris and Dennis,
2012). This suggests that the beginning of a response is set up to be pro-inflammatory with predominantly
AA being released and utilized for eicosanoid production followed by release of ω-3 PUFA causing a
switch to resolution through inhibition of COX, shunting substrates from the COX to the LOX pathway,
and serving as substrates for SPMs. Supplementation with ω-3 PUFA and subsequent incorporation into
cellular membranes can, therefore result in a stronger and quicker resolution phase.
Both EPA and AA are substrates for the PGHS enzymes, and the two fatty acids compete with
each other for the enzymes. Thus, increasing the amount of available EPA in the membrane should result
in increased synthesis of prostanoids of the 3 series with a decrease in the amount of AA being turned into
prostanoids of the 2 series (Mattos et al 2003; Rees et al., 2006). Another explanation for effects of EPA
may be that EPA reduces the activity or expression of phospholipase A2, COX, and/or prostaglandin H
synthase (PGHS) genes (Bousserouel et al., 2003; Wada et al., 2007) leading to reduced synthesis of
PGE2 and PGF2α. Suppression of secretion of luteolytic PGF2α is necessary for maintenance of the CL and
progesterone production, which is required for establishment of pregnancy (Bazer et al., 2010).
Omega-3 PUFAs inhibit PIC production by preventing the phosphorylation and degradation of
Iκ-Bα by the proteasome complex, thus inhibiting NF-κB signaling pathways (Ren and Chung, 2007).
Both EPA and DHA inhibited IL-1β, TNF-α, and IFNγ production by human lymphocytes in vitro
(Purasiri et al., 1997), perhaps through inhibition of NF-κB signaling.
Flaxseed contains high amounts of the ω-3 PUFA α-linolenic acid (18:3 n-3), which can be
converted by animal tissues to EPA and DHA. The objective of the following two studies was to examine
if providing supplementary ω-3 PUFAs in the form of whole flaxseed to ewes would have beneficial
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effects on the inflammatory response to an LPS challenge during early pregnancy. Reducing the
inflammatory response to bacterial infections could help mitigate early embryonic loss in dairy cows.

Results
Clinical Signs
Temperature
Treatment with LPS (p<0.001) increased rectal temperature that peaked at hour 4 before returning
to normal (p<0.001). Ewes fed the flaxseed supplement had a blunted temperature increase in response to
LPS, peaking at 40.05 ± 0.26 oC compared to the CL group which peaked at 41.03 ± 0.14oC. Temperatures
in the FL group returned to normal by hour 6; the temperatures in the CL group did not return to normal
until hour 8 (p<0.0064, Figure 2).
Behavior changes/Mucosal Response
Due to the low frequency of each individual sickness symptom, observed mucosal response (nasal
discharge, vaginal discharge, coughing, and diarrhea) and behavioral change (loss of appetite, lethargic,
lying down, and heavy breathing) were summed for each ewe over the 12 hours post treatment. Ewes
treated with LPS (p<0.0001) displayed both mucosal responses and sickness behaviors, whereas no PBS
ewes did, with the FL ewes averaging 8 symptoms and the CL ewes averaging 4 symptoms over the 12
hours. There was a tendency for effects of feed (p=0.0945) and feed x LPS interaction (p=0.0588, Figure
3) to increase sickness symptoms.

Immune System
White Blood Cell Counts
Counts of white blood cells (WBCs) decreased between hour 0 and 1 in all groups and then
returned to normal concentrations in the PBS groups by hour 2. The LPS (p<0.001) groups had a larger
decrease in WBCs after treatment, and it took until hour 5 for the FL group and until hour 6 for the CL
group to return to normal counts (p=0.0056). The more rapid return to normal WBC counts in the FL
group resulted in a feed effect (p=0.0157) and a feed x LPS x hour effect (p=0.0056) (Figure 4b). White
blood cells started to increase above the hour 0 values at hour 6 in the flaxseed groups and after hour 7 in
the control supplement groups regardless of LPS or PBS (p<0.0001, Figure 4a). From hour 7 to 12 the
flaxseed groups had more WBCs than the control supplement groups (p<0.0001).
Acute Phase Proteins
Concentrations of Hp differed by feed (p<0.0001), LPS (p<0.0001) and feed x LPS (p<0.0001)
with the FL group having the highest concentration of Hp (0.68 ± 012 mg/ml). The CL (0.14±0.01
mg/ml) group had increased Hp counts compared to PBS (FP 0.04 ± 0.00 mg/ml, CP: 0.04 ± 0.00 mg/ml)
groups, but not as elevated as the FL group (Figure 5a). Plasma concentratinos of SAA were affected by
feed (p=0.02116), LPS (p<0.0001), and feed x LPS (p<0.001) with the CL (1.86 ± 0.22 μg/ml)) group
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having lower SAA levels than the other 3 groups (FL 4.67 ± 0.44 μg/ml, FP 4.83 ± 0.6 μg/ml, CP 5.82 ±
0.23 μg/ml, Figure 5b).
Cortisol
Plasma cortisol levels were affected by feed (p=0.0468) and LPS (p<0.001). Lipopolysaccharide
increased cortisol levels (LPS 124.76 ± 12.96 ng/ml, PBS 42.17 ± 7.77 ng/ml) and ewes on the flaxseed
supplement had lower cortisol levels (Flaxseed 67.67 ± 12.5 ng/ml, Control 99.26 ± 15.01 ng/ml, Figure
6).
Gene Expression
Fold change in gene expression of CXCL8 was affected by LPS (p<0.0001) and feed (p=0.0486)
with LPS increasing CXCL8 (LPS 7.32 ± 1.5, PBS 1.1 ± 0.19) and the flaxseed supplement decreasing
CXCL8 (Flaxseed 2.76 ± 0.61, Control 5.67 ± 1.72). There was a feed x LPS interaction on CXCL8 (FL
4.31 ± 0.99, FP 1.2 ± 0.45, CL 7.52 ± 2.2, CP: 1 ± 0, p=0.027), such that the flaxseed supplement
dampened the CXCL8 increase in response to LPS (Figure 7a). Expression of TLR4 was increased by
LPS (LPS 4.6 ± 0.77, PBS 1.06 ± 0.06, p<0.0001) with flaxseed dampening the increase in response to
LPS treatment (p=0.0326) (CP 1 ± 0, CL 6.1 ± 3.73, FP 1.13 ± 0.32, FL 3.11 ± 1.15) (Figure 7d). No
effects were found with regards to NF-κB expression, but the CL group had the largest fold change (2.46
± 1.15) followed by the FP group (1.92 ± 0.39) and then the FL group (1.38 ± 0.43) compared to the CP
group (Table 8). IL-6 was affected by feed x LPS (p=0.0296) with the FL group (2.09 ± 0.54) having a
smaller fold changed compared to the FP (2.82 ± 0.69) and CL (2.62 ± 0.63) groups (Figure 7b). There
was no differences in TNFα or COX2 (Table 8) expression among treatment groups. LPS (p=0.0024)
decreased IFNγ expression (LPS 0.58 ± 0.14, PBS: 1.26 ± 0.23) (Figure 7c). C3 increased in response to
LPS (LPS 4.02 ± 0.67, PBS 1.79 ± 0.32, p=0.0065) with the CL group having the largest change (CP 1,
CL 4.81±0.33, FP 2.58±0.48, FL 3.32±0.77) (Figure 7e). MRC1 decreased in response to LPS (LPS 0.34
± 0.07, PBS 0.96 ± 0.08, p<0.0001) and fold change was similar between the FP (0.92±.15) and CP (1±0)
groups and between the FL (0.35 ± 0.09) and CL (0.33 ± 0.12) groups (Figure 8a). IL-10 was not affected
by LPS, feed, or their interaction but FL (2.82 ± 0.96) had the greatest fold change followed by FP (2.07
± 0.49) and then CL (1.67 ± 0.61) compared to the CP (1 ± 0) group (Table 8). PPARγ was not affected
by LPS, feed, or their interaction (p=0.0702) but the FL (0.65 ± 0.16) group did have a reduction in fold
change compared to the other 3 groups (CP 1, CL 1.18 ± 0.24, FP 1.18 ± 0.16, Table 8). LPS decreased
FOXP3 expression (LPS 0.73 ± 0.2, PBS 0.91 ± 0.05, p=0.0259, Figure 8c) and increased SOD2
expression (LPS 4.31 ± 0.82, PBS 1.00 ± 0.08, p<0.0001, Figure 8b).
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Reproductive System
Progesterone
Progesterone concentrations were not among between the 4 treatment groups on 5/6 dpc (FL 1.74
± 0.17 ng/ml, FP 1.93 ± 0.2 ng/ml, CL 1.71 ± 0.27 ng/ml, CP 1.65 ± 0.26 ng/ml) or 25/26 dpc. When
comparing all four groups, the flaxseed supplement increased P4 (CP 2.33 ± 0.58 ng/ml, CL 2.9 ± 0.66
ng/ml, FP 4.4 ± 0.22 ng/ml, FL 3.29 ± 0.57 ng/ml, p=0.0752) (Figure 9a). However, when comparing P4
concentrations on day 25/26 post coitus only between the supplement s (Flaxseed 3.84 ± 0.37 ng/ml,
Control 2.62 ± 0.43 ng/ml), supplementary flaxseed increased P4 concentrations (p=0.0481) (Figure 9b).

Trial 2 Supplement Study
Results
Clinical Signs
Temperature
Ewes treated with LPS (p<0.0001) had an increase in rectal temperature that peaked at 4 hours
(CP 39.23 ± 0.18oC, CL 39.89 ± .29oC, FP 38.87 ± 0.1oC, FL 40.56 ± 0.29oC) post treatment before
decreasing and approaching normal temperatures by hour 6 (p<0.0001, Figure 12a). There was a flaxseed
x LPS effect (p=0.0164); ewes fed the flaxseed supplement and given LPS had higher temperatures than
the other 3 groups at hour 2 (p=0.009), 3 (p<0.0001), 4 (p<0.0001), 5 (p<0.001), and hour 6 (p=0.014)
(Figure 12a). Comparing the average rectal temperature over the 6 hours post treatment, LPS (p<0.0001)
caused an increase in temperature but more so in the flaxseed-fed ewes than in the control supplement
fed ewes (CP: 39.29 ± 0.07oC; CL: 39.59 ± 0.11oC; FP: 38.94 ± 0.04oC; FL: 39.94 ± 0.1oC, p<0.0001,
Figure 12b).
Behavior changes/Mucosal Responses
Due to the low frequency of each individual symptom, all observed mucosal responses and
behavioral changes were summed for each ewe over the 12 hours post treatment. Administration of LPS
caused ewes to have observable physiological changes (LPS 1.18 ± 0.38, PBS 0.15 ± 0.11, p<0.0001).
Neither feed nor its interaction with treatment affected display of symptoms (Figure 13).

Immune System
White Blood Cell Counts
Treatment with LPS (p=0.0037) resulted in a drop in white blood cells from hour 0 to 1.
Concentrations then returned to normal by hour 6 and continued to increase so that the LPS ewes had
higher WBCs at hours 12 and 24 compared to the PBS ewes (Figure 14a). Examining the hours (hour 0-6)
from the LPS (p<0.0001) induced drop in WBCs until recovery; there was an hour effect (p=0.0004) and
a LPS x hour (p<0.0001) effect with the LPS groups having significantly lower WBCs at hour 1

88

(p=0.0002), 2 (p=0.0002), 3 (p<0.0001), 4 (p<0.0001), 5 (p=0.019) (Figure 14b). There was no effect of
supplement.
Acute Phase Proteins
Concentrations of Hp were affected by LPS (p=0.0327), hour (p=0.0078), and the interaction of
LPS x hour (p=0.0165) with concentrations of Hp increasing in the two LPS groups starting after hour 6.
Hp increased more in the FL group, giving them more Hp at hour 24 compared to the control supplement
ewes that received LPS (FL: 0.15±0.01 mg/ml; CL: 0.07±0.02 mg/ml, p=0.0009, Figure 15a). SAA was
affected by hour (p=0.0023) and the FP group had different SAA concentrations compared to the CP
group at hour 2 (FP: 34.84 ± 8.17 μg/ml; CP: 17.88 ± 4.68 μg/ml, p=0.0265) and hour 12 (FP 40.67 ±
12.55 μg/ml, CP 17.38 ± 3.21 μg/ml, p=0.0029, Figure 15b).
Cortisol
Concentrations of plasma cortisol increased in response to LPS (p<0.0001) and were affected by
feed (p=0.0235), hour (p<0.0001) and the interactions feed x LPS (p=0.0007), LPS x hour (p<0.0001),
and feed x LPS x hour (p=0.0105) (Figure 16). Cortisol started to increase in the FL group right after LPS
administration, peaked at hour 1 before gradually decreasing back to normal by hour 12. The control
supplement ewes given LPS, however, had a spike in cortisol only at hour 3. These patterns (Figure 16)
resulted in the FL group having more cortisol than the CL group at hour 1 (FL 129.67 ± 11.3 ng/ml, CL
24.61 ± 12.31 ng/ml, p<0.0001), hour 2 (FL 127.62 ± 17.91 ng/ml, CL 38.98 ± 7.9 ng/ml, p<0.0001), and
hour 6 (FL 65.5 ± 20.63 ng/ml, CL 22.23 ± 4.26 ng/ml, p=0.013).
Gene Expression
Treatment with LPS (p=0.016) upregulated expression of CXCL8. Expression in the CL ewes
increased after treatment, peaked at hour 4 (58.19 ± 53.37), and then decreased to normal by hour 9. The
CL ewes had higher expression at hour 4 compared to the CP ewes (CL 58.19 ± 53.37, CP 1.98 ± 0.55,
p=0.0004). Expression in the FL ewes increased more gradually and peaked at hour 6 (FL 29.03 ± 26.99)
before going back to normal by hour 9 (Figure 17a). There was no significant effect of the flaxseed or any
of its interactions with LPS.
LPS administration (p=0.0002) upregulated TLR4 expression. In both LPS groups, expression
increased after hour 1 and peaked at hour 3 before returning to normal by hour 9 (hour p<0.0001; LPS x
hour p<0.0001). The FL group had greater expression compared to FP ewes at hour 3 (FL 12.82 ± 1.73,
FP 2.3 ± 0.29, p<0.0001) and hour 6 (FL 8.04 ± 0.97, FP 0.98 ± 0.18, p<0.0001). The control ewes
administered LPS had greater expression of TLR4 compared to PBS ewes at hour 3 (CL 9.57 ± 2.78, CP
3.4 ± 0.86, p<0.0001, Figure 17c).
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There were no main effects or interactions that affected NF-κB, IL-6, TNFα, IFNγ, or IL-10
expression (Table 9). Expression of COX2 fluctuated with time (p=0.0119), but there were no supplement
or treatment effects (Figure 17d).
Expression of C3 was upregulated in response to LPS (LPS 1.01 ± 0.13, PBS 0.75 ± 0.07,
p=0.0107) and was affected by the feed (Flaxseed 1.03± 0.12, Control 0.74 ± 0.08, p=0.0041), hour
(p<0.0001), and the interaction of LPS x hour (p<0.0001). The FP ewes had greater expression 15
minutes post treatment compared to the FL ewes (FP 1.38 ± 0.82, FL 0.41 ± 0.11, p=0.0246) while the FL
ewes had greater C3 expression at hour 3 (FP 0.70 ± 0.3, FL 2.97 ± 0.78, p<0.0001) and at hour 6 (FP
0.78 ± 0.39, FL 3.11 ± 0.62, p<0.0001). Compared to the CP ewes, the CL ewes had greater C3
expression at hour 3 (CP 0.63 ± 0.03, CL 2.04 ± 0.52, p=0.0014) and hour 6 (CP 0.68 ± 0.05, CL 2.09 ±
0.30, p=0.0014) (Figure 17b).
Administration of LPS downregulated MRC1 expression (LPS 0.61 ± 0.16, PBS 1.24 ± 0.20,
p=0.0118), which was also affected by hour (p=0.0004) and the interaction of LPS x hour (p=0.0091).
Expression decreased after LPS administration, reached its lowest expression at hour 12 and had started to
go back up by hour 24. Compared to CP ewes, the CL ewes had significantly lower expression at hour 12
(CP 1.74± 1.00, CL 0.26 ± 0.14, p=0.0143) (Figure 18a).
Expression of PPARγ was affected by LPS (LPS 0.79 ± 0.10, PBS 1.62 ± 0.15, p=0.0014) and
hour (p=0.0436). While expression in the two PBS groups fluctuated across time, expression change in
the LPS groups had a pattern. PPARγ expression increased in the CL group from hour 1 to 3, decreased
until hour 9 and then stayed low. Expression in the FL group increased only gradually from hour 1 to 6
before decreasing and staying low. Compared to the CP group, the CL group had significantly lower
PPARγ expression at hour 6 (CP 2.78 ± 0.93, CL 0.96 ± 0.36, p=0.0085) (Figure 18c).
Expression of FOXP3 was affected by the interaction of LPS x hour (p=0.0242). Expression in
the FL group increased from hour 0 to 2 before decreasing until hour 12. Expression had resumed slightly
by hour 24. Expression in the CL group fluctuated until hour 3 before decreasing at hour 6 and then
gradually increasing back to normal by hour 24. Compared to the FP group, expression in the FL group
was decreased at hour 12 (FP 1.43 ± 0.62, FL 0.10 ± 0.06, p=0.0208) and hour 24 (FP 1.59 ± 0.48, FL
0.33 ± 0.12, p=0.0268). Compared to the CP group, the CL group had decreased expression at hour 12
(CP 1.72 ± 0.47, CL 0.57 ± 0.67, p=0.0441) (Figure 18d).
Expression of TGFβ was affected by hour (p=0.0117). The PBS groups gradually decreased in
expression from hour 0 to hour 3, increased at hour 4, and then decreased in expression at hour 6. The FL
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group gradually decreased in TGFβ expression from hour 0 until hour 9 before increasing expression at
hour 12. The CL group just gradually decreased in expression from hour 0 until hour 12. Compared to the
FP group, the FL group had lower expression at hour 4 (FP 1.85 ± 0.32, FL 0.97 ± 0.54, p=0.0363) and
hour 9 (FP 1.28 ± 0.06, FL 0.34 ± 0.08, p=0.0132). Compared to the CP group, the CL group had lower
expression at hour 12 (CP 1.20 ± 0.16, CL 0.28 ± 0.09, p=0.015) (Figure 18e).
Expression of SOD2 was affected by LPS (LPS 5.93 ± 0.81, PBS 1.83 ± 0.15, p<0.0001), hour
(p<0.0001), and the interaction of LPS x hour (p<0.0001). While SOD2 expression stayed level in the
PBS groups it increased in the LPS groups from hour 0 to hour 3 before decreasing back to normal by
hour 12. Compared to the FP group, the FL group had higher SOD2 expression at hour 1.5 (FP 3.14 ±
1.09, FL 8.1 ± 2.11, p=0.0413), hour 3 (FP 2.14 ± 0.51, FL 18.35 ± 7.60, p<0.0001) and hour 6 (FP 1.24 ±
0.08, FL 16.04 ± 6.96, p<0.0001). Comparing the two control supplement groups, the ewes given LPS had
significantly more SOD2 expression at hour 3 (CP 2.58 ± 0.42, CL 10.82 ± 2.07, p<0.0001) and hour 6
(CP 1.75 ± 0.37, CL 8.23 ± 0.64, p=0.0017) (Figure 18b).

Reproductive System
Progesterone
Neither supplement nor LPS treatment affected progesterone on day 9/10 post coitus (3.15 ± 0.18
ng/ml) or on day 25/26 post coitus (3.90 ± 0.28 ng/ml, Figure 19).
Pregnancy diagnosis/lambing data
The number of ewes pregnant at 25/26 dpc in each group did not differ. Neither treatment nor
feed affected loss of pregnancy. Logistic regression confirmed the contingency analyses: neither
treatment, feed, nor the interaction could predict the odds of a ewe having a lamb (p=0.8156). The
number of lambs born in each treatment group from mating that took place before the experiment did not
differ among groups.

Discussion
In both trials, LPS caused fever, decreases in WBCs, muscosal responses, behavioral changes,
increases in Hp, cortisol, and gene expression of CXCL8, TLR4, C3, SOD2, and decreases in gene
expression of MRC1 and Foxp3.
Trial 1 showed beneficial effects of supplementary flaxseed on temperature response, change in
WBCs, and APP and cortisol. APPs are non-specific markers of inflammation and used to restore
homeostasis; an increase in these proteins in the FL compared to CL group could accelerate pathogen
clearance and inflammation resolution in the flaxseed fed ewes. Plasma of cortisol were affected by
supplement and LPS. The HPA axis is activated by PGE2 produced peripherally in response to LPS that
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circulates to the brain or produced by brain endothelial cells in response to PICs. Reduced cortisol levels
in the flaxseed group suggests a dampened inflammatory response. LPS caused noticeable behavior and
mucosal changes and there was no differences between ewes fed the different supplement s. These results
agree with Farran et al. (2008) who fed supplement s with either ground flaxseed (12.9% DM) or tallow
(4% DM) to beef steers for 14 days before LPS challenge (0.2 μg/kg of BW). Lipopolysaccharide caused
an increase in rectal temperature, TNFα, and Hp, while decreasing WBCs within the first hour after
challenge. Steers fed flaxseed had a reduced response in rectal temperature compared to the tallow fed
steers.
The ω-3 PUFAs in flaxseed can be incorporated into cellular membranes, which will influence
cytokine production and the type of eicosanoids produced in response to inflammatory signals (Endres et
al., 1989; Calder, 1996). Fever is induced by PGE2; decreased production of 2 series prostaglandins by
switching AA for ω-3 PUFAs in cell membranes may be the mechanism of flaxseed’s effect on
temperature response to LPS. ALA can be converted into EPA and DHA by animal cells (Calder, 1996),
which can compete with AA for enzymes resulting in a reduction in production of PIMs such as the 2
series PGs and 4-series LTs (Calder, 1998). Indeed, when Farren et al. (2008) fed crossbred heifer calves
a supplement containing ground flaxseed (12.9% DM) for 35 days, plasma lipids were significantly
enriched in ALA (C18:3n3) and EPA (C20:5n3) with a decrease in dihomo-γ-linolenic acid (c20:3n6)
compared to the heifers being fed supplement s with added tallow or rolled full-fat soybeans.The addition
of fish oil (high omega 3 FAs) to supplement s of human volunteers resulted in reduced IL-1β, IL-1α, and
TNFα production from PBMCs stimulated in vitro with LPS, reduced PGE2 production when stimulated
with S. epidermidis, and reduced neutrophil chemotaxis in response to LTB4 (measured as increase over
random migration). The decreased production of PICs went along with a decreased ratio of AA to EPA in
the membrane phospholipids of the volunteer’s PBMCs (Endres et al., 1989).
With regard to gene expression of cytokines, chemokines, transcription factors, receptors, and
enzymes involved in the inflammatory response, LPS increased expression of CXCL8, TLR4, C3, and
SOD2, while decreasing expression of IFNγ, MRC1, and Foxp3. The flaxseed supplement decreased gene
expression of CXCL8 and TLR 4. There was a flaxseed x LPS effect on gene expression of CXCL8,
TLR4, and IL-6 with the increase in expression of the 3 genes in response to LPS being blunted by the
flaxseed supplement indicating flaxseed dampens the inflammatory response. After controlling for the
false discovery rate by the Benjamini-Hochberg procedure due to making multiple comparisons, the only
effects that were still significant were the LPS effects. However, all the genes examined are involved in
the inflammatory response, the sample size was small and due to pooling samples the time points had to
serve as trials to analyze the data, which could have impaired the ability to find important differences
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between groups. Therefore, expression of all genes examined in trial 1 were examined in trial 2 with a
larger sample size and time as an effect.
In trial 1, flaxseed fed ewes had greater plasma P4 on day 25/26 post coitus compared to control
supplement fed ewes (Figure 12b). This could mean that flaxseed dampened inflammation induced
changes in luteal function.
In trial 2, LPS caused an inflammation and APR evidenced by an increase in rectal temperature,
Hp, cortisol, a decrease in WBCs, and observable behavioral and mucosal changes. Neutrophils are the
first responders to an inflammatory site. CXCL8 is one chemokine that recruits neutrophils; increased
expression of this chemokine in LPS challenged ewes also demonstrates the occurrence of an
inflammatory response (Figure 21a). LPS leads to the production of NO and ROS as these are used by
immune cells to kill pathogens. These products can damage host cells and must be scavenged or
neutralized. SOD2 is one enzyme responsible for protecting the host from damage; increased gene
expression of SOD2 in the LPS challenged ewes indicates an inflammatory response (Figure 23b).
Lipopolysaccharide stimulates immune cells at the inflammatory site to produce PICs that can
then circulate in the blood to the brain vasculature where they are either actively transported across the
blood-brain barrier or penetrate into the brain through circumventricular organs. LPS also can stimulate
cytokine production by endothelial cells in circumventricular organs (Breder et al., 1988; Spangelo et al.,
1990; Netea et al., 2000). These pyrogenic cytokines (TNFα, IL-6, IL-1β) induce COX2 expression and
PGE2 synthesis. Acting on the hypothalamus, PGE2 is the major mediator of the fever response (Engstrӧm
et al., 2012; Wilhelms et al., 2014). These three PICs also mediate the effects of LPS on the HPA axis
causing CRH release (McCann et al., 1995). They can activate the HPA axis independently or in
combination resulting in synergistic effects (Sapolsky et al., 1987; Naitoh et al., 1988; Bernardini et al.,
1990; Imura et al., 1991; Perstein et al., 1991; Perstein et al., 1993). During an infection or inflammatory
response, TNFα is usually produced first, closely followed by IL-1 production and then IL-6 (Hesse et al.,
1988; Akira et al., 1990; van Deventer et al., 1990). After cells have been initially stimulated to
synthesize these cytokines, for example through PRR activation, these PICs can further stimulate their
own production in an autocrine manner. In addition, TNFα and IL-1 stimulate secretion of each other, and
both stimulate IL-6. However, IL-6 inhibits secretion of the other two cytokines and their effects on target
tissues. GCs can inhibit the production of all 3 cytokines, but IL-6 is the least responsive to GC inhibition.
Instead, IL-6 works with GCs to stimulate hepatic production of APPs (Hirano et al., 1990; Boumpas et
al., 1993). Catecholamines stimulate IL-6 production, which will then inhibit TNFα and IL-1, stimulate
GCs, and induce the APR (Chrousos, 1995).
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Lipopolysaccharide increased the average rectal temperature (from immediately before treatment
until 6 hours post treatment) with the flaxseed supplement ing enhancing the febrile response (CP: 39.29
± 0.07oC; CL: 39.59 ± 0.11oC; FP: 38.94 ± 0.04oC; FL: 39.94 ± 0.1oC). An elevation in body temperature
associated with infection could affect embryonic loss as heat stress in cattle that raised body temperature
during embryonic development (Days 1 to 7) led to decreased survival of embryos recovered/assessed on
day 7 (Putney et al., 1988). LPS increased temperature in both supplement groups but more so in the
flaxseed-fed ewes, which may put their embryos at a greater risk of damage.
PICs along with stress hormones induce fever, sleepiness, fatigue, loss of appetite, decreased
libido, and activate hepatic production of APPs; responses labeled as “sickness behavior” and the “acute
phase response” (Elenkov and Chrousos, 1999). Observable discomfort was obvious in the LPS treated
ewes noted as lethargy, lying down, inappetence, coughing, nasal discharge, and vaginal discharge but
there was no effect of supplement .
WBCs dropped immediately after LPS treatment before gradually recovering back to normal
levels by hour 6. The drop in cells is likely due to extravasation into tissues. After returning to normal
levels at hour 6, the number of cells continued to increase in the LPS groups likely a result of the
inflammatory response stimulating hematopoiesis. Unlike in trial 1 where the flaxseed supplement
hastened the recovery of normal cell counts, there was no difference in the response of WBCs to LPS
between the two supplement treatments. Farran et al (2008) also reported no difference in WBC response
after LPS challenge between supplement s containing ground flaxseed or tallow.
Similar to Farran et al. (2008), who did not observe a change in plasma Hp in LPS-challenged
steers until 24 hours post treatment; ewes challenged with LPS had a delayed response in the APR.
Plasma Hp in the FL ewes was not elevated until hour 12 and was still elevated at hour 24. Hp in plasma
increased more gradually and less in the CL ewes, but the highest concentration still occurred at hour 24.
In trial 1, the flaxseed supplement enhanced the increase in Hp levels in response to LPS, but there was
no feed x LPS effect in trial 2, likely due to the high variation in levels at hour 12. However, the FL ewes
did have significantly more Hp at hour 24 compared to the CL ewes. SAA was affected only by time with
the most fluctuation occurring in the FP group. Thus, it may not be a good marker of inflammation
occurring in this LPS challenge model. Increased Hp in the FL ewes may accelerate pathogen clearance
and inflammation resolution as Hp limits bacterial growth by binding free hemoglobin and reducing
available iron (Cray et al., 2009), inhibiting prostaglandin synthase and PGE2 synthesis (Jue et al., 1983;
Saeed et al., 1997) and can reduce cytokine production by PBMCs (Arredouani et al., 2005). APP
production is stimulated by GCs and IL-6. There were no experimental effects on IL-6 gene expression,
but the flaxseed supplement enhanced the LPS increase in cortisol, which could be associated with the
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increased Hp in this group. Cortisol increased immediately after LPS administration in the FL group and
did not return to normal until hour 12 compared to the CL ewes that had a spike in cortisol only at hour 3
(Figure 20). Initial levels (hour 0) in the FL group were 54.06 ± 9.85 ng/ml and peaked at hour 1 with
129.67 ± 11.3 ng/ml (difference 75.55 ± 1.46 ng/ml) before slowly declining. Initial levels (hour 0) in the
CL group were 28.73 ± 5.72 ng/ml with spike to 81.59 ± 61.55 ng/ml (difference 52.87 ± 34.57 ng/ml).
Activation of the HPA axis has both anti- and pro-inflammatory effects. The end products of the
adaptive response to stress, cortisol from the adrenal gland and catecholamines (epinephrine &
norepinephrine) from the sympathetic nervous system, have anti-inflammatory effects (Chrousos, 1995;
Elenkov and Chrousos, 1999; Agelaki et al., 2002). Glucocorticoids can prevent leukocyte migration from
the circulation into extravascular fluid spaces, reduce monocyte and granulocyte accumulation at the
inflammation site, and suppress the production and/or activation of certain cytokines and inflammatory
mediators (Chrousos, 1995).
Effects of GC on leukocyte and granulocyte migration are due to inhibition of adhesion molecules
and their corresponding receptors (Cronstein et al., 1992). Glucocorticoids control inflammation by
suppressing transcription of genes for the enzymes PLA2, COX2, and NOS responsible for producing
prostanoids, platelet activating factor, and nitric oxide (Nakano et al., 1990; O’Banion et al., 1992;
Boumpas et al., 1993; Moncada and Higgs, 1993). Catecholamines, acting on adrenergic receptors
expressed by immune cells, stimulate intracellular cAMP production that suppresses chemotaxis, the
release of inflammatory mediators, the lytic activity of NK cells and cytotoxic T cells, and the
proliferation of T cells (Madden et al., 1995).
Stress hormones favor a humoral response rather than a cell-mediated response through control of
cytokine production by inhibition of transcription factors like AP-1 and NF-κB (Elenkov et al., 1999).
Both GCs (Ramírez et al., 1996) and catecholamines (Madden et al., 1995) inhibit IL-2 and IFNγ
production by Th1 cells (Elenkov et al., 1999). Furthermore, dexamethasone, epinephrine and
norepinephrine inhibited the LPS-induced IL-12 production by human peripheral blood mononuclear
leukocytes in vitro (Elenkov et al., 1996). Glucocorticoids not only inhibit IL-12 production by APCs but
also downregulate IL-12 receptors on T and NK cells, favoring Th2 polarization since IL-12 is a major
cytokine for polarization of Th1 cells (Elenkov and Chrousos, 1999). Shifting from Th1 to Th2
polarization will decrease IFNγ production, as this cytokine is produced by Th1 cells. In addition,
catecholamines (norepinephrine and epinephrine) stimulate IL-10 production, which stimulates Th2
polarization (Elenkov et al., 1996). Due to these various anti-inflammatory and immune modulating
effects of GCs, the greater cortisol in the FL ewes may accelerate resolution of inflammation and limit
inflammation at the maternal-fetal interface, which is critical for preventing direct damage to the embryo
as well as maintaining luteal function and maternal-fetal tolerance.
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Lipopolysaccharide challenge caused gene expression of TLR4 to increase until hour 3 before
returning to normal by hour 9. The FL group peaked at a higher fold change compared to the CL group
but the change from hour 0 to 3 between the two LPS groups was similar and there was no Feed or Feed x
LPS effect. Although there are no treatment, supplement, or interaction effect on fold change in gene
expression of the transcription factor NF-κB, the PICs TNFα and IFNγ, the enzyme COX2, or the antiinflammatory cytokines IL-10 or TGFβ, gene expression does not always reflect protein levels or provide
information about activity. TLR4 is known to lead to activation of the transcription factors NF-κB and
AP-1 to promote inflammation. The febrile response, HPA axis activation, and APP production are all
downstream of PICs and PGE2 suggesting NF-κB and COX2 are active in the LPS treated ewes and
TNFα, IL-1β, IL-6, and PGE2 are being produced, even though that is not reflected in the gene expression
data. In addition, Farran et al (2008) reported elevated TNF-α protein in LPS challenged steers, and LPS
has been shown to increase TNFα plasma levels in sheep (Graham, 2014). The flaxseed fed ewes had an
increased febrile response, cortisol production, and Hp production, and tended to have a greater increase
in TLR4 expression when treated with LPS compared to CL ewes. Downstream of TLR4 activation, the
FL ewes could have greater production of PICs, enhanced activity of COX2 and PGE2 production but this
cannot be determined from the present results.
Peroxisome proliferator-activated receptors are transcription factors with anti-inflammatory
functions (Clark et al., 2000; Dinarello, 2010; Li et al., 2014; Lian et al., 2015). After binding to an
agonist, PPARs reduce expression of PICs, chemokines, and adhesion molecules by interfering with other
transcription factors (Ricote et al., 1998; Clark et al., 2000; Lappas et al., 2002; Genolet et al., 2004;
Feige et al., 2006; Szanto and Nagy, 2008; Dinarello, 2010; Li et al., 2014; Lian et al., 2015). The 15LOX metabolites of ALA, 13-(S)-hydroperoxyoctadecatrienoic acid (13-(S)-HPOTrE) and 13-(S)hydroxyoctadecatrienoic acid (13-(S)-HOTrE), acting on PPARγ had anti-inflammatory effects in LPS
stimulated RAW 264.7 cells (MΦ cell line) and in mouse peritoneal MΦs. The anti-inflammatory effects
seen in cultured MΦs included decreasing levels of LPS-induced NO and ROS, increasing expression of
IL-10, decreasing expression of iNOS, IL-1β, IL-18, NLRP3 and TNFα, and decreasing NF-κB
translocation. Inhibition of NLRP3 inflammasome activation by the metabolites also contributes to
reduced IL-1β production in response to LPS. In vivo, mice pre-treated with the metabolites had a higher
survival rate and displayed less sickness behaviors after LPS injection, while mice that received the
metabolites and underwent cecal ligation and puncture (sepsis induced by polymicrobial infection) had
decreased expression of NLRP3, iNOS and IL-1β with an increase in IL-10 compared to controls (Kumar
et al., 2016). PPARγ expression decreased in response to LPS challenge in ewes and there was no
supplement effect (Figure 24a). Flaxseed is rich in ALA, therefore, the flaxseed ewes potentially had
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more PPARγ agonists that could have had anti-inflammatory effects. However, flaxseed-fed ewes did not
have increased IL-10 expression, decreased TNFα expression, or display less sickness symptoms when
compared to control supplement fed ewes when challenged with LPS.
RAW 264.7 cells pretreated with ALA metabolites before LPS stimulation had increased COX2
expression and levels of PGE2 and PGD2 (Kumar et al., 2016). PGD2 can be converted into PGJ2 and the
metabolites 12ΔPGJ2 and 15d-PGJ2 (a natural ligand of PPARγ) (Scher and Pillinger, 2005). Activation of
PPARγ and increased PGE2 (Heusinkveld et al., 2011; Li et al., 2014) has been associated with a change
in MΦ subtype from M1 to M2 cells (Castrillo and Tontonoz, 2004). Kumar et al. (2016) reported
activation of PPARγ and increased PGE2 levels in MΦs exposed to ALA metabolites. A switch in MΦ
subtype may be involved in the anti-inflammatory effects of ALA metabolites. It is important that the
majority of MΦs at the maternal-fetal interface are the M2 phenotype to maintain fetal tolerance; feeding
flaxseed could help maintain the tolerogenic phenotypes of immune cells at the maternal-fetal interface
through ALA metabolites interacting with PPARγ.
Prostaglandins such as PGE2 are produced during the initial inflammation phase (Levy et al.,
2001) that are involved in the early steps in the control of blood flow and vessel dilation needed for
leukocytes to undergo firm adhesion and diapedesis (Williams and Peck, 1977). In addition to
chemokines, LTB4 controls trafficking of neutrophils from the post capillary lumen to the interstitial space
(Pouliot et al., 2002). Production of PGE2 occurs early in infection/inflammation through upregulation of
COX2 and PGE synthase 1 in MΦs, endothelial cells, and DCs. Prostaglandin E2 has pro- and antiinflammatory effects (Fullerton et al., 2014). Binding to prostaglandin E receptors (EP1, EP2, EP3, EP4),
PGE2 is responsible for several of the cardinal signs of inflammation early in a response such as pain,
edema, local heat production, fever, and vasodilation. PGE2 also enhances LTB4 mediated neutrophil
extravasation and increases vascular permeability (Bray et al., 1981; Serhan 2007; Lazarus et al., 2007;
Serhan 2014). Later in the response, PGE2 causes expression of 12/15-LOX in cells such as MΦs and
neutrophils leading to production of SPMs that resolve the inflammation. Therefore, PGE2 plays a
controlling role in eicosanoid class switching (switch from pro-inflammatory PG production to antiinflammatory lipoxins production) (Levy et al., 2001; Serhan and Savill, 2005; Norris et al., 2014). In
addition, inactivation of PGE2 by prostaglandin dehydrogenase converts PGE2 into 15-keto-PGE2 which
is a ligand for PPARγ, a receptor with anti-inflammatory effects (Harmon et al., 2010; Dennis and Norris,
2015).
Macrophages have been shown to have the EP2 and EP4 receptors and respond to PGE2 by
decreasing TNFα production and increasing IL-10 production, a result of regulation of cytokine gene
expression. The increased IL-10 may be involved in decreasing TNFα production (Kunkel et al., 1988;
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Renz et al., 1988; Shinomiya et al., 2001; Treffkorn et al., 2004). Paracrine or autocrine PGE2 signaling at
the inflammatory site may play a role in switching production of cytokines from pro- to antiinflammatory (Shinomiya et al., 2001). Cyclooxygenase 2 expression in the 4 experimental groups
fluctuated over time without any effect of supplement or treatment and which eicosanoids were produced
in each group of ewes is not known. However, the enhanced febrile response in the FL ewes is indicative
of more PGE2 production. The combination of more PGE2 that is involved in initiation of inflammation
resolution and is responsible for eicosanoid class switching with the flaxseed providing ω-3 PUFAs
(substrates to make SPMs) potentially encourages a more rapid resolution of inflammation, which would
be critical at the maternal-fetal interface.
Lipopolysaccharide challenge increased gene expression of C3 and decreased expression of
MRC1 and FOXP3 but there was no difference in response to LPS between the two supplements. The
role of complement is to kill pathogens enough to keep the infection from spreading while an adaptive
immune response is being generated, to promote inflammation by causing production of PICs, to recruit
additional immune cells and to opsonize pathogens and immune complexes to target them for clearance
by phagocytes (Molina, 2005; Murphy, 2012). Complement activation during pregnancy has been shown
to promote inflammation and embryo loss (Xu et al., 2000; Mellor et al., 2001; Mao et al., 2003;
Caucheteux et al., 2003). Increased C3 expression in the LPS-treated ewes indicates gram negative
bacterial infections can cause embryonic loss through complement activation.
Mannose receptor C 1 binds to and is involved in endocytosis of glycoproteins. It is expressed on
MΦs and DCs to help with neutralization and clearance of pathogens (Shepard et al., 1990; Engering et
al., 1997). A decrease in MRC1 expression during a bacterial infection could hinder pathogen clearance,
delay inflammation resolution and increase the chance of embryonic loss.
Forkhead box P3 is the transcription factor that regulates pathways that give Treg cells their
immune suppressive functions. Tregs cells are critical for controlling inflammation at the maternal-fetal
interface and generating maternal-fetal tolerance (Fiorentino et al., 1991b; Fallarino et al., 2003;
Ghiringhelli et al., 2005a; Mahnke et al., 2007;Shevach et al., 2009). Reduced numbers of Tregs or
diminished suppressive function of these cells result in embryonic loss (Aluvihare et al., 2004;
Zenclussen et al., 2005; Zhao et al., 2007). Tregs are not a terminally differentiated cell type; in the
presence of high amounts of PICs they can turn into effector T cells (Gao et al., 2012). Reduced Foxp3
expression in ewes challenged with LPS could indicate a reduction in Treg cells, perhaps because they are
switching into inflammatory T cell subsets, which would be detrimental to pregnancy success. Expression
of Foxp3 in the LPS-challenged ewes does start to rebound back to normal, which could be due to the
short-lived response (hours) to the LPS challenge. An actual bacterial infection would take a lot longer to
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clear and the prolonged inflammatory response is likely to have negative consequences on Treg cell
numbers and function resulting in inflammation induced damage to the embryo, loss of luteal function,
and loss of maternal-fetal tolerance.
Ovarian P4, conceptus IFN-τ, and PGs regulate endometrial functions important for conceptus
elongation and implantation during the peri-implantation period of pregnancy (Dorniak et al., 2011). P4
action for 8-10 days induces expression of elongation and implantation related genes in the endometrial
luminal epithelium and glandular epithelium (Simmons et al., 2010; Charpigny et al., 1997a; Eggleston et
al., 1990). Some of the gene changes are mediated by cortisol and PGs. P4 upregulates HSD11B1 and
PTGS2 expression while IFN-τ affects their activity (Simmons et al., 2010; Dorniak et al, 2013b).
Cortisol also induces HSD11B1 expression needed for production of cortisol from corticosterone
(Simmons et al., 2010). Infusing cortisol into the uterus of cyclic ewes from day 10-14 after estrus,
Dorniak et al. (2013b) showed that cortisol stimulates endometrial HSD11B1 expression and activity,
increases endometrial PTGS2 activity and the amount of PG in the uterine lumen, and up-regulates many
conceptus elongation-related genes in the endometrium. PGE2 and PGI2, produced by prostaglandin
synthase 2, mediate some of P4’s effects on gene expression as well as regulating blastocyst implantation,
decidualization, and uterine angiogenesis (Dorniak et al., 2011). Inflammation/infections can 1: lead to
luteolysis and reduced P4 levels, 2: trigger production of PICs that cause apoptosis of trophoblast cells
and reduced IFN-τ levels, 3: activate the HPA axis through PICs to increase cortisol levels, and 4:
stimulate PG production. These changes in mediators that regulate elongation- and implantation-related
genes could result in asynchrony of an implantation-competent embryo and a receptive uterus, thus the
‘window of implantation” being missed, resulting in implantation failure. Lipopolysaccharide challenge
on day 5/6 post coitus caused activation of the HPA axis and cortisol production, which may alter timing
of the expression of uterine genes. The short-lived inflammatory response to the one LPS dose in the
experiment may not cause much damage in regards to cortisol altering gene expression in the uterus, but a
prolonged bacterial infection could affect pregnancy success in this manner.
There was no difference in P4 levels on either 8/9 or 25/26 dpc indicating LPS treatment did not
affect luteal function. Neither pregnancy diagnosis by ultrasound nor lambing data revealed differences
between the treatment groups in regards to pregnancy success suggesting the LPS challenge did not cause
embryonic loss and the flaxseed supplement did not improve pregnancy rates. However, the sample size
of this study was small compared to other studies that have used hundreds of ewes to examine embryonic
loss (Dixon et al., 2014).
In both ω-3 PUFA studies, feed analysis of samples of the prepared supplement s reported more
neutral detergent fiber (NDF) and less non-fiber carbohydrate (NFC) in the flaxseed supplement. NDF is
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a reflection of the amount of structural plant components. Therefore, it makes sense that the flaxseed,
with a seed coat, had higher NDF than the control supplement with added cracked corn, soybean meal,
and soybean oil (SBO). NFC consists of starch, simple sugars, and soluble fiber and the calculation to
determine NFC includes percent NDF; therefore, it makes sense that the flaxseed supplement that had a
higher percent NDF, had a lower NFC percent. It also fits that the control supplement had a higher
percent NFC because the components of the supplement (cracked corn) would have provided additional
starch. Supplement s with low NDF/high NFC, like the control supplement compared to the flaxseed
supplement, can cause ruminal acidosis and decrease the rate of VFA absorption from the rumen.
However, the ewes in the present study were on pasture, and grass would have increased fiber intake. In
addition, the amount being fed was split between two feedings per day, and the rumen was not exposed to
all of the starch at once. Both supplement s were eaten readily when presented and there were no changes
in body weight of the ewes.
The addition of unprotected fats to ruminant supplement s can decrease dry matter intake and
reduce digestibility of non-lipid energy sources as a result of changes to ruminal fermentation, gut
motility, palatability, release of gut hormones, and oxidation of fat in the liver (Allen, 2000). Numerous
studies feeding flaxseed to ruminants in various forms (whole, ground, rolled, extruded) have investigated
effects on digestibilities, rumen health, VFA production, and incorporation of fats into tissues and milk.
Overall, feeding flaxseed did not have negative effects on ruminant digestion, and ω-3 PUFAs were
available for use by the animal to incorporate into tissues and milk. This was especially true when feeding
whole flaxseed since the seed coat helped to protect the oil from rumen bacteria (Wachira et al., 2000;
Petit et al., 2002; Gonthier et al., 2004; Scholljegerdes and Kronberg, 2008; Petit and Côrtes et al., 2010;
Côrtes et al., 2010; Mesgaran et al., 2012; Schroeder et al., 2014). Even though flaxseed has a hard outer
coat, ruminants are able to extract and utilize fats from the seeds post-rumen (Oba et al., 2009).
Soybean oil was one of the components used in the control supplement of the present experiments
to match the flaxseed in fat and crude protein content using the Pearson Square method. Soybean oil
contains unprotected fat and thus can potentially be more damaging to rumen health than the flaxseed.
However, Wonsil et al. (1994) fed Holstein cows an amount of SBO per pound of animal per day
comparable to that fed in the present studies (Wonsil et al.: 0.0012 lb SBO/lb cow/day, present study:
0.0011lb SBO/lb ewe/day). Compared to their control supplement that contained no supplemental fat, the
addition of SBO did not affect total or individual VFA concentrations or the ratio of acetate to propionate.
There were no changes in dry matter intake or apparent digestibility (in the rumen or total tract) of dry
matter, acid detergent fiber, organic matter or nitrogen, indicating that SBO was not toxic to rumen
microorganisms (Wonsil et al., 1994). There is no information on rumen health or digestibilities of the
supplement s for the present studies; however, based on previous studies that supplemented comparable
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amounts of flaxseed or SBO and the fact that weights of the ewes (recorded on: the day the supplement
started, after 7 days on the supplement, and the day the supplement was stopped: ~28 days) did not
change (data not shown) it should be fair to say the experimental supplement did not negatively affect
digestion in ewes.
Fat in SBO is 14% saturated (10% palmitic; 4% stearic) and 81% unsaturated (51% linoleic; 23%
oleic; 7% linolenic) (Gunstone, 1996) with most of the fat being linoleic. While SBO contains some
ALA, levels are way below the ALA content in flaxseed (53% of the total FAs). In addition, the fat in
SBO is not protected from rumen microbes and will be subject to biohydrogenation increasing duodenal
flow of stearic and oleic acid, not ω-3 PUFAs. Therefore, even though SBO contains some ALA, feeding
SBO does not change circulating levels of ALA, EPA, or DHA (Wonsil et al., 1994). The high ALA
content in whole flaxseed is protected from rumen biohydrogenation by the seed coat, however, making
ω-3 PUFAs available to the animal (Oba et al., 2009).
Omega-3 PUFAs are known to have anti-inflammatory effects, and it was hypothesized that
feeding flaxseed to ewes would dampen the inflammatory response to an LPS challenge. Between the two
trials, the effect of flaxseed when LPS was given was not consistent for all measurements. In trial 1,
flaxseed dampened both the febrile response and HPA axis activation in response to LPS but enhanced
the temperature increase and cortisol levels in trial 2. TLR4 gene expression in response to LPS was
dampened with flaxseed in trial 1, but tended to be increased in trial 2 compared to the CL group, but did
not reach statistical significance. In trial 1, the flaxseed supplement hastened the recovery of the decrease
in WBC counts in reponse to LPS but there was no difference in the second study. Flaxseed enhanced the
LPS increase in Hp in trial 1 and tended to do so in trial 2. Possible explanations for the discrepancies
include small sample sizes (especially in trial 1), the amount of flaxseed supplemented might have been
insufficient to get significant anti-inflammatory effects, the feeding period may have been inadequate (~8
days) to get a significant amount of ω-3 PUFAs incorporated into cellular membranes before LPS was
administered, and the fat content of the flaxseed was greater in trial 1 (39.11%) compared to trial 2
(32.89%), which would have provided less ω-3 PUFAs to the ewes in trial 2. Another likely possibility is
that the ewes in the spring had a higher intake of ω-3 PUFAs due to spring grass being higher in ω-3
PUFA than fall grass, and both sets of ewes were kept on pasture. In conclusion, additional studies need
to be conducted that address the above mentioned issues before stating that flaxseed has beneficial effects
with regards to inflammation induced by LPS treatment.
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Tables
Table 1: Analysis of whole flaxseed used in trial 1 of the ω-3 PUFA study (Spring 2015). Whole flaxseed
was purchased from Valley Point Feed (Albright, WV; Lot # DM1415) and analyzed by the Rumen
Fermentation Profiling Laboratory at WVU.
%Dry Matter*
% Moisture
% Crude Protein
% Crude Fat
%TDN
NEG, Mcal/lb
NEM, Mcal/lb
NEL, Mcal/lb
*Dry Matter of sample as
received.

%"As Sampled"
91.38
8.62
15.84
39.11
118.70
1.14
1.44
1.50

%Dry Matter Basis

17.33
42.80
129.9
1.25
1.58
1.64

Table 2: Composition of supplements fed to ewes in trial 1 of the ω-3 PUFA study. Ewes received a total
of 1lb/per day. *Sheep ration consisted of cracked corn, soybean meal, minerals, limestone, and Bovatec
58 and was already prepared by WVU farm crew. Based on flaxseed analysis (Table 1), cracked corn,
soybean meal, and soybean oil were used to match the flaxseed in fat content (39.11%) and crude protein
(15.84%).
Ingredient
Sheep
Ration*
(total .45lb)

Whole
Flaxseed
Soybean Oil

Soybean Meal
(11.89%)

0.054 lb

Sheperd’s pride
minerals (8.86%)
Limestone (2.53%)
Bovatec 68
(0.05%)

0.04 lb

Control
Supplement
0.35 lb
+
0.2 lb
(36.36%)
0.054 lb
+
0.21 lb
(38.18%)
0.04 lb

0.011 lb
0.0023lb

0.011 lb
0.0023lb

.55 lb

0

0

0.14 lb
(25.45%)

Cracked Corn
(76.69%)

Flaxseed
Supplement
0.35 lb
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Table 3: Results from feed analysis conducted on samples of the prepared supplements used in trial 1 of
the ω-3 PUFA study. Samples were analyzed by the Rumen Fermentation Profiling Laboratory at WVU.
T-tests were used to compare each variable between supplements; Bonferroni correction (0.05/10) was
used to control for multiple comparisons. α=0.005 Results reported as mean ± SEM.
Variable
Percent Dry Matter
Percent Moisture
Percent Crude Protein
Percent Crude Fat
Percent Neutral Detergent
Fiber
Percent Ash
Percent Non-Fiber
Carbohydrate
Percent Total Digestible
Nutrients
Net Energy for Gain
Net Energy for Maintenance

Control Supplement
(n=4) (mean±SEM)
90.55±0.104
9.45±0.104
15.49±0.585
21.52±1.383
6.77±0.281

Flaxseed Supplement
(n=4) (mean±SEM)
90.15±0.24
9.86±0.24
16.58±1.071
16.57±1.09
19.70±0.776

P value

5.20±0.371
41.58±0.907

3.90±0.392
33.39±0.666

0.053
0.0005

76.26±0.922

74.00±0.40

0.084

0.88±0.013
0.59±0.012

0.85±0.005
0.56±0.007

0.0938
0.1078

103

0.1931
0.1931
0.4144
0.0326
0.0001

Table 4: Primer sequences of the housekeeping and genes of interest.
Gene Name

Gene
Symbol

Forward Primer (5’-3’)
Reverse Primer (5’-3’)

bp

T M OC

Complement component
3
Cyclooxygenase 2

C3

87

81.5

94

82

Forkhead box P3

Foxp3

90

80.5

Glyceraldehyde 3Phosphate
Dehydrogenase

GAPDH

GCACTGTCCACCAACCTCA
ATCAGGCTTCTGCTTCTCCA
CTACCCGCCTCATATTCCTG
CCAAATGGTGGCATACATCA
GAAACAGCACATTCCCAGAGT
GGATGAGGGTGGCATAGGT
CAGGAGCACGAGAGGAAGAG
AATGTATGGAGGTCGGGAGA

91

83

Interferon gamma

IFNγ

97

81

Interleukin 6

IL-6

80

79.5

Interleukin 8

CXCL8

86

77

Interleukin 10

IL-10

105

82

Mannose Receptor, type
C1
Nuclear Factor kappa B

MRC1

94

78.5

Peroxisome Proliferator
Activated Receptor
gamma

PPARγ

ATGACCTGTCGCCAAAATC
GCAGGCAGGAGAACCATTAC
TAACCACTCCAGCCACACAC
GATAACCTTTGCGTTCTTTACCC
GGATTCACGAGTTCCTGTTCA
CTGTGAGGTAGAAAGATGACTGAGA
TTTCCCTGACTGCCCTCTAA
GCTCCCTGGTTTCTCTTCCT
GGAGGGAACACAAGGGATG
GCAAGGAAGGGTCAGGTTG
ATTCAGCCCTTTGCCCATCT
ATGGGATGTCAGTGGCGTTA
CTTGACGGGAAAGACGACA
GCTGATGTGCTTGAACTTGATT

97

75.5

Superoxide Dismutase 2

SOD2

Toll Like Receptor 4

TLR4
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82.5

COX2

NF-κB

TCACAGCATCTTCTGGACAA
TGCTCCTTATTGAAGCCAAG
GGCATCATCTTCATCGTCCT
CCACTCCAGGTAGGTGTTCC

Table 5: Analysis of the whole flaxseed used in trial 2 of the ω-3 PUFA study. Whole flaxseed was
purchased from Valley Point Feed (Albright, WV; Lot # 15-0072 GS1 Lot: (10)1-22373) and analyzed by
the Rumen Fermentation Profiling Laboratory at WVU.
%Dry Matter*
% Moisture
% Crude Protein
% Crude Fat
%TDN
NEG, Mcal/lb
NEM, Mcal/lb
NEL, Mcal/lb
*Dry Matter of
sample as received.

%"As Sampled"
92.77
7.23
21.01
32.89
115.2
1.09
1.39
1.41

%Dry Matter Basis

22.65
35.45
124.2
1.18
1.50
1.52
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Table 6: Composition of supplements fed to ewes in trial 2 of the ω-3 PUFA study. Ewes received a total
of 1lb/per day. *Sheep ration consisted of cracked corn, soybean meal, minerals, limestone, and Bovatec
58 and was already prepared by WVU farm crew. Based on flaxseed analysis (Table 5), cracked corn,
soybean meal, and soybean oil was used to match the flaxseed in fat content (32.89%) and crude protein
(21.01%).
Ingredient
Sheep
Ration*
(total .45lb)

Whole
Flaxseed
Soybean Oil

Soybean Meal
(11.89%)

0.054 lb

Sheperd’s pride
minerals (8.86%)
Limestone (2.53%)
Bovatec 68
(0.05%)

0.04 lb

Control
Supplement
0.35 lb
+
0.1694 lb
(30.81%)
0.054 lb
+
0.2089 lb
(37.98%)
0.04 lb

0.011 lb
0.0023lb

0.011 lb
0.0023lb

.55 lb

0

0

0.1716 lb
(31.20%)

Cracked Corn
(76.69%)

Flaxseed
Supplement
0.35 lb
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Table 7: Results from feed analysis conducted on samples of the prepared supplements used in trial 2 of
the ω-3 PUFA study. Samples were analyzed by the Rumen Fermentation Profiling Laboratory at WVU.
T-tests were used to compare each variable between supplements; Bonferroni correction used to control
for multiple comparisons. α=0.005 Results reported as mean±SEM.
Variable
Percent Dry Matter
Percent Moisture
Percent Crude Protein
Percent Crude Fat
Percent Neutral Detergent Fiber
Percent Ash
Percent Non-Fiber Carbohydrate
Percent Total Digestible
Nutrients
Net Energy for Gain
Net Energy for Maintenance

Control Supplement (n=7)
(mean±SEM)
89.01±0.213
10.99±0.213
18.18±0.625
13.63±0.364
10.48±0.863
4.27±0.433
42.46±0.886
72.12±0.552

Flaxseed Supplement (n=5)
(mean±SEM)
89.84±0.118
10.16±0.118
16.81±0.417
13.76±2.236
21.39±1.852
4.03±0.552
32.84±1.327
71.57±0.868

P value

0.83±0.007
0.54±0.007

0.82±0.012
0.53±0.012

0.5995
0.5393
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0.0128
0.0128
0.1283
0.8959
0.0002
0.7394
<0.0001
0.5838

Table 8: Fold change in cyclooxygenase 2, interleukin-10, nuclear factor kappa B, peroxisome
proliferator-activated receptor gamma, and tumor necrosis alpha expression compared to the CP group in
white blood cells in trial 1 of the supplement study. Data analyzed by ANOVA. Data for IL-10 and
COX2 were log transformed before analysis. (FL (n=3): flaxseed supplement + LPS, FP (n=3): flaxseed
supplement + PBS, CL (n=5): control supplement + LPS, CP (n=5): control supplement + PBS) Mean ±
SEM
Gene/Time
points
COX-2
0, .5, 1,
1.5, 2.5, 3
hrs
IL-10
0, 1.5, 3, 4,
5, 6, 10 hrs

NF-κB
0,1.5,2.5,3,
4,5,6,7,9,
10,12,24
hrs
PPARγ
0, 0.5, 1,
1.5, 3, 5, 6,
7, 8, 9, 10,
11, 12, 24
hrs
TNFα
.5, 1, 1.5,
2.5, 3, 4, 5,
6 hrs

Treatment
Group

Mean ± SEM

FL
FP
CL
CP

2.37 ± 0.65
2.65 ± 0.63
1.86 ± 0.74
1±0

FL
FP
CL
CP

2.82 ± 0.96
2.07 ± 0.96
1.67 ± 0.61
1±0

FL
FP
CL
CP

1.38 ± 0.43
1.92 ± 0.39
2.46 ± 1.15
1±0

FL
FP
CL
CP

0.65 ± 0.16
1.18 ± 0.16
1.07 ± 0.24
1±0

FL
FP
CL
CP

1.6 ± 0.43
1.6 ± 0.43
1.74 ± 0.52
1±0

Supplement
Effect
p=0.27

p=0.15

Supplement
x LPS Effect
p=0.18

p=0.08

p=0.43

p=0.88

p=0.90

p=0.47

p=0.13

p=0.45

p=0.17

p=0.07

p=0.57

p=0.35

p=0.35
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LPS Effect

Table 9: Fold change in interferon gamma, interleukin-6, interleukin-10, nuclear factor kappa B, and
tumor necrosis alpha gene expression to LPS or PBS in early pregnant ewes fed a whole flaxseed or
control supplement (supplement study trial 2). Data expressed as the fold change in gene expression using
the 2-ΔΔCt method with GAPDH as the housekeeping gene and the reference time point being the sample
collected at CIDR withdraw. Data analyzed by repeated measures ANOVA. Mean ± SEM. Mean is the
overall mean of the fold change across the time points but analyzed with time as the repeated measure.
(FL (n=11): flaxseed supplement + LPS; FP (n=10): flaxseed supplement + PBS; CL (n=11): control
supplement + LPS; CP (n=10): control supplement + PBS)
Gene/Time
points
IFNγ
0,0.5, 1.5,
3, 6, 9, 12,
24 hrs
IL-6
0, 0.25,
0.75, 1.5,
2, 3, 6 hrs
IL-10
0,1.5,3,6,
9, 12 hrs

NF-κB
0, 1.5, 3, 6,
9 hrs

TNFα
0, 0.5, 1 hr

Treat
ment
Group

Mean ±
SEM

FL
FP
CL
CP

0.82 ± 0.27
1.09 ± 0.19
0.66 ± 0.13
3.92 ± 1.15

FL
FP
CL
CP

0.65 ± 0.21
0.84 ± 0.32
0.3 ± 0.08
0.61 ± 0.14

FL
FP
CL
CP

9.52 ± 3.21
4.47 ± 1.73
8.4 ± 2.91
3.7 ± 0.89

FL
FP
CL
CP

0.82 ± 0.39
1.05 ± 0.24
0.58 ± 0.14
0.75 ± 0.18

FL
FP
CL
CP

1.1 ± 0.20
1.13 ± 0.31
0.78 ± 0.14
0.53 ± 0.09

Supple
ment
Effect

LPS
Effect

Hour
Effect

Supplem
ent x
Hour

LPS x
Hour

Suppleme
nt x LPS
x Hour

p=0.29

Supplem
ent x
LPS
Effect
p=0.56

p=0.75

p=0.13

p=0.96

p=0.51

p=0.52

p=0.27

p=0.22

p=0.90

p=0.62

p=0.79

p=0.45

p=0.85

p=0.96

p=0.28

p=0.86

p=0.06

p=.99

p=.35

p=0.36

p=0.24

p=0.60

p=0.90

p=0.54

p=0.54

p=0.46

p=0.06

p=0.16

p=0.60

p=0.71

p=0.22

p=0.79

p=0.26

p=0.21
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Figures
Trial 1: The effect of supplementing with ω-3 PUFA on LPS challenge in early pregnant Dorset ewes

Figure 2: Hourly response in rectal temperature to LPS or PBS in early pregnant ewes fed a whole flaxseed or
control supplement. Flax p<0.001, LPS P<0.001, Flax x LPS p=0.0064, Hour p<0.001, LPS x Hour p<0.001 (FL
(n=3): flaxseed supplement + LPS, FP (n=3): flaxseed supplement + PBS, CL (n=5): control supplement + LPS, CP
(n=5): control supplement + PBS) Data were analyzed by repeated Measures ANOVA. Mean ± SEM
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Figure 3: Frequency of sickness symptoms displayed by flaxseed and control supplement fed ewes
receiving either LPS or PBS. Changes in behavior or mucosal responses were noted at each blood sample
collection, added up for each ewe over the 12 hours post-treatment, and averaged for each treatment group. LPS
p<0.0001 (FL (n=3): flaxseed supplement + LPS, FP (n=3): flaxseed supplement + PBS, CL (n=5): control
supplement + LPS, CP (n=5): control supplement + PBS). Data analyzed by ANOVA. Mean ± SEM

Figure 4: Hourly response in white blood cells to LPS or PBS in early pregnant ewes fed a whole flaxseed or control
supplement from 0-12 hours (a) and 0-5 hours (b) post treatment. Figure a: Flax p<0.0001, Hour p<0.0001,
Figure b: Flax p=0.0157, LPS p<0.001, Hour p=0.0039, LPS x Hour p=0.0054, Flax x LPS x Hour p=0.0056
(FL (n=3): flaxseed supplement + LPS, FP (n=3): flaxseed supplement + PBS, CL (n=5): control supplement + LPS,
CP (n=5): control supplement + PBS). Data were analyzed by repeated measures ANOVA. Mean ± SEM
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Figure 5: Plasma concentration of acute phase proteins post treatment. Haptoglobin (a) was measured in samples
collected at time points 0, 30 minutes, 1, 1.5, 2, 2.5, 3,6,9, and 12 hours. Data was log transformed before analysis;
graph displays untransformed data. Both FL and CL are significantly different from the other 3 groups. Flax
p<0.0001, LPS p<0.0001, Flax x LPS p<0.0001. Serum amyloid A (b) was measured in samples collected at time
points 0, 30 minutes, 1, 1.5, 2, 2.5, 3,6,9,12, and 24 hours. CL had significantly lower SAA concentration compared
to the other 3 groups. Flax p=0.0216, LPS p<0.0001, Flax x LPS p<0.001 (FL (n=3): flaxseed supplement + LPS;
FP (n=3): flaxseed supplement + PBS, CL (n=5): control supplement + LPS, CP (n=5): control supplement + PBS)
Data were analyzed by ANOVA with Tukey’s HSD. Mean ± SEM

Figure 6: Plasma concentration of cortisol post treatment. Cortisol was measured in samples collected at time points
0, 30 minutes, 1, 1.5, 2, 2.5, 3,6,9, and 12 hours. Flax p=0.0468, LPS p<0.001 (FL (n=3): flaxseed supplement +
LPS, FP (n=3): flaxseed supplement + PBS, CL (n=5): control supplement + LPS, CP (n=5): control supplement +
PBS) Data were analyzed by ANOVA. Mean ± SEM
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Figure 7: Fold change in gene expression of pro-inflammatory factors measured in white blood cells. Ct values were
normalized to GAPDH and ΔΔ Ct values were obtained in reference to the CP group. (a) CXCL8 measured at 3, 4,
5, 6, 7, 8 hours post treatment. LPS p<0.0001, Flax p=0.0486, Flax x LPS p=0.027 (b) IL-6 measured at 5, 1, 1.5,
2.5, 3, 4, 5, 6 hours post treatment. Flax x LPS p=0.0296 (c) IFNγ measured at 0, .5, 1, 1.5, 4, 6, 8, 10, 12, 24 hours
post treatment. Data log transformed before analysis; graph displays untransformed data. LPS=0.0024 (d) TLR4
measured at 3, 4, 5, 6, 7, 8, 9, 10 hours post treatment. Flax p=0.0484, LPS<0.0001, Flax x LPS p=0.0326 (e) C3
measureed at collected 0, .5, 1, 1.5, 2.5, 3, 4, 5, 6 hours post treatment. Data log transformed before analysis; graph
displays untransformed data. LPS=0.0065 (FL (n=3): flaxseed supplement + LPS, FP (n=3): flaxseed supplement +
PBS, CL (n=5): control supplement + LPS, CP (n=5): control supplement + PBS) Data were analyzed by ANOVA.
Mean ± SEM
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Figure 8: Fold change in gene expression of anti-inflammatory factors measured in white blood cells. Ct values were
normalized to GAPDH and ΔΔ Ct values were obtained in reference to the CP group. (a) MRC1 measured at .5, 1,
1.5, 2.5, 6, 7, 8, 9, 10, 11, 12, 24 hours post treatment. LPS p<0.0001 (b) SOD2 measured in samples collected at
1.5, 2.5, 3, 4, 7, 9, 11, 12, 24 hours post treatment. Data log transformed before analysis; graph displays
untransformed data LPS p<0.0001 (c) Foxp3 measured in samples collected at 1,1.5,3,4,6,7,8,9,10,11,12,24 hours
post treatment and on d16 & d25 post coitus. Data log transformed before analysis; graph displays untransformed
data. LPS p=0.0259 (FL (n=3): flaxseed supplement + LPS; FP (n=3): flaxseed supplement + PBS; CL (n=5):
control supplement + LPS, CP (n=5): control supplement + PBS) Data were analyzed by ANOVA. Mean ± SEM
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Figure 9: Plasma progesterone levels. (a) Progesterone on day 25/26 post coitus comparing all 4 treatment groups.
Data analyzed by 2-way ANOVA. Flax p=0.0752, LPS p=0.6854, Flax x LPS p=0.2026 (FL (n=3): flaxseed
supplement + LPS, FP (n=3): flaxseed supplement + PBS, CL (n=5): control supplement + LPS, CP (n=5): control
supplement + PBS) (b) Progesterone on day 25/26 post coitus comparing only between supplements. Data was
analyzed by a T-test p=0.0481 (flaxseed n=6, control n=10) (FL (n=3): flaxseed supplement + LPS, FP (n=3):
flaxseed supplement + PBS, CL (n=5): control supplement + LPS, CP (n=5): control supplement + PBS) Mean ±
SEM

Figure 10: Comparison of the neutral detergent fiber (a) and non-fiber carbohydrate (b) in samples of the prepared
supplements. Samples were analyzed by the Rumen Fermentation Profiling Laboratory at WVU. Data analyzed by
T-test with Bonferroni correction with α=0.005. NDF: p=0.0001, NFC: p=0.0005 (flaxseed supplement samples
n=4; control supplement samples n=4) Mean ± SEM
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Trial 2: the effect of supplementing with ω-3 PUFA on LPS challenge in early pregnant ewes

Figure 11: Timeline outlining the steps in the breed effects and the omega-3 PUFA effect on LPS challenge studies
conducted in the Fall 2015.

Figure 12: Rectal temperature to LPS or PBS in early pregnant ewes fed a whole flaxseed or control supplement. (a)
Hourly response in rectal temperature. Data analyzed by repeated Measures ANOVA. LPS p<0.0001, Flax x LPS
p=0.0164, Hour p<0.0001 (b) Average rectal temperature for the first six hours post treatment. Data were analyzed
by ANOVA. LPS p<0.0001, Flax x LPS p<0.0001 (FL (n=11): flaxseed supplement + LPS, FP (n=10): flaxseed
supplement + PBS, CL (n=11): control supplement + LPS, CP (n=10): control supplement + PBS)
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Figure 13: Frequency of sickness symptoms displayed by flaxseed and control supplement fed ewes receiving either
LPS or PBS. Changes in behavior or noticeable sickness symptoms were noted at whole hour (hrs 0,1,2,3,4,5,6,9,12)
blood sample collection times, added up for each ewe over the 12 hours post-treatment, and averaged for each
treatment group. LPS p<0.0001 (FL (n=11): flaxseed supplement + LPS, FP (n=10): flaxseed supplement + PBS;
CL (n=11): control supplement + LPS, CP (n=10): control supplement + PBS) Data were analyzed by ANOVA
Mean ±SEM

Figure 14: Response in white blood cells to LPS or PBS in early pregnant ewes fed a whole flaxseed or control
supplement from (a) 0-24 hours post treatment. LPS p=0.0037 (b) 0-6 hours post treatment. LPS p<0.0001, Hour
p=0.0004, LPS x Hour p<0.0001 (FL (n=11): flaxseed supplement + LPS, FP (n=10): flaxseed supplement + PBS;
CL (n=11): control supplement + LPS, CP (n=10): control supplement + PBS) Data were analyzed by repeated
measures ANOVA. Mean ± SEM

116

Figure 15: Acute phase proteins were measured in plasma at 0, 2, 6, 12, and 24 hours post-treatment. (a)
Haptoglobin: LPS p=0.0327, Hour p=0.0078, LPS x Hour p=0.0165 (b) Serum Amyloid A: Hour p=0.0023 (FL
(n=11): flaxseed supplement + LPS, FP (n=10): flaxseed supplement + PBS, CL (n=11): control supplement + LPS,
CP (n=10): control supplement + PBS) Data were analyzed by repeated measures ANOVA Mean ± SEM

Figure 16: Cortisol was measured in plasma at 0, 1, 2, 3, 6 and 12 hours post-treatment. Flax p=0.0235, LPS
p<0.0001, Flax x LPS p=0.0007, Hour p<0.0001, LPS x Hour p<0.0001, Flax x LPS x Hour p=0.0105 (FL
(n=11): flaxseed supplement + LPS, FP (n=10): flaxseed supplement + PBS, CL (n=11): control supplement + LPS,
CP (n=10): control supplement + PBS) Data were analyzed by repeated measures ANOVA Means ± SEM
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Figure 17: Fold change in gene expression of pro-inflammatory factors measured in white blood cells in response to
LPS or PBS in early pregnant ewes fed a whole flaxseed or control supplement. (a) CXCL8: LPS p=0.0160 (b) C3:
Flax p=0.0041, LPS p=0.0107, Hour p<0.0001, LPS x Hour p<0.0001 (c) TLR4: LPS p=0.0002, Hour p<0.0001,
LPS x Hour p<0.0001 (d) COX2: Hour p=0.0119 Gene Expression normalized to GAPDH and referenced to
expression levels in the sample collected at CIDR withdraw. (FL (n=11): flaxseed supplement + LPS, FP (n=10):
flaxseed supplement + PBS, CL (n=11): control supplement + LPS, CP (n=10): control supplement + PBS) Data
were analyzed by repeated measures ANOVA. Mean ±SEM
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Figure 18: Fold change in gene expression of anti-inflammatory factors measured in white blood cells in response to
LPS or PBS in early pregnant ewes fed a whole flaxseed or control supplement (a) MRC1: LPS p=0.0118, Hour
p=0.0004, LPS x Hour p=0.0091 (b) SOD2: LPS p<0.0001, Hour p<0.0001, LPS x Hour p<0.0001. (c) PPARγ:
LPS p=0.0014, Hour p=0.0436 (d) Foxp3: LPS x Hour p=0.0242 (e) TGFβ: Hour p=0.0117 (c) TLR4: LPS
p=0.0002, Hour p<0.0001, LPS x Hour p<0.0001 Gene Expression normalized to GAPDH and referenced to
expression levels in the sample collected at CIDR withdraw. (FL (n=11): flaxseed supplement + LPS, FP (n=10):
flaxseed supplement + PBS, CL (n=11): control supplement + LPS, CP (n=10): control supplement + PBS). Data
were analyzed by repeated measures ANOVA. Mean ± SEM
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Figure 19: Plasma concentration of progesterone on day 25/26 post coitus in ewes fed flaxseed or a control
supplement and administered LPS or PBS on day 5/6 post coitus. Data were analyzed by 2-way ANOVA. Flax
p=0.4303, LPS p=0.8523, Flax x LPS p=0.1766 (FL (n=11): flaxseed supplement + LPS, FP (n=10): flaxseed
supplement + PBS, CL (n=11): control supplement + LPS, CP (n=10): control supplement + PBS)

Figure 20: Comparison of the neutral detergent fiber (a) and non-fiber carbohydrate (b) in samples of the prepared
supplement s. Samples were analyzed by the Rumen Fermentation Profiling Laboratory at WVU. Data were
analyzed by T-test with Bonferroni correction with α=0.005. NDF: p=0.0002, NFC: p<0.0001 (flaxseed
supplement samples n=5, control supplement samples n=7) Mean ± SEM

120

Chapter 4: Effect of Breed on the LPS Response in Early Pregnant Ewes
Introduction
The fetus was once thought to be ignored by the maternal immune system due to physical
separation, immunological immaturity of the fetus, and maternal immune inertness (Billington, 2003). It
is now appreciated that a dynamic dialogue between maternal and fetal tissues has to occur to allow for
immune tolerance of the fetus, angiogenesis and cytokine and hormonal balance (Dosiou & Giudice,
2005; Thaxton & Sharma, 2010; Sharma, 2014). During pregnancy, maternal immune cells are in contact
with fetal trophoblast cells, which express paternal antigens and in order to have a successful pregnancy,
the maternal immune system has to tolerate the semi-allogeneic fetus (Erlebacher, 2013; Sharma, 2014).
The immune cells in the pregnant uterus that are in charge of this tolerance are tolerogenic DCs, M2
MΦs, and regulatory T cells (Tregs). During pregnancy these cells are responsible for creating a
microenvironment that is compatible with pregnancy and supports placentation (Sharma, 2014) including
a shift towards T helper (Th) 2 cytokine dominance and inhibition of complement activation (Mellor et
al., 2001; Girardi et al., 2006).
Infection is an important trigger for inflammation causing changes in the function of immune
cells at the maternal-fetal interface which can cause embryonic loss (Aisemberg et al., 2013; Kwak-Kim
et al., 2014; Sharma et al., 2014). Pattern recognition receptors at the maternal-fetal interface recognize
PAMPs; binding of these receptors to pathogen molecules results in the activation of anti-pathogen
responses, such as the synthesis and secretion of chemokines and PICs, often through the activation of
transcription factors such as NF-κB and Ap-1(Akira et al., 2006; Koge et al., 2014; Gioia et al., 2015).
Toll like receptors are one family of these innate immune system PRRs and TLR4 is the member that
recognizes the gram negative bacterial cell wall component, LPS (Abrahams, 2008). Lipopolysaccharide
triggers a robust inflammatory response characterized by the production of PICs, such as TNFα and IL1β, shifts in the Th1/Th2 balance (Park et al., 2009) and induces uterine NK cell cytotoxic activation
(Murphy et al., 2005). The immune mediators that are released stimulate cells to upregulate inflammation
locally, while systemically they activate the HPA axis, cause the release of APPs, and induce the febrile
response (Chrousos, 1992; 1995; Gabay & Kushner, 1999; Kabaroff et al 2006). While this immune
response is necessary to clear an infection, over activation of this pathway is detrimental to pregnancy and
neutralization of LPS, or blockage of TLR4 signaling has been shown to prevent fetal loss in murine
pregnancy (Friable et al., 2011).
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Early embryonic loss in response to bacterial infections can be due to several reasons; 1) direct
embryotoxic effects of PIMs on the blastocyst, 2) apoptosis of blastocyst cells by PICs that hamper
blastocyst growth and reduce IFNτ production which will affect maternal recognition of pregnancy, the
prevention of luteolysis, and P4 production, 3) luteolysis (direct action of PICs on the CL or through
production of PGF2α) and loss of P4 production, (P4 is immunosuppressive and needed to help generate
maternal tolerance to the fetus in addition to regulating elongation and implantation genes), 4) reduced
blastocyst size due to apoptosis by PICs and altered gene expression due to decreased IFNτ and P4 can
result in missing the “window of implantation,” a time when the uterus is receptive to implantation and
the blastocyst is implantation competent, 5) inflammation changing the normal spatial-temporal
expression of cytokines involved in implantation, 6) and loss of maternal fetal tolerance. A highly proinflammatory uterine environment can cause the local immune cells to switch from a tolerogenic
phenotype (tolerogenic DC, uterine NK cell, M2 MΦ, Treg) to an immunogenic phenotype (immunogenic
DC, peripheral NK cell, M1 MΦ, effector T cell) that will no longer tolerate the presence of foreign
paternal antigens.
After acquiring antigen, APCs travel to lymph nodes to present the antigen and activate T cells. If
the APC is displaying a bacterial antigen, a Th1/pro-inflammatory response would be expected in order to
clear the pathogen. If the APC was displaying a seminal plasma antigen, a Treg polarization is needed to
acquire maternal tolerance to the fetus; failure to generate significant numbers of Treg cells specific to
paternal antigens results in fetal loss (Robertson et al., 2013). A problem generating maternal tolerance
could occur if there is a substantial uterine bacterial presence after mating resulting in predominantly Th1
polarization and infiltration of inflammatory cells into the uterus. This could result from failure of a dairy
cow to efficiently deal with uterine contamination postpartum during NEB and/or by bacterial
introduction during mating or AI. DCs are professional APC involved in the activation of T cells.
Tolerogenic DCs have a specific immature or semi-immature phenotype that is pivotal in the activation
and expansion of Treg cells (Steinman et al., 2003). Tolerogenic DCs have diminished expression of the
co-stimulatory molecules CD80 and CD86; they do not express the Th1-polarizing cytokine IL-12
(Steinman et al., 2003) but do express IDO, which allows them to activate resting Tregs, convert
CD4+CD25- T cells to CD4+CD25+FOXP3+ Tregs, and stimulate Tregs to maintain suppressive activity
(Sharma et al., 2007). DCs that are differentiated in the presence of TGFβ, IL-10, GM-CSF, and IL-4 are
reported to behave like tolerogenic DCs and reliably induce CD4+CD25+ Tregs that have
immunosuppressive function (Sato et al., 2003).
Estrogen is immune stimulatory. However, post-partum before ovarian activity resumes, estrogen
is low which can predispose the uterus to bacterial colonization through loss of specific responses
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(antigen specific T helper cells), leaving the innate immune system to handle any bacterial contamination
(Bondurant, 1999). Nonspecific responses may be compromised, however. When an LPS infusion was
used to induce endometritis, the oxygen dependent mechanism (respiratory burst-generation of reactive
oxygen species) of killing phagocytized bacteria by neutrophils was reduced (Kluciñski et al., 1995).
Authors suggested that gram-negative bacterial contamination of the uterus postpartum compromised the
ability of the first line of defense to control and clear pathogens. In addition, being in a state of NEB is
immune suppressive and neutrophil function was reported to decline as parturition approached and DMI
decreased and remained depressed after parturition in dairy cows for several weeks (Hammon et al.,
2006). Kimura et al (1999) also reported that the onset of lactation as well as hypocalcemia (Kimura et
al., 2006) reduced the bactericidal activity of neutrophils and the expression levels of adhesion molecules
on neutrophils needed for the cells to enter tissues. For pathogens introduced during estrus, E2 levels are
rapidly declining, which may allow the pathogen time to establish itself in the reproductive tract.
Progesterone is immune suppressive, and any bacterial contamination present after ovulation could turn
into an infection. Therefore, bacterial infections can increase the calving interval and impact lifetime milk
production, obvious concerns for a producer.
The present study was conducted to gain information on the mechanism of bacterial infection
induced embryonic loss using an LPS challenge in early pregnant ewes by measuring aspects of the innate
immune response and APR. In a previous experiment at WVU, Dorset and Suffolk ewes appeared to have
a differential response to LPS challenge. The objective in this study was to see if Dorset and Suffolk ewes
responded to LPS differently in regard to rectal temperature,WBCs, observable symptoms, APPs, gene
expression of cytokines, chemokines, receptors, and enzymes and whether pregnancy rates were
associated with the inflammatory response.

Results
Clinical Signs
Temperature
Rectal temperature was affected by breed (Dorset 39.16 ± 0.05oC, Suffolk 39.45 ± 0.06oC,
p=0.0284), LPS (LPS 39.54 ± 0.06oC, PBS 38.99 ± 0.04oC, p=0.0001), hour (p<0.0001), and the
interactions breed x hour (p=0.0330) and LPS x hour (p<0.0001) with the ewes receiving LPS having an
increase in temperature from hour 0 (DL 39.08 ± 0.15oC, SL 38.6 ± 0.08oC) until hour 4 (DL39.89 ±
0.34oC, SL 40.11 ± 0.19oC) before decreasing back towards normal (hour 6- DL 39.51 ± 0.26oC, SL 39.32
± 0.14oC) (Figure 21a). Although, PBS did not change temperature, the PBS- treated Suffolk ewes had a
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lower temperature than PBS-treated Dorset ewes (DP 39.3 ± 0.07oC, SP: 38.8 ± 0.03oC, p=0.0073)
(Figure 21a).
The change in temperature at each hour from hour zero was affected by LPS (LPS 0.88 ± 0.06oC,
PBS 0.09 ± 0.03oC, p<0.0001), hour (p=0.0005), and the interactions LPS x breed (DL 0.59 ± 0.09oC, SL:
1.08 ± 0.07oC, p=0.0314) and LPS x hour (p=0.0001) with LPS causing an increase in temperature in both
breeds; however, the Suffolk ewes had a greater increase in temperature in response to LPS at hour 2 (DL
0.56 ± 0.18oC, SL 0.84 ± 0.1oC, p=0.0024), hour 3 (DL 0.73 ± 0.25oC; SL 1.32 ± 0.18oC, p<0.0001), hour
4 (DL 0.82 ± 0.28oC, SL 1.51 ± 0.19oC p<0.0001), hour 5 (DL 0.61 ± 0.3oC, SL 1.08 ± 0.21oC,
p=0.0011), and hour 6 (DL 0.43 ± 0.25oC, SL 0.73 ± 0.18oC, p=0.0191) (Figure 21b).
Behavior changes/Mucosal Responses
Due to the low frequency of each individual sickness symptom, all observed mucosal responses
(nasal discharge, vaginal discharge, coughing, and diarrhea) and behavioral changes (inappetence,
lethargic, lying down, and heavy breathing) were summed for each ewe over the 12 hours post treatment.
LPS administration caused ewes to have observable physiological changes (LPS 4.37 ± 0.71, PBS 0.12 ±
0.08, p<0.0001) and Suffolk ewes administered LPS experienced a higher frequency of sickness
symptoms than Dorset ewes (DL 1.18 ± 0.62, SL 6.56 ± 0.72, p=0.0029). The Dorset ewes that received
PBS displayed 0.3±0.21 symptoms while no symptoms were noted for any Suffolk ewes that received
PBS (Figure 22).

Immune System
White Blood cell counts
Lipopolysaccharide (LPS 6,688,566 ± 241,538.4, PBS 9,692,214 ± 200,412.5, p<0.0001)
treatment caused a decrease in WBCs in both breeds. There was also an effect of hour (p<0.0001) and an
interaction of LPS x hour (p<0.0001). The LPS groups had significantly lower total WBCs at hour 1,2,3,4
(all p<0.0001) and hour 5 (p=0.0015). White blood cells decreased between hour 0 and hour 1 in both
breeds receiving LPS. In the SL ewes, total WBCs stayed at that low level at hours 2 and 3 before
gradually increasing. In the DL ewes, after the decrease in WBCs from hour 0 and 1, cell numbers started
gradually increasing (Figure 23).
Acute Phase Proteins
Plasma Hp was influenced by breed (Dorset 0.04 ± 0.003 mg/ml, Suffolk 0.12 ± 0.01 mg/ml,
p=<0.0001), hour (p=0.0405), and the interaction of breed by LPS (p=0.0357) with Suffolk ewes having
more Hp than Dorset ewes receiving LPS (DL 0.05 ± 0.01 mg/ml, SL 0.10 ± 0.01). All groups had an
increase in Hp levels from hour 12 to 24, but the largest increase was in the SL group (Figure 24a).
Plasma SAA was affected by the interactions of breed x hour (p<0.0001) and breed x LPS x hour
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(p=0.0330), which was due to fluctuations in SAA in both breeds when treated with LPS over the sample
time (Figure 24b).
Cortisol
Plasma cortisol increased in response to LPS (LPS 59.30 ± 6.58 ng/ml, PBS 30.93 ± 3.25 ng/ml,
p=0.0029). There were also effects of breed (Dorset 35.62 ± 4.24 ng/ml, Suffolk 54.61 ± 6.31 ng/ml,
p=0.0284) and the interactions breed x LPS (DL 40.10 ± 6.75 ng/ml, SL 78.5 ± 9.98 ng/ml, p=0.0257),
LPS x Hour (p<0.0001), and breed x LPS x hour (p=0.0085). Cortisol increased right after LPS
administration in the Suffolk ewes and stayed elevated until hour 3 before decreasing back to normal by
hour 12. In the Dorset ewes receiving LPS, cortisol did not increase until after hour 2, peaked at hour 3,
and decreased back to normal by hour 6. Lipopolysaccharide had significant effects on cortisol at hour 1
(p<0.0001), hour 2 (p=0.0006), hour 3 (p<0.0001), and hour 6 (p=0.0156). However, this was mainly due
to the high values in the Suffolk ewes at those time points as the Dorset ewes had an increase in cortisol at
only hour 3. (Figure 25).
Gene Expression
Lipopolysaccharide treatment upregulated CXCL8 expression (LPS 17.74 ± 3.8, PBS 2.26 ± 0.44,
p=0.0003) similarily in both breeds. There was an hour (p=0.0005) and a LPS x hour (p=0.0142)
interaction. CXCL8 increased from treatment administration (DL 3.67 ± 1.93, SL 6.54 ± 2.87) until hour
4 (DL 58.19 ± 53.37, SL 48.66 ± 18.05) before decreasing back to normal by hour 9 (DL 2.29 ± 1.12, SL
1.29 ± 0.21). The PBS groups had no change in CXCL8 expression (Figure 26a).
TLR4 expression was upregulated in response to LPS (LPS 3.78 ± 0.55, PBS 1.78 ± 0.26,
p=0.0036) and was also affected by breed (Dorset 3.58 ± 0.52, Suffolk 1.98 ± 0.36, p=0.0030), hour
(p=0.0121), and LPS x hour (p=0.0105). In the DL group, TLR4 expression increased from treatment
administration (1.93 ± 0.77) to hour 3 when it peaked (9.57 ± 1.86), and then decreased back to normal by
hour 9 (1.88 ± 0.21). In the SL group there was a more gradual increase in TLR4 expression from
treatment administration until hour 6 (hour 0 0.96 ± 0.25, hour 6 5.38 ± 1.49) followed by a decrease until
hour 9 (2.2 ± 0.67). While PBS did not cause a change in TLR4 expression, Dorset ewes that received
PBS had greater TLR4 expression at hour 1.5 (DP 3.92 ± 1.29, SP 0.59 ± 0.22, p=0.0004), and hour 3 (DP
3.40 ± 0.86, SP 0.71 ± 0.26, p=0.0023) than Suffolk ewes (Figure 26d).
Nuclear factor-kappa B expression spiked at hour 6 in Suffolk ewes receiving LPS and PBS while
there was no major changes in expression in the Dorset ewes. The breed x LPS interaction had a p value
of 0.0443 but using the Benjamini-Hochberg procedure, this was no longer significant. There was no
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effect of breed, LPS, hour, or any interaction effect on NF-κB expression (Table 10). There was no main
effect or any interaction effects on TNFα expression (Table 10).
Interleukin-6 expression was affected by breed (Dorset 0.46 ± 0.08, Suffolk 3.82 ± 0.52,
p=0.0007) and breed x LPS (DL 0.3 ± 0.08, SL 2.39 ± 0.57, p=0.0024) with the Suffolk ewes treated with
LPS starting out with greater IL-6 expression and having an increase in IL-6 expression in response to
LPS. The other 3 groups did not have a change in IL-6 expression. Compared to the SP group, the SL
group had significantly greater IL-6 expression at hour 0 (SP 0.44±0.17, SL 1.42±0.71, p=0.0046), 15
minutes (SP 0.68 ± 0.34, SL 1.79 ± 0.9, p=0.018), 45 minutes (SP 0.42 ± 0.21, SL 2.46 ± 1.95,
p=0.0122), hour 1.5 (SP 0.48 ± 0.2, SL 1.29 ± 0.64, p=0.0209), hour 2 (SP 0.48 ± 0.18, SL 4.18 ± 3.22,
p=0.0196), hour 3 (SP 0.43 ± 0.21, SL 2.33 ± 0.38, 0.0137), and hour 6 (SP 0.83 ± 0.56, SL 3.1 ± 1.58,
p=0.0004) post-treatment (Figure 26b).
Expression of IFNγ was affected by breed (Dorset 2.29 ± 0.61, Suffolk 2.99 ± 0.59, p=0.0153)
where the Suffolk ewes had higher expression compared to the Dorset ewes especially at hour 0 (Dorset
2.3 ± 1.08, Suffolk: 4.43 ± 2.06), hour 6 (Dorset: 1.02 ± 0.45; Suffolk: 2.68 ± 3.45) and hour 9 (Dorset
1.16 ± 0.59, Suffolk: 3.05 ± 1.92) (Figure 26c). COX 2 expression also was affected by breed (Dorset
0.43 ± 0.05, Suffolk: 1.43 ± 0.19, p=0.0002) with Suffolk ewes having higher expression than Dorset
ewes. The SL group had its highest COX2 expression at 45 minutes post treatment (DP 0.58 ± 0.29, DL
0.18 ± 0.04, SP 0.52 ± 0.26, SL 2.94 ± 1.83), and the SP group had its highest expression 30 minutes post
treatment (DP 0.55 ± 0.23, DL 0.5 ± 0.30, SP 2.08 ± 0.9, SL 0.88 ± 0.3). Expression in the DL (0.32 ±
0.07) group was different from expression in both the SL (1.65 ± 0.35) (p=0.0022) and the SP (1.2 ± 0.16)
(p=0.0040) group. The DP (0.53 ± 0.07) group was not different from any other group (Figure 26e).
Lipopolysaccharide treatment increased C3 expression (LPS 2.11 ± 0.48, PBS 0.85 ± 0.25,
p=0.0004). Suffolk ewes had higher C3 expression (Dorset 0.74 ± 0.08, Suffolk 2.22 ± 0.53, p=0.0077),
and expression was affected by hour (p<0.0001), and the interactions breed x LPS (DL 0.85 ± 0.16, SL
3.32 ± 0.87, p=0.0004) and LPS x hour (p<0.0001). In the DL ewes, expression started increasing after
hour 1 (DL 0.20±0.01). In response to LPS, the Suffolk ewes had a spike in C3 expression at 45 minutes
(SL 3.10 ± 2.1) and expression increased after hour 1 (0.49 ± 0.16). At hour 6, expression was still
elevated in both LPS groups (DL 2.09 ± 0.3, SL 14.33 ± 4.16) (Figure 26f).
There was an effect of LPS (LPS 0.52 ± 0.1, PBS 1.20 ± 0.14, p=0.0028) and hour (p=0.0003) on
MRC1 expression. The DP, SP, and SL groups had some fluctuation in expression over time but only the
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DL group had a pattern where expression decreased after LPS treatment until hour 9 and then stayed low
(Figure 27a).
Interleukin-10 expression was affected by breed (Dorset 5.95 ± 1.51, Suffolk 2.93 ± 1.10,
p=0.0448) with the SL ewes having a spike in expression at hour 6 (DP 2.61 ± 2.23, DL 4.61 ± 2.44, SP
0.46 ± 0.33, SL 14.15 ± 11.56) and the DL ewes having an increase in expression from hour 6 to 12 with
significantly higher values at hour 12 compared to the DP ewes (DP 1.58 ± 0.68, DL 23.54 ± 13.28,
p=0.0049 (SP 0.56 ± 0.4, SL 0.13 ± 0.063)) (Figure 27b).
Peroxisome proliferator-activated γ expression was affected by breed (Dorset: 1.36 ± 0.16;
Suffolk: 0.65 ± 0.07, p=0.0016) with Dorset ewes having a higher fold change in PPARγ expression than
Suffolk ewes. LPS (LPS: 0.78 ± 0.1; PBS: 1.24 ± 0.15, p=0.0056), hour (p=0.0059), and the interaction
LPS x hour (p=0.0054) also affected PPARγ expression. In both breeds, LPS caused a spike in expression
at hour 3 that then returned to normal levels. At hour 9, the SL group had a lower fold change in
expression compared to the DL group (DL: 0.62±0.24; SL: 0.2±0.04; p=0.0497). The DP ewes had the
highest fold change in PPARγ expression, being different from the SP ewes at hour 3 (DP: 1.80±0.86; SP:
0.51±0.16; p=0.0338) and hour 6 (DP: 2.78±0.94; SP: 0.7±0.18; p=0.0147) (Figure 27e).
Forkhead box P 3 expression was affected by breed (Dorset 1.13 ± 0.10, Suffolk 0.54 ± 0.05,
p=0.0001) with Dorset ewes having greater fold change in expression than Suffolk ewes. The biggest
differences occurred at hour 0 and hour 24. At hour 0, the two LPS groups differed by breed (DL 1.48 ±
0.85, SL 0.37 ± 0.09, p=0.0148) as did the two PBS groups (DP 1.45 ± 0.4, SP 0.42 ± 0.16, p=0.0333).
The two LPS groups differed from each other at hour 24 (DL 1.08 ± 0.62, SL 0.29 ± 0.1, p=0.0382) as did
the two PBS groups (DP 1.34 ± 0.13, SP 0.51 ± 0.10, p=0.0203). The interaction of LPS x hour
(p<0.0001) affected FOXP3 expression. LPS caused a decrease in expression in the Dorset ewes from
hour 3 to 6, which then rebounded by hour 24. In the Suffolk ewes, LPS caused an increase in expression
from hour 0 to 2 after which expression decreased back to pre-treatment values (Figure 27f).
Transforming growth factor β was affected by hour (p=0.0161) with most of the change in
expression occurring in the Suffolk ewes. This breed had greater expression than the Dorset ewes at
several time points, but the breed effect did not reach significance (p=0.0808). The Suffolk ewes had
greater expression compared to the Dorset ewes at hour 6, however. Compared to the DP ewes, the SP
ewes had more expression at hour 6 (DP 0.69 ± 0.14, SP 2.14 ± 0.79, p=0.0131). Compared to the DL
group, the SL group had higher expression at hour 6 (DL 0.69 ± 0.14, SL 2.72 ± 1.35, p=0.0006) (Figure
27c).
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Lipopolysaccharide (LPS 3.88 ± 0.44, PBS 1.49 ± 0.15, p=<0.0001) treatment, hour (p=0.0001),
and their interaction (LPS x hour p<0.0001) affected SOD2 expression. In the Dorset ewes, LPS caused a
sharp increase in SOD2 expression from hour 0 until hour 3. Expression then decreased until hour 12 with
a slight increase at hour 24. In the Suffolk ewes, LPS caused a more gradual increase in SOD2 expression
until hour 6 followed by a gradual decrease until hour 24. LPS caused a greater increase in the Dorset
compared to the Suffolk ewes, and the DL group had greater SOD2 expression compared to the SL group
at hour 1.5 (DL 4.87±1.42, SL 2.18 ± 0.74, p=0.0415) and hour 3 (DL 10.82 ± 2.07, SL 4.62 ± 1.28,
p=0.0292). The DL group also had a higher fold change in expression than the SL group at hour 24 (DL
2.94 ± 0.57, SL 1.13 ± 0.25, p=0.0205) due to expression in that group having a slight increase from hour
12 to 24. Superoxide dismutase 2 expression was also affected by breed (Dorset 3.58 ± 0.42, Suffolk 1.81
± 0.25, p=0.0002) and while the PBS groups had no major changes in expression, the DP group had
greater expression compared to the SP group at hour 1.5 (DP 3.06 ± 1.05, SP 1.08 ± 0.28, p=0.0225), hour
3 (DP 2.58 ± 0.42, SP 0.62 ± 0.14, p=0.0006), and hour 12 (DP 1.86 ± 0.49, SP 0.57 ± 0.21, p=0.0102)
(Figure 27d).

Reproductive System
Progesterone
Neither breed nor treatment affected plasma progesterone on day 8/9 post coitus (3.38 ± 0.18
ng/ml) or on day 25/26 post coitus (3.93 ± 0.15 ng/ml) (Figure 28).
Pregnancy diagnosis/lambing data
Pregnancy diagnosis was determined by ultrasound on day 25/26 and the number of ewes found
to be pregnant was greatest in the SL group (p=0.0421) (Figure 29a) but there was no difference when
only comparing between breeds (Dorset 42.86%, Suffolk 68.75%, p=0.0613). After the ewes lambed, the
date of lambing and the average gestation length was used to backtrack to day of conception. Neither
experimental group (p=0.0873, Figure 29b), breed (p=0.0564), nor treatment (p=0.5007) affected loss of
pregnancy. Logistic regression confirmed the contingency analyses; neither treatment, breed, nor the
interaction could predict the odds of a ewe having a lamb (p=0.0987). The number of lambs born from
each group from mating’s that occurred during the experiment did not differ between the groups
(p=0.3568, data not shown).

Discussion
The temperature response to LPS in Suffolk ewes was about double compared to Dorset ewes.
Although there were no differences in pregnany rates in this study, an elevation in body temperature
associated with infection could affect embryonic loss as research studying heat stress in cattle that raised
body temperature during embryonic development (Days 1 to 7) led to decreased embryonic survival
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(embryos recovered/assessed on day 7) (Putney et al., 1988). As the Suffolk ewes had a greater fever
response, embryos of Suffolk ewes are likely to be at a greater risk of damage due to heat. Temperature is
increased in response to IL-1β and IL-6, mediated by PGE2; SL ewes had a greater increase in IL-6 gene
expression compared to the DL ewes, which fits with them having a greater increase in temperature. IL1β and TNFα stimulate IL-6 production (and production of each other); SL ewes had high gene
expression of IL-6; and IL-1β is a major driver of the fever response. PGE2 produced peripherally in
response to pathogenic stimuli can travel through the blood-brain barrier and initiate a fever response
(Netea et al., 2000; Evans et al., 2015). Suffolk ewes had a greater change in gene expression of COX2
and while specific PGs were not measured, LPS is known to stimulate production of PGE2 (Herath et al.,
2009). Elevated peripheral PGE2 production would also contribute to the increased fever response in
Suffolk ewes. Suffolk ewes tended to have a greater increase in expression of NF-κB which leads to PIC
production which fits with the greater fever response. IL-1β causes PGF2α and PGE2 secretion by
endometrial stromal and epithelial cells (Davidson et al., 1995) while TNFα has been shown to cause
PGF2α secretion by stromal endometrial cells through activation of PLA2 (Skarzynski et al., 2000).
Prostaglandin F2α is not only luteolytic but is thought to have negative effects on embryo development
and may be embryotoxic, especially during the morula to blastocyst transition (Buford et al., 1996; Seals
et al., 1998; Scenna et al., 2004). If Suffolk ewes produce more PGF2α during inflammation, they may be
more susceptible to embryonic loss in response to bacterial infections during the pre-implantation period.
Acting on the brain, PICs cause behavioral changes that serve as an adaptive response to enhance
recovery by conserving energy to fight acute inflammation. These behavioral changes include appetite
disturbances, sleep disturbances, reduction of locomotor activity, exploration and grooming, reduced
interest in the social and physical environment, loss of sexual interest, and impaired cognitive abilities
(Konsman et al., 2002). Circulating LPS causes mucosal responses in the respiratory, digestive, and
reproductive tracts. Observable changes in response to LPS that were noted during the experiment
included lethargy, lying down, inappetence, heavy breathing, coughing, diarrhea, vaginal discharge, and
nasal discharge. Ewes challenged with LPS had noticeable changes in sickness symptoms. The increase in
discomfort and greater fever response in Suffolk ewes suggests a greater immune response to LPS in this
breed.
The number of WBCs in the circulation decreased in response to LPS from hour 0 to 1 before
slowly recovering over the next few hours. After treatment, the WBCs end up in the lungs and muscosal
linings where they are responsible for the muscosal and respiratory changes. The change in WBCs in the
LPS groups confirms that the LPS elicited an immune response. The first innate immune cells to be
attracted to an inflammatory site are neutrophils, with one of their chemokines being CXCL8, activated
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by NF-κB. Interleukin-8 gene expression increased in response to LPS, confirming that an inflammatory
response was generated. Nuclear factor-κB activation occurs in response to a signaling cascade initiated
by a PAMP binding to a PRR; TLR4 is the PRR that binds LPS. Lipopolysaccharide treatment increased
TLR4 expression, and Dorset ewes had more TLR4 expression, which potentially means there could be
increased interaction between LPS and TLR4 in the Dorset ewes leading to a greater inflammatory
response. Indeed, infertile cows had greater endometrial expression of TLR4, IL-1beta, and a greater ratio
of IL-1β to IL-10 (Herath et al, 2009). However, looking at temperature response, symptoms, cortisol
levels, and gene expression of other inflammatory mediators, the Dorset ewes had a reduced
inflammatory response compared to the Suffolk ewes suggesting better clearance mechanisms. The
peripheral blood mononuclear cells in Dorset ewes may be releasing TLR4 to its soluble form, which still
binds LPS but does not increase cytokine production. Instead, soluble TLR4 binds LPS attached to LPSbinding protein, and the complex is them phagocytosed by macrophages (Oever et al., 2014). If this is
occurring in the Dorset ewes it would explain the higher TLR4 gene expression compared to Suffolk ewes
but the reduced inflammatory response to LPS.
The complement system is activated during bacterial infections to kill pathogens, promote
inflammation through stimulating production of PICs, recruit inflammatory cells, and opsonize and clear
immune complexes (Molina, 2005; Murphy, 2012). Proper control of complement in the uterine
environment has been shown to be critical to prevent excessive inflammation and embryo loss (Xu et al.,
2000; Mellor et al., 2001; Mao et al., 2003; Caucheteux et al., 2003). Expression of C3 in LPS challenged
ewes increased with time starting from hour 1 but increased more in the Suffolk ewes. Immunoglobulin A
will bind LPS in mucosal linings and cause activation of the classical complement pathway leading to
production of pro-inflammatory cytokines. Suffolk ewes had increased C3 expression, and in response to
LPS, an increased fever response, cortisol, sickness symptoms, and IL-6 expression. These responses are
all downstream of pro-inflammatory cytokines that can be produced after complement activation.
The two major ovine APPs are Hp and SAA (Cray et al., 2009; Lecchi et al., 2012; Chapwanya et
al., 2013) and are important in restoring homeostasis. Expression of SAA fluctuated over time, being
affected by the interactions of breed x hour and breed x LPS x hour. Lipopolysaccharide caused in
increase in Dorset SAA but did not cause a change in Suffolk SAA perhaps putting Suffolk ewes at a
disadvantage at resolving an infection/inflammatory response. Suffolk ewes had more Hp compared to
Dorset ewes and had a larger increase in Hp in response to LPS. Hp has been reported to dampen LPS
induced inflammatory effects in vitro and in vivo. Hp can bind to innate immune cells and in vitro
reduced cytokine (TNF-α, IL-12p70, IL-10) production by human PBMCs stimulated with LPS
(Arredouani et al., 2005).
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Lipopolysaccharide led to activation of the HPA axis with a greater increase in corticol in the SL
ewes. This could be a reflection of the greater IL-6 gene expression induced in these ewes by LPS and
potentially greater PGE2 levels (increased COX2 expression). Cortisol is responsible to sickness
symptoms and the increase in cortisol in the Suffolk ewes fits with their greater display of sickness
symptoms. Downstream of cortisol and IL-6 is activation of APPs; therefore, greater concentrations of Hp
levels in the Suffolk ewes also fits. Acute phase proteins are general markers of inflammation. Suffolk
ewes having greater Hp might be a reflection of generally being in a more pro-inflammatory state
reflected by having greater gene expression of COX2, C3, IFNγ, and lower gene expression of PPARγ,
Foxp3, and IL-10 (even without treatment).
There were no significant effects on NF-κB expression; however, the Suffolk ewes tended to have
a greater increase in expression. The breed x LPS effect was significant until the Benjamini-Hochberg
procedure was used to control for multiple comparisons with the Suffolk ewes receiving LPS having a
greater increase in NF-κB expression than Dorset ewes. Potentially more NF-κB in the Suffolk ewes
would fit with the increase in IL-6 gene expression in this breed. NF-κB also causes transcription of
TNFα and IL-1β. While IL-1β was not measured, TNFα gene expression was not affected by breed or
treatment. Gene expression does not always reflect protein levels, however, and TNFα protein has been
shown to increase in response LPS in sheep (Graham, 2014) and has been shown to be embryotoxic (Soto
et al., 2003a; Loureiro et al., 2007). Whether, there is a difference between Suffolk and Dorset ewes is yet
to be determined. A difference in IFNγ gene expression was shown with Suffolk ewes having higher
expression. Because IFNγ is embryotoxic by limiting trophectoderm proliferation (Hill et al., 1987),
embryos in Suffolk ewes may be at a higher risk of damage compared to embryos in Dorset ewes.
PICs and ROS are damaging to embryos. IL-1β and TNFα stimulate the production of
eicosanoids, NO, and ROS to help fight infections (Tracey, 2002), and nitric oxide has been shown to
block development of preimplantation bovine embryos in vitro (Soto et al., 2003b). Although neither NO
or ROS were measured, gene expression of SOD2, an enzyme that neutralizes ROS, increased with LPS
treatment in both breeds. Neutrophils are a major producer of reactive oxygen species and are the first
responders to any type of infection or inflammation. Increased expression of the neutrophil
chemoattractant CXCL8 along with increased SOD2 expression indicates the elevated production of
reactive oxygen species occurs in this LPS model. Expression of SOD2 increased more in the DL ewes,
and greater expression would allow them to neutralize ROS more rapidly and minimize damage to other
cells and the embryo.
Suffolk ewes had greater levels of IL-6, a cytokine with various functions depending on the
presence and quantity of other mediators. It plays a role in regulating the balance between IL-17
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producing Th17 cells, which are pro-inflammatory and Treg cells that have suppressive functions. In
conjunction with TGFβ, IL-6 induces naïve CD4+ cells to polarize into Th17 cells. However, TGFβ in
conjunction with IL-2 induces Treg polarization; IL-6 can inhibit this TGFβ function (Robertson et al.,
2013). Not only is TGFβ important for polarization towards Treg cells, but it is produced by Tregs and
tDCs to mediate some of their suppressive functions (Simpson et al., 2002; Ghiringhelli et al., 2005a).
Treg cells are not a terminally differentiated cell type; they can turn into Th1 or Th17 cells if
exposed to high amounts of PICs, such as IL-6, IFNγ, or IL-1 (Gao et al., 2012). The only significant
effect on TGFβ expression was hour, but Suffolk ewes tended to have a greater increase in expression of
the cytokine. Expression in the SL ewes spiked at hour 6, the same hour the SL group had elevated
expression of IL-6, and peak expression of TLR4, NF-κB, IFNγ, C3, IL-10, and SOD2. TGFβ, IL-10, and
SOD2 are anti-inflammatory mediators while the others are pro-inflammatory. With regards to
inflammation at the maternal-fetal interface, the specialized immune cells in charge of regulating
implantation and maternal tolerance to the fetus can change function. Tolerogenic DCs can become
immunogenic, anti-inflammatory M2 MΦs can become pro-inflammatory M1 MΦs, uterine NKs can gain
cytotoxic functions, and Tregs can become effector T cells. The necessity of maintaining these
tolerogenic phenotypes has been demonstrated in various in vivo studies, and the balance of protein
expression and activity of the pro- versus anti-inflammatory mediators will determine if immune cells
change phenotype. Suffolk ewes having increased gene expression of IL-6 and TGFβ may mean their
Tregs and switching to Th17 cells.
Treg cell depleted mice (Aluvihare et al., 2004; Zhao et al., 2007) and abortion-prone mice
(Zenclussen et al., 2005) have demonstrated the necessity of Tregs in allogenic pregnancy to generate
maternal tolerance to paternal antigen expressed by the fetus. Treg cell derived factors are needed by DCs
for maintenance of their tolerogenic phenotype (Fiorentino et al., 1991b, Mahnke et al., 2007), by M2
MΦs, and by uterine NKs cells to maintain their non-cytotoxic phenotype (Ghiringhelli et al., 2005a).
Wegorzewska et al. (2014) exerted a local inflammatory response by injecting LPS into the fetal
liver of mice in utero and reported an increase in effector T cells (CD8+ T cells and non-Treg CD4+ T
cells) and a decrease in Treg cells in uterine tissue surrounding the resorbed fetuses (increased Teff/Treg
ratio). An increase in CD25 (α chain of the IL-2 receptor) on all of the T cell subsets may indicate
increased activation of T cells in the uterus during inflammation and/or increased proliferation. Indeed,
LPS induced inflammation in the fetus caused proliferation of both effector T cells and Treg cells with a
higher proportion of effector T cells to Tregs in uterine tissue surrounding resorbed fetuses
(Wegorzewska et al., 2014). A shift in the effector to Treg balance will result in embryonic loss due to
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loss of control over the tolerogenic uterine environment. Inflammatory mediators produced in response to
infection enter systemic circulatation. The resident immune cells in the uterus during early pregnancy can
be exposed to these circulating mediators and Suffolk ewes having a more intense inflammatory response
may expose their uterine immune cells to elevated levels of these inflammatory mediators. This would
increase the chance of the immune cells switching from a tolerogenic to immunogenic phenotype.
The transcription factor Foxp3 is the master regulator of multiple downstream pathways that
govern Treg cell function. A decrease in Foxp3 could mean that there are less Treg cells or the cells are
expressing less of the transcription factor, which will reduce their immune suppressive functions. Foxp3
expression was affected by LPS x hour causing decreases in Foxp3 expression. Suffolk ewes had
significantly less Foxp3 expression compared to Dorset ewes suggesting Tregs in Suffolk ewes have
reduced suppressive function. This is critical since infection induced dampening of Treg suppression at a
time when sustained tolerance to fetal antigen is essential, such as the peri-implantation period (Shima et
al., 2010), plays a crucial role in pregnancy loss (Rowe et al., 2012b).
Transforming growth factor β is an important regulator of inflammation. One method of action is
cross-talk with TLR4 signaling pathways leading to decreased NF-κB activation and production of PIMs.
TGFβ null mice, even in the absence of an inflammatory trigger, have increased gene expression of
TLR4, TNFα, IL-1β, and inducible NOS that can be prevented by blocking NF-κB activation. While
Suffolk ewes tended to have higher TGFβ expression and had lower TLR4 expression, they had higher
NF-κB and IL-6 expression suggesting a strong inflammatory response even with the presence of the antiinflammatory cytokine.
Interleukin-10 is an anti-inflammatory cytokine that downregulates expression of PICs and
stimulates and reinforces changes to both the innate and adaptive immune system such as inducing
regulatory phenotypes in DCs, MΦs, and T cells (Fiorentino et al., 1991a; Fiorentino et al., 1991b;
Maynard and Weaver, 2008). Interleukin-10 is involved in generating Treg cells and is produced by Tregs
to mediate some of their suppressive functions (Maynard and Weaver, 2008; Shevach, 2009; Huber et al.,
2011). This cytokine has been shown to be critical during an inflammatory response to prevent fetal loss
(Murphy et al., 1990; Robertson et al., 2007; Prins et al., 2015). Suffolk ewes had reduced IL-10
expression which probably contributes to their enhanced inflammatory response compared to Dorset
ewes. In addition, the lower IL-10 expression in Suffolk ewes may make their uterine immune cells more
susceptible to phenotype switching during inflammation, which would be detrimental to pregnancy.
Interleukin-10 and TGFβ are produced by Tregs and tDCs in the uterus to regulate fetal tolerance
and the cytokine milieu at the maternal-fetal interface (Simpson et al., 2002) regulating the
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response/phenotype of uNK cells to pathogens. While uNK cells do not display the cytotoxic functions of
their peripheral counterparts, uncontrolled or exaggerated inflammation at the maternal-fetal interface can
cause uNK cells to revert back into their peripheral NK cell phenotype and cause embryonic loss (Murphy
et al., 2005; Murphy et al., 2009; Kwak-Kim et al., 2014). Uterine NK cells with cytotoxic capability
cause apoptosis of trophoblast cells by transferring granulysin with the help of perforin (Nakashima et al.,
2008). IL-12 stimulates IFNγ production by NK cells and induces their cytotoxic activity. The PICs
TNFα, IL-1β, and IL-15 synergize with IL-12 to induce IFNγ production and IL-15 also promotes NK
cell maturation. IL-10 can regulate IFNγ production by NK cells by inhibiting IL-12 production while
TGFβ can block proliferation and cytotoxicity of NK cells as well as inhibit IFNγ and IL-12 production
(Biron et al., 1999; Eriksson et al., 2004; Eriksson et al., 2006). While Suffolk ewes tended to have higher
TGFβ gene expression, they had lower IL-10 gene expression and higher IFNγ gene expression, which
would make their uNKs vulnerable to becoming cytotoxic and killing the embryo.
Peroxisome proliferator-activator receptors (PPARs) are nuclear receptors and ligand activated
transcription factors (Dinarello, 2010; Lian et al., 2015) with anti-inflammatory functions (Clark et al.,
2000; Feige et al., 2006; Dinarello, 2010; Li et al., 2014; Lian et al., 2015) that are expressed in the ovine
endometrium (Cammas et al., 2006). Peroxisome proliferator-activator receptor agonists reduce
expression of several PICs, chemokines, and adhesion molecules and affect T cell proliferation (including
in the placenta) by interfering and inhibiting other transcription factors (Ricote et al., 1998; Clark et al.,
2000; Lappas et al., 2002; Genolet et al., 2004; Feige et al., 2006; Szanto and Nagy, 2008; Dinarello,
2010; Li et al., 2014; Lian et al., 2015). Lipopolysaccharide caused a decrease in PPARγ gene expression
in both breeds after hour 3 post treatment. Dorset ewes however, had more PPARγ expression compared
to Suffolk ewes. This also indicates Suffolk ewes will have a prolonged inflammatory response as
methods to stop the production of inflammatory mediators are dampened in this breed.
Peroxisome proliferator-activator receptors γ can inhibit gene expression and release of IL-6,
COX-2, INFγ and APPs while increasing IL-10 production (Ricote et al., 1998; Jiang et al., 1998; Jackson
et al., 1999; Takano et al., 2000; Wang et al., 2001; Genoler et al., 2004; Bensinger and Tontonoz, 2008;
Szanto and Nagy, 2008). The smaller change in PPARγ in Suffolk ewes may be associated with the larger
change in IL-6, COX2, IFNγ and SAA and smaller change in IL-10 gene expression compared to Dorset
ewes. PPARγ regulates the response of immune cells to inflammatory stimuli and influences the
polarization of Th1 versus Th2 cells (Genolet et al., 2004). The transcription factor promotes alternative
activation of MΦs (M2) by preventing MΦs from being activated in response to PIMs (M1 MΦs)
(Genoler et al., 2004; Bensinger and Tontonoz, 2008) and inhibits their response to LPS or IFNγ (Ricote
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et al., 1998). In DCs, activation of PPARγ reduces the cell’s ability to be stimulated by TLR agonists, its
capacity to stimulate T cell proliferation, and inhibits cytokines for Th1 polarization and chemokines for
Th1 cell recruitment (Faveeuw et al., 2000; Gosset et al., 2001; Appel et al., 2005). Lower PPARγ
activity in Suffolk ewes would lead to a more robust inflammatory response and, at the maternal-fetal
interface, a change in the phenotypes of immune cells followed by embryonic loss.
Mannose receptor C type 1 is expressed by MΦs and DCs to neutralize/clear pathogens and for
antigen uptake and presentation (Shepard et al., 1990; Engering et al., 1997). The receptor recognizes
complex carbohydrate structures on glycoproteins and mediates the endocytosis of glycoproteins by MΦs.
Lipopolysaccharide has been shown to decrease MRC1 activity on MΦs in vitro that could be prevented
by pre-treatment of the MΦs with dexamethasone (Shepherd et al., 1990) likely due to GCs increasing
mannose receptor synthesis (Shepherd et al., 1985). Lipopolysaccharide challenge in ewes caused a
decrease in MRC1 expression with the most change occurring in the DL group; however, there was no
breed x LPS effect. MRC1 expression may not have changed as much in the Suffolk ewes due to higher
cortisol levels in this breed (Shepherd et al., 1985; 1990). Potentially reduced expression of the receptor
by MΦs and DCs during a bacterial infection would prolong clearance of the pathogen and increase the
risk of embryonic loss.
Progesterone is a critical hormone for pregnancy (Bazer et al., 2008). There was no difference in
P4 levels between the four groups on day 8/9 or 25/26 post coitus suggesting LPS challenge did not result
in luteolysis, or ewes that were open had recycled and were back in a luteal phase. Pregnancy diagnosis
by ultrasound had significantly more ewes in the SL group being pregnant compared to the other 3
groups. However, after lambing when conception date was determined retrospectively, there was no
difference between groups on the percentage of ewes that carried a lamb(s) from the mating that occurred
during the experiment (no difference in embryonic loss). Bacterial infections are known to decrease
pregnancy rates, but this was not seen with the LPS challenge. This could be because the immune
response to the experimental LPS challenge is less than 12 hours in duration for most of the factors
measured, whereas, depending on the condition of the animal, an actual infection could last days to
weeks. So while this LPS model provides insight into the mechanisms of bacterial infection induced
embryonic loss, it may not sustain physiological changes long enough to cause a significant amount of
embryonic loss.
Small sample size potentially limited detecting differences in embryonic loss. Suffolks have
greater losses in embryos and fetuses compared to Dorset ewes (Dixon et al., 2014). As seen from the
present results, Suffolk ewes tend to have a stronger inflammatory response that could result in a change
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in the production of hormones needed to time the “window of implantation” (including P4), could damage
or cause death of the embryo, and/or change the phenotype of the local immune cells resulting in loss of
maternal-fetal tolerance. Therefore, the difference in the inflammatory response seen between the two
breeds in the present study may help explain the differences seen in pregnancy loss reported by Dixon et
al. (2014). Both breeds originated in England and gram negative bacteria are everywhere; therefore, the
differential inflammatory response between the breeds in unlikely to be due to selection pressure. Instead,
perhaps different haplotypes in TLR4 exist that make the LPS response in the Suffolk ewes more severe
(Koets et al., 2010). In using this model to mimic mastitis in the dairy cow, it is important to note that the
breeds differ in their responses. This may impact the results of a study examining ways to dampen the
inflammatory response to prevent embryonic loss; a given treatment may work better or worse in the
Suffolk breed that experiences an elevated inflammatory response or the treatment dose may need to be
adjusted. In addition, the response in one of the breeds may more closely match the response of a mastitic
dairy cow and would provide more applicable results.
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Tables
Table 10: Fold change in nuclear factor kappa B and tumor necrosis alpha gene expression to LPS or PBS in early
pregnant Dorset and Suffolk ewes. Data expressed as the fold change in gene expression using the 2 -ΔΔCt method
with GAPDH as the housekeeping gene and the reference time point being the sample collected at CIDR withdraw.
Data analyzed by repeated measures ANOVA. Mean ± SEM. Mean is the overall mean of the fold change across the
time points but analyzed with time as the repeated measure. (SL (n=16): Suffolk ewe + LPS; SP (n=16): Suffolk ewe
+ PBS; DL (n=11): Dorset ewe + LPS, DP (n=10): Dorset ewe + PBS)
Gene/Time
points
NF-κB
0, 1.5, 3, 6,
9 hrs

TNFα
0, 0.5, 1 hr

Treat
ment
Group

Mean ±
SEM

SL
SP
DL
DP

2.62 ± 0.72
2.48 ± 1.52
0.58 ± 0.14
1.45 ± 0.53

SL
SP
DL
DP

0.79 ± 0.2
0.49 ± 0.13
0.78 ± 0.14
0.53 ± 0.09

Breed
Effect
p=0.05

p=0.41

LPS
Effect

Hour
Effect

Breed x
Hour

LPS x
Hour

p=0.97

Breed x
LPS
Effect
p=0.04

p=0.43

p=0.60

p=0.18

Breed x
LPS x
Hour
p=0.18

p=0.06

p=0.67

p=0.24

p=0.66

p=0.21

p=0.14

Figures

Figure 21: Response in rectal temperature to LPS or PBS in early pregnant Dorset and Suffolk ewes. (a) Hourly
temperature: Breed p=0.0284, LPS p=0.0001, Hour p<0.0001, Breed x Hour p=0.0330, LPS x Hour p<0.0001
(b) Change in rectal temperature at hours 1-6 compared to time 0: LPS p<0.0001, LPS x Breed p=0.0314, Hour
p=0.0005, LPS x Hour p=0.0001 (SL (n=16): Suffolk ewe + LPS, SP (n=16): Suffolk ewe + PBS, DL (n=11):
Dorset ewe + LPS, DP (n=10): Dorset ewe + PBS). Data were analyzed by repeated measures ANOVA Mean ±
SEM
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Figure 22: Frequency of sickness symptoms displayed by Suffolk and Dorset ewes receiving either LPS or PBS.
Changes in behavior or noticeable sickness were noted at whole hour (hrs 0, 1, 2, 3, 4, 5, 6, 9, 12) blood sample
collection times, added up for each ewe over the 12 hours post-treatment, and averaged for each treatment group.
LPS p<0.0001, LPS x Breed p=0.0029 (SL (n=16): Suffolk ewe + LPS, SP (n=16): Suffolk ewe + PBS, DL (n=11):
Dorset ewe + LPS, DP (n=10): Dorset ewe + PBS) Data were analyzed by ANOVA. Mean ± SEM

Figure 23: Response in white blood cells to LPS or PBS in early pregnant Dorset and Suffolk ewes from hours 0-6
post treatment. LPS p<0.0001, Hour p<0.0001, LPS x Hour p<0.0001 (SL (n=16): Suffolk ewe + LPS, SP (n=16):
Suffolk ewe + PBS, DL (n=11): Dorset ewe + LPS, DP (n=10): Dorset ewe + PBS). Data were analyzed by repeated
measures ANOVA. Mean ± SEM
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Figure 24: Response in acute phase proteins to LPS or PBS in early pregnant Suffolk and Dorset ewes from 0-24
hours post treatment. (a) Haptoglobin: Breed p<0.0001, Breed x LPS p=0.0357, Hour p=0.0405 (b) Serum
Amyloid A: Breed x Hour p<0.0001, Breed x LPS x Hour p=0.0330 (SL (n=16): Suffolk ewe + LPS, SP (n=16):
Suffolk ewe + PBS, DL (n=11): Dorset ewe + LPS, DP (n=10): Dorset ewe + PBS). Data were analyzed by repeated
measures ANOVA. Mean ± SEM

Figure 25: Cortisol response to LPS or PBS in early pregnant Dorset and Suffolk ewes from 0-12 hours post
treatment. Breed p=0.0284, LPS p= 0.0029, Breed x LPS p=0.0257, Hour p<0.0001, LPS x Hour p<0.0001,
Breed x LPS x Hour p=0.0085 (SL (n=16): Suffolk ewe + LPS, SP (n=16): Suffolk ewe + PBS, DL (n=11): Dorset
ewe + LPS, DP (n=10): Dorset ewe + PBS). Data were analyzed by repeated measures ANOVA. Mean ± SEM
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Figure 26: Fold change in gene expression of pro-inflammatory factors measured in white blood cells in response
to LPS or PBS in early pregnant Suffolk and Dorset ewes. Gene Expression normalized to GAPDH and referenced
to expression levels in the sample collected at CIDR withdraw. (a) CXCL8: LPS p=0.0003, Hour p=0.0005, LPS x
Hour p=0.0142 (b) IL-6: Breed p=0.0007, Breed x LPS p=0.0024 (c) IFNγ: Breed p=0.0153 (d) TLR4: Breed
p=0.0030, LPS p=0.0036, Hour p=0.0121, LPS x Hour p=0.0105 (e) COX2: Breed p=0.0002 (f) C3: Breed
p=0.0077, LPS p=0.0028, Breed x LPS p= 0.0004, Hour p<0.0001, LPS x Hour p<0.0001 (SL (n=16): Suffolk
ewe + LPS, SP (n=16): Suffolk ewe + PBS, DL (n=11): Dorset ewe + LPS, DP (n=10): Dorset ewe + PBS) Data
were analyzed by repeated measures. ANOVA Mean ± SEM
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Figure 27: Fold change in gene expression of anti-inflammatory factors measured in white blood cells in response
to LPS or PBS in early pregnant Suffolk and Dorset ewes. Gene Expression normalized to GAPDH and referenced
to expression levels in the sample collected at CIDR withdraw. (a) MRC1: LPS p=0.0028, Hour p=0.0003 (b) IL10: Breed p=0.0448 (c) TGFβ: Breed p=0.0808, Hour p=0.0161 (d) SOD2: Breed p=0.0002, LPS p<0.0001,
Hour p=0.0001, LPS x Hour p<0.0001 (e) PPARγ: Breed p=0.0016, LPS p=0.0056, Hour p=0.0059, LPS x
Hour p=0.0054 (f) Foxp3: Breed p=0.0001, LPS x Hour p<0.0001 (SL (n=16): Suffolk ewe + LPS, SP (n=16):
Suffolk ewe + PBS, DL (n=11): Dorset ewe + LPS, DP (n=10): Dorset ewe + PBS). Data were analyzed by repeated
measures ANOVA. Mean ± SEM
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Figure 28: Plasma concentration of progesterone on day 25/26 post coitus in Dorset and Suffolk ewes administered
LPS or PBS on day 5/6 post coitus. Breed p=0.2137 LPS p=0.2739 Breed x LPS p=0.3254. Data were analyzed by
2-way ANOVA. Mean ± SEM (SL (n=16): Suffolk ewe + LPS, SP (n=16): Suffolk ewe + PBS, DL (n=11): Dorset
ewe + LPS, DP (n=10): Dorset ewe + PBS)

Figure 29: Analysis examining (a) whether a ewe was found to be pregnant or open by ultrasound on 25/26 days
post coitus (Pearson’s chi square p=0.0421) or (b) whether or not a ewe had a lamb as a result of the mating that
took place during the experiment (Pearson’s chi square p=0.0873) was contingent on experimental group. (SL
(n=16): Suffolk ewe + LPS, SP (n=16): Suffolk ewe + PBS, DL (n=11): Dorset ewe + LPS, DP (n=10): Dorset ewe
+ PBS)
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Chapter 5: Discussion
Mastitis impacts the profit of dairy producers associated with lost milk production, clinical
treatment, culling, and increased replacement animals. Bar et al. (2008), using information from five dairy
farms in New York, estimated, that lost revenue from a case of clinical mastitis at $179; milk loss ($115),
increased mortality ($14), and treatment associated costs ($50). However, as the price of milk increases,
cost due to mastitis increases due to increased profit losses. Mastitis is often caused by environmental
bacteria, such as gram negative E. coli, which induce inflammation via its cell wall component LPS. The
energy demands of lactation early postpartum put dairy cows into a state of negative energy balance that
impairs immune function, making them susceptible to infections. Dairy cows with mastitis, as well as
other diseases, can experience various reproductive issues including impaired resumption of ovulation
postpartum, compromised fertilization, impaired conceptus development, changes in expression of genes
associated with conceptus development and implantation, increased early pregnancy loss, and reduced
pregnancy per insemination. Overall, these reproductive issues increase the calving interval, which is
detrimental to profits of dairy producers. Mechanisms of how periparturient diseases lead to reproductive
issues has not been clarified (Santos and Ribeiro, 2014), but pre-implantation is known to be a critical
period for embryonic loss in lactating dairy cows (Wiltbank et al., 2016).
Binding of LPS to TLR4, initiates an immediate response involving activation of intracellular
signaling cascades and the expression of inflammatory mediators including IL-1β, TNFα, IL-6, IFNγ,
CXCL8, and PGs. During mastitis, circulating levels of TNFα, IL-1, and IL-6 can increase. Cells from
infected mammary glands have increased mRNA expression for IL-1β, TNFα, IL-10, and IL-12 and
increased TNFα protein (Riollet et al., 2001; Ślebodziński et al., 2002; Hansen et al., 2004). The
inflammatory mediators have local and systemic effects and recruit additional immune cells to the
infection site to eliminate the pathogen. These mediators can travel from the mammary gland to the
reproductive tract and influence follicle growth, oocyte quality, uterine function, embryo development,
and implantation (Turner et al., 2012).
Systemic administration of LPS to early pregnant ewes in the current studies consistently resulted
in an inflammatory response characterized by fever, increased mucosal secretions, and behavioral
changes, decreased number of circulating WBCs, increased serum Hp, activation of the HPA axis,
increased gene expression of C3, CXCL8, TLR4, and SOD2, and decreased gene expression of MRC1,
Foxp3, and PPARγ. All of these changes were expected as the animal believes it has a bacterial infection
that needs to be cleared.
Lipopolysaccharide signals through this TLR4 and LPS will activate the complement system.
Downstream of TLR4 and complement (C3) is transcription of CXCL8 that recruits neutrophils to the
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inflammatory site. As neutrophils are the first responders to pathogen invasion, increased expression of
CXCL8 and neutrophil mobilization were expected. Neutrophils use ROS to control the increase in, and
spread of bacteria, but ROS are not specific when it comes to causing damage and can have effects on
host cells. Therefore, antioxidants are secreted to convert ROS into less harmful molecules. In all three
studies, gene expression of the antioxidant, SOD2, was upregulated with LPS treatment, suggesting an
increase in ROS. Excessive ROS in the reproductive tract will damage embryonic and uterine cells. This
might be one mechanism contributing to embryonic loss caused by bacterial infections.
Lipopolysaccharide, TNFα, and IFNγ have been shown to induce NO synthase and NO inhibits
embryonic development (Athanassakis et al., 2000; Soto et al., 2003b). Thus, providing additional
antioxidants during early pregnancy might benefit reproductive success. Suffolk ewes had a reduced
change in expression of SOD2 compared to Dorset ewes, which may put their embryos at increased risk
of oxidative damage. Therefore, therapies to reduce ROS may have siginificant effects on embryonic loss
in Suffolk ewes more than Dorset ewes.
Lipopolysaccharide treatment consistently decreased PPARγ, Foxp3, and MRC1 expression.
Peroxisome proliferator-activated receptor γ is a transcription factor important for inhibiting gene
transcription of pro-inflammatory mediators such as IL-6, COX-2, INFγ, and APPs while increasing
expression of anti-inflammatory IL-10 (Ricote et al., 1998; Jiang et al., 1998, Jackson et al., 1999, Takano
et al., 2000, Wang et al., 2001, Genoler et al., 2004, Bensinger and Tontonoz, 2008, Szanto and Nagy,
2008). Forkhead box P3 is the transcription factor responsible for suppressive functions of Tregs. These
cells are responsible for the generation and maintenance of maternal tolerance to fetal antigens. A
decrease in Foxp3 expression could be due to loss of Tregs, or loss of their suppressive functions and
conversion into effector T cells in response to exposure to PICs. Changes in quantity or function of Tregs
leads to embryonic loss (Rowe et al., 2012b). Mannose receptor c type 1 is a receptor on MΦs that is a
marker for alternatively activated M2 MΦs that produce Th2 cytokines compared to classically activated,
pro-inflammatory M1 MΦs that produce PICs (Gordon and Martinez, 2010). A loss in MRC1 expression
suggests conversion of M2 to M1 MΦs and increased production of PICs. When in animal has an
infection, the goal is to clear the pathogen as soon as possible, this process is initiated with a strong
inflammatory response. A decrease in these genes, which allows for an inflammatory response, therefore,
is not unexpected. However, the inflammatory products produced and phenotype switching of immune
cells from tolerogenic to immunogenic will put the embryo at risk.
With regard to Foxp3, there was a breed effect with Suffolk ewes having less expression, which
fits with their enhanced inflammatory response. Fold change in gene expression on the experimental day
was in reference to expression on the day of CIDR withdrawal (7 to 8 days prior) in the fall experiments.
All of the Dorset ewes had an increase in Foxp3 between the two days (hour 0), but this increase did not
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occur in Suffolk ewes. Regulatory T cells increase in early pregnancy and accumulate in the uterus to
establish maternal tolerance. This also results in increased Tregs in circulation. A lower fold change in
Foxp3 expression in the Suffolk ewes at hour 0 may suggest differences in the generation of Tregs in
early pregnancy in this breed, which is likely to be associated with increased rates of embryonic loss.
No effects of LPS on gene expression of IL-6, COX2, IFNγ, or IL-10 were detected. This does
not mean a change in plasma protein levels of these mediators did not occur, however. While a change in
gene expression of TNFα was not detected, protein levels of TNFα have been shown to increase after LPS
treatment in early pregnant ewes (Graham, 2014). In addition, gene expression of NF-κB was not affected
by LPS, but this transcription factor is downstream of TLR4, which was upregulated, and it turns on
transcription of CXCL8, IL-6, IL-1β, and TNFα. Possibly, changes in gene transcription of NF-κB were
not detected because it may be rapidly translated. This transcription factor is mainly regulated by the Iκκ
protein complex that holds it in the cytoplasm until activation of signal transduction pathways cause
release of the Iκκ proteins and translocation of NF-κB into the nucleus. Graham (2014) showed elevated
TNFα protein in response to LPS in ewes; current studies showed upregulation of CXCL8 expression; IL1β and IL-6 induce the fever response through activation of PGE2 in the brain, as well as activation of the
HPA axis; and cortisol and IL-6 activate production of APPs, of which, Hp was increased in the current
studies in response to LPS. Therefore, LPS likely increased production of TNFα, IL-1β, and IL-6.
Additional studies should focus on measuring protein levels of these to get a clearer picture of the
immune response to LPS in sheep. Measurement of TNFα and IL-1β protein expression using ELISA kits
was unsuccessful. Future attempts should use radioimmunoassays instead.
Lipopolysaccharide always resulted in activation of the HPA axis and production of cortisol.
Suffolk ewes had an enhanced production of cortisol in response to LPS, as did the flaxseed fed ewes in
trial 2. Glucocorticoids have pro- and anti-inflammatory effects; they activate APP production, cause
behavioral changes, and modulate cytokine production. Effects of LPS on TNFα and IL-6 gene
expression were not detected, but protein levels of these cytokines are likely to have been increased as
they are upstream of cortisol, the temperature response, and the sickness symptoms. Glucocorticoids can
inhibit PIC production, but, associations between elevated cortisol levels and PIC concentrations were not
determined. The consistent increase in Hp by LPS treatment suggests that cortisol was acting in a proinflammatory manner, however. The increase in Hp concentrations in the LPS treated ewes agrees with
studies reporting that cows with uterine disease after parturition have increased production of Hp
(Sheldon et al., 2001). Suffolk ewes had higher concentrations of the APP. This could be due to higher
baseline levels, which could be beneficial in controlling bacterial growth, or Suffolk ewes may normally
be in a more pro-inflammatory state compared to Dorset ewes.

145

The complement system has a critical role in initiating inflammatory responses and activation of
complement is known to result in pregnancy failure (Molina, 2005; Xu et al., 2000, Mellor et al., 2001,
Mao et al., 2003; Caucheteux et al., 2003). LPS in the current studies increased expression of the
complement molecule, C3, showing that complement is involved in mediating inflammation in this LPS
model, and bacterial induced embryonic loss likely involves complement activation. LPS treated Suffolk
ewes had an enhanced increase in C3 expression, which could lead to a greater inflammatory response in
this breed. Indeed, even though Suffolk ewes had a lower expression of TLR4, they had a greater increase
in temperature, “sickness symptoms,” cortisol and Hp concentrations, and change in IL-6 and IFNγ gene
expression in response to LPS. This could be explained by increased complement activation and PIC
production downstream of complement activation. Suffolk ewes also had a reduced change in PPARγ and
Foxp3 expression, two transcription factors regulating anti-inflammatory functions, and the antiinflammatory cytokine IL-10. All of this information shows a more pro-inflammatory response in Suffolk
ewes.
Embryotrophic factors produced by the oviduct and endometrium also are often immune
modulators, including pro-inflammatory factors. Changes in the amount or temporal expression of these
factors, such as during an infection, can affect embryonic development. The enhanced inflammatory
response in Suffolk ewes will make them more susceptible to embryonic loss. Therapies that dampen the
inflammatory response, therefore, will be more cost effective in Suffolk ewes that have higher rates of
embryonic loss (Dixon et al., 2014). In addition, sheep producers may be interested in crossing the two
breeds to try to get animals with a reduced inflammatory response compared to the Suffolk breed. In
addition, studies investigating possible therapies for mastitis and reducing embryonic loss in dairy cows
should be conducted using Suffolk ewes that have an exaggerated inflammatory response to LPS.
A possible reason for the breed differences may be modifications in the LPS-TLR4 interaction
due to single nucleotide polymorphisms (SNPs) in TLR4. Susceptibility to bacterial infections in cattle
has been associated with SNPs in TLR2, which led to changes in the immune response to pathogens
(Koets et al., 2010). SNPs in TLR 2, 4, 6, and 9 have also been found in cattle but only a small effect was
found on susceptibility to uterine infection (Pinedo et al., 2013). In order to investigate this possibility,
TLR4 would need to be sequenced in the two breeds of sheep and compared
Prostaglandins are produced by COX enzymes, and LPS is known to increase production of PGE2
(Herath et al., 2009; Bromfield et al., 2015). Although no change in gene expression of COX2 in response
to LPS was detected, PGs are mainly produced in tissues and not by circulating WBCs. Again, while it is
likely that PGs were produced, measuring levels would confirm this and allow for the effects of the
flaxseed supplement and breed to be determined. Suffolk ewes did have higher expression of COX2
compared to Dorset ewes, but whether they have increased PGE2 levels should be confirmed with
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measurement of protein. PICs induce PGE2 production by brain endothelial cells. The PG then acts on the
hypothalamus to cause behavioral changes (Elenkov and Chrousos, 1999). In all 3 studies, LPS caused
noticeable discomfort in ewes, further evidence of PIC production and COX pathway activation.
“Sickness behavior” was most pronounced in the Suffolk breed, also suggestive of increased PG
production in these ewes.
Lipopolysaccharide consistently caused fever, which also is induced by PGE2 action on the
hypothalamus (Netea et al., 2000; Evans et al., 2015). The enhanced temperature increase in the Suffolk
ewes in response to LPS is likely to be a result of increased PGE2, as this breed had higher expression of
COX2. Studies investigating heat stress have shown that elevated body temperature negatively impacts
early embryonic development (Putney et al., 1988; Ealy et al., 1993), and the fever response to LPS likely
has negative effects on embryo function. In trial 1 of the supplement study, feeding flaxseed dampened
the fever response, but this was not the case in trial 2. A differential effect of flaxseed between the trials
also occurred with gene expression of IL-6, IL-8, and TLR4 where in trial 1, a flaxseed x LPS interaction
occurred with the increase in expression of the pro-inflammatory factors being dampened compared to
control fed ewes. These effects were not seen in trial 2. This could be due to a lower fat content in the
flaxseed used in trial 2, thus lower omega 3 PUFA intake. Another possiblility for the differential effects
is grass content of ω-3 PUFAs. In both the spring and fall trials, the ewes were on pasture and grass in the
spring has a higher ω-3 PUFA content than grass in the fall. Therefore, the ewes in trial 1 (spring)
probably ingested an increased amount of ω-3 PUFAs. In order to have the same anti-inflammatory
effects in trial 2 (fall) we probably needed to increase the amount of flaxseed being fed. Antiinflammatory effects of flaxseed should be investigated further by feeding different amounts of flaxseed,
for various amounts of time prior to LPS treatment, to examine if there is a threshold intake level needed
for beneficial effects on the inflammatory response. Flaxseed could reduce fever through altering the
products of the COX pathway towards more pro-resolving mediators and less inflammatory PGs (Jones et
al., 2013a, Jones et al., 2013b; Serhan et al., 2014). This could be especially important in the Suffolk ewes
because they have higher COX2 expression and, therefore, may have increased PG production compared
to Dorset ewes, therefore, possible anti-inflammatory effects of flaxseed should also be investigated in
Suffolk ewes.
In conclusion, information gained from these studies suggest gram negative bacterial infections
are likely to cause embryonic loss through the involvement of ROS, complement activation, heat damage
to the embryo, production of PGs, production of PICs, conversion of Tregs to effector T cells, conversion
of M2 to M1 MΦs, and loss of maternal tolerance to the fetus. Differences in gene expression indicate
Suffolk ewes are set up for a more rapid, intense, and prolonged inflammatory response compared to
Dorset ewes and this enhanced response was observed when LPS was administered. The information
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gained with this research can be benefical to sheep producers deciding what breeds of sheep to raise and
when making decisions about cross-breeding. In addition, knowledge of the immune response to LPS in
sheep can be used to develop therapies for use by the dairy industry to combat economic losses associated
with bacterial infections.
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Table 11: Summary of p-values across the three studies for main effects and interactions. The Benjamini
Hochberg procedure was used to control for the false discovery rate (FDR=0.10)
Variable

Experiment

LPS

Feed or
Breed

Hour

Feed or
Breed X
LPS

Feed or
Breed x
Hour

LPS x
Hour

Temperature

Supplement
Trial 1
Supplement
Trial 2
Breed

<0.001

<0.001

<0.001

0.0064

0.6540

<0.001

Feed or
Breed
X Hour
X LPS
0.2683

<0.0001

0.9942

<0.0001

0.0164

0.1445

<0.0001

0.3016

0.0001

0.0284

<0.0001

0.0879

0.0330

<0.0001

0.0862

Supplement
Trial 1
Supplement
Trial 2
Breed

<0.0001

0.0945

0.0588

<0.0001

0.0498

0.0498

<0.0001

0.3183

0.0029

Supplement
Trial 1
Supplement
Trial 2
Breed

<0.001

0.0157

0.0039

0.8608

0.4827

0.0054

0.0056

<0.0001

0.2284

0.0004

0.4034

0.5096

<0.0001

0.9275

<0.0001

0.3240

<0.0001

0.3045

0.4592

<0.0001

0.6694

Supplement
Trial 1
Supplement
Trial 2
Breed

<0.0001

<0.0001

0.0327

0.0982

0.0078

0.9681

0.2903

0.0165

0.0802

0.6804

<0.0001

0.0405

0.0357

0.2366

0.2712

0.4907

Supplement
Trial 1
Supplement
Trial 2
Breed

<0.0001

0.0216

0.4771

0.4496

0.0023

0.0552

0.1324

0.5375

0.0844

0.0848

0.3228

0.3431

0.2221

<0.0001

0.6979

0.0330

Supplement
Trial 1
Supplement
Trial 2
Breed

<0.001

0.0468

<0.0001

0.0235

<0.0001

0.0007

0.1750

<0.0001

0.0105

0.0029

0.0284

<0.0001

0.0257

0.1262

<0.0001

0.0085

Symptoms

WBCs

Haptoglobin

Serum
Amyloid A

Cortisol

Gene expression of pro-inflammatory factors
C3
Supplement 0.0065
0.2651
Trial 1
Supplement 0.0107
0.0041
Trial 2
Breed
0.0028
0.0077

<0.0001

<0.001

0.8277

0.1020
<0.0001

0.2770

0.8603

<0.0001

0.7626

<0.0001

0.0004

0.3877

<0.0001

0.5603
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Variable

Experiment

LPS

Feed or
Breed

COX2

Supplement
Trial 1
Supplement
Trial 2
Breed

0.1469

0.2671

0.1497

0.3335

0.0119

0.2874

0.0002

0.7742

Supplement
Trial 1
Supplement
Trial 2
Breed

0.0024

0.3768

0.2852

0.7478

0.1325

0.9118

0.0153

0.4470

Supplement
Trial 1
Supplement
Trial 2
Breed

0.3356

0.3186

0.2174

0.2738

0.6169

0.5316

0.0007

0.7256

Supplement
Trial 1
Supplement
Trial 2
Breed

<0.0001

0.0486

0.0160

0.3185

0.1215

0.0003

0.5996

0.0005

Supplement
Trial 1
Supplement
Trial 2
Breed

0.4731

0.90

0.6009

0.2375

0.5398

0.9684

0.0518

0.4320

Supplement
Trial 1
Supplement
Trial 2
Breed

<0.0001

0.0484

0.0002

0.5209

0.2734

0.0036

0.0030

0.0121

Supplement
Trial 1
Supplement
Trial 2
Breed

0.3482

0.5703

0.6070

0.1603

0.2229

0.0608

0.4093

0.2390

IFNγ

IL-6

IL-8

NF-κB

TLR4

TNFα

Gene expression of anti-inflammatory factors
Foxp3
Supplement 0.0259
0.8934
Trial 1
Supplement 0.1249
0.4214
Trial 2
Breed
0.2861
0.0001

Hour

Feed or
Breed x
LPS

Feed or
Breed x
Hour

LPS x
Hour

Feed or
Breed x
Hour x
LPS

0.7254

0.6789

0.1702

0.0262

0.1441

0.8189

0.9809

0.5316

0.5615

0.9550

0.5091

0.5203

0.6391

0.5154

0.1554

0.1996

0.9012

0.7886

0.4452

0.8527

0.0024

0.9561

0.7193

0.8528

0.3238

0.3742

0.0990

0.2952

0.4210

0.8304

0.0142

0.6080

0.9022

0.5339

0.4623

0.0563

0.0443

0.6027

0.1815

0.1836

0.0496

0.2734

<0.0001

0.1865

0.0608

0.0572

0.0105

0.9920

0.7149

0.7932

0.2600

0.2130

0.6700

0.6566

0.2085

0.1443

0.1748

0.8616

0.0296

0.027

0.1283

0.0326

0.3482

0.2878
0.2116

0.0914

0.0956

0.0242

0.4022

0.2819

0.5833

0.4560

<0.0001

0.9459
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Variable

Experiment

LPS

Feed or
Breed

IL-10

Supplement
Trial 1
Supplement
Trial 2
Breed

0.4274

0.0813

0.2788

0.9603

0.0646

0.1459

0.0448

0.3033

Supplement
Trial 1
Supplement
Trial 2
Breed

<0.0001

0.8170

0.0118

0.3273

0.0004

0.0028

0.5054

0.0003

Supplement
Trial 1
Supplement
Trial 2
Breed

0.1696

0.4523

0.0014

0.2355

0.0436

0.0056

0.0016

0.0059

Supplement
Trial 1
Supplement
Trial 2
Breed

<0.0001

0.8022

<0.0001

0.0779

<0.0001

<0.0001

0.0002

0.1503

MRC1

PPARγ

SOD2

TGFβ

P4 25/26 dpc

Supplement
Trial 1
Supplement
Trial 2
Breed
Supplement
Trial 1
Supplement
Trial 2
Breed

Hour

Feed or
Breed x
LPS

Feed or
Breed x
Hour

LPS x
Hour

Feed or
Breed x
LPS x
Hour

0.8639

0.9854

0.3456

0.3585

0.7898

0.2340

0.8370

0.6515

0.9326

0.9950

0.0091

0.9807

0.5817

0.3018

0.1294

0.9159

0.9671

0.7764

0.6366

0.6932

0.1483

0.9956

0.0054

0.5925

0.0226

0.2068

<0.0001

0.1794

0.0001

0.3674

0.4452

<0.0001

0.5132

0.1003

0.0117

0.2196

0.8771

0.0691

0.2573

0.4916

0.0808

0.0161

0.5908

0.0144

0.1860

0.5186

0.6854

0.0752

0.2026

0.8523

0.4303

0.1766

0.2739

0.2137

0.3254

0.8777

0.6190

0.0702

0.7071
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